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ABSTRACT
New and improved methods for introducing radioisotopic hydrogen (tritium) and carbon 
(positron-emitting short-lived carbon-11, ty2 = 20.4 min) into organic molecules for 
application in biological research have been explored.
In Chapter 1 the applications of radioactive isotopes in biological and clinical 
research is surveyed, with particular emphasis on the value of p-emitting tritium and 
positron-emitting carbon-11.
In Chapter 2 we report the use of the non-radioactive hydrogen isotope, deuterium, 
as a surrogate for tritium in the development of microwave-enhanced labelling 
procedures, based on catalytic hydrogen transfer to olefins (e.g. styrene, styrene 
derivatives, cinnamic acid and its derivatives). Hydrogen or deuterium donors (e.g. 
formate salts) were used alone or in combination with other sources (e.g. D20). The 
method was found to give fully hydrogenated products using very short microwave 
irradiation times (~ 2 min) and was highly reproducible. Importantly, the method is 
environmentally clean, as when extended to tritiated formates little or no radioactive waste 
is produced.
In Chapter 3 we explored the labelling of CGP 62349 {3-[l-(i?)-[3-(4- 
methoxybenzyl)phosphinyl-2-(iS)-hydroxy-propyl-amino]ethyl]benzoic acid}, a y- 
aminobutyric acid type B (GABAb) receptor antagonist, with carbon-11 in order to 
provide a prospective radioligand for medical imaging with positron emission tomography 
(PET). Labelling agents, [n C]iodomethane and [n C]methyl triflate, prepared by 
improved methods, were used in the rapid methylation of desmethyl-CGP 62349. 
Substantially higher radiochemical yields (78%) of [n C]CGP 62349 were achieved by the 
new methods compared to that produced in a previously published procedure (9%). In 
addition, the use of [n C]methyl triflate rather than [n C]iodomethane has the advantage of 
giving a high radiochemical yield and a lower amount of carrier.
In Chapter 4 we report on the use of [n C]carbon monoxide as a labelling agent. 
This has been done in two ways, namely by investigating, (i) the direct insertion of the 
carbonyl group into amines and (ii) by the palladium(II)-mediated cross coupling 
carbonylations of organostannanes with either aryl iodides or diaryliodonium salts. 
[n C]Carbon monoxide insertion into lithiated amines was found to be impractical. 
Palladium(II)-mediated cross coupling u C-carbonylation was found to provide an 
efficient means to label substituted benzophenones. High radiochemical yields were 
achieved under very mild reaction conditions and in short reaction times (1 min). When 
various substituted diaryliodonium salts were used to partner phenyltributylstannane, the 
expected [n C]ketones were produced in moderate radiochemical yields (30 -  43%). By 
the use of variously substituted arylstannanes with diphenyliodonium bromide, several 
[n C]ketones were rapidly synthesised in exceptionally high radiochemical yields (typically 
98%).
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ABBREVIATIONS
Bq Becquerel (radiation unit); it is the radioactivity of a nuclide decaying at a rate, 
on average, of one spontaneous nuclear transition per second (1 Bq = 1 s-1)
c Velocity of light in meters per second
°C Temperature unit (Centigrade)
CA Carrier added
CDCI3 Deuteriated chloroform
CF Carrier free
CHCI3 Chloroform
Ci Curie (radiation unit); 1 Ci = 3.7 x 1010 Bq.
Cmpd. Compound
D Deuterium
DME 1,2-Dimethoxy ethane
DMF V,V-Dimethyl formamide
DMSO Dimethyl sulfoxide
DPM Disintegration per minute
E Energy in Joules
EOB End of bombardment
Exp. Experiment
Fig. Figure
GABA y-Amino-ft-butyric acid
GC Gas chromatography
HI Hydroiodic acid
HMDS Hexamethyldisilazane
HPLC High performance liquid chromatography
Kd The equilibrium dissociation constant
Ki Inhibition constant
m Mass in kilograms
mg Weight unit (milligram)
min Time unit (minute)
ml Volume unit (millilitre)
M Molar
MS Mass spectrometry
MW Microwave
NCA No carrier added
NMP TV-Methylpiperidine-2-one
NMR Nuclear magnetic resonance
Pd/C Palladium on charcoal
PdCl2 Palladium(II) chloride
PDC Phthaloyl dichloride
PET Positron emission tomography
PLC Programmable logic control
PPM Part per million
PPO 2,5-Diphenyloxazole
t\/2 Half-life
T Tritium
THF Tetrahydrofuran
THIQ 1,2,3,4-T etrahydroisoquinoline
TLC Thin layer chromatography
TMEDA Tetramethylethylenediamine
TMS Tetramethylsilane
Tos Tosylate
Vol. Volume
Wt. Weight
Symbols
a  Has two meaning in this thesis (i) as a particle called alpha as in Chapter 1 or
(ii) as a chemical position as in Chapter 2,
P a
C6H5CH = CR2
P Chemical position as in Chapter 2, see above
p+ Particle called positron = e+
P" Beta particle = e~
y Gamma ray radiation
e Electron
v Neutrino
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Isotopes of Hydrogen and Carbon as 
Labels in Biological and Clinical
Research
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Chapter 1 Isotopes of Hydrogen and Carbon as Labels in Biological and Clinical Research
1.1 Isotopes
Isotopes of an element are nuclides with the same atomic number (number of protons, Z) 
as the parent nuclide but with a different mass number (number of protons and neutrons, 
A) to the parent nuclide. Consequently, the electronic structure is unchanged and this 
means that they share a common chemistry. Isotopes are of two kinds: stable and 
radioactive. Radioisotopes emit different kinds of radiation, and these have valuable 
properties: (i) they can be detected and measured with very great sensitivity, so that 
minute traces of material can be studied; (ii) the radiations are characteristic of the atoms 
from which they arise, so they can be used for identification and (iii) y-rays can penetrate 
matter which enables one to obtain information about the material inside an animal or 
human body. The use of isotopes, either stable or radioactive, constitutes one of the most 
important techniques for the investigation of bio-mechanisms and physiology, both in 
vitro and in vivo.
The tracer method is based on the principle that isotopes of the same element are 
virtually identical in their chemistry. Radiotracers obtained through the process of 
radiolabelling1, are widely used in the investigation of phenomena such as enzymatic 
transformations, protein synthesis and metabolism; in addition they are used as diagnostic 
aids in clinical biochemistry. The fate of any given compound in an organism or biological 
process can be determined by introducing an easily detectable radiotracer; the rate of a 
process can be measured by following the incorporation of a radioisotope into a particular 
product as a function of time. However, one must remember that a labelled molecule is 
only a good tracer if it does not perturb the biological system it is intended to measure. 
Furthermore, radioisotopes can be used as internal standards for measuring the efficiency 
of extraction of compounds from biological material2.
Most of the human body consists of compounds of hydrogen, carbon, nitrogen and 
oxygen. Isotopes of these elements, both radioactive and stable, have been used to study 
and understand human biochemistiy, pharmacology and molecular biology so 
encompassing the whole biomedical field.
2
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Radioisotopes are produced using nuclear reactions. Radioactive decay occurs via, 
(i) emission of a charged particle such as a-particle, P“-particle or positron (J3+) and/or (ii) 
y-radiation. These various types of radiations have different penetration abilities in tissue, 
those of the first group being lower. Radioisotopes have found more widespread use than 
their stable counterparts, due to their greater availability, coupled to the sensitive 
analytical techniques that are available and consequently ease of detection2,3. Therefore, 
radiolabelled compounds are preferred to compounds labelled with stable isotopes in many 
research applications, such as for the elucidation of the metabolic fate of compounds that 
are of interest to the pharmaceutical industry4,5.
The value of the specific radioactivity, usually refered to as specific activity, 
describes how far the compound can be diluted with the same unlabelled compound -  the 
latter is called a carrier. Three terms are used in this context: carrier-free (CF) refers to 
the situation where no known dilution has taken place, whilst no-carrier-added (NCA) 
refers to the situation where no carrier has been intentionally added during the preparation. 
The third category, carrier-added (CA) refers to the state where a known amount of 
carrier has been added to the labelled compound.
The position of the label can have a significant effect on the utility of the labelled 
compound. Before labelling a new compound, it is necessary to consider which is the 
simplest synthetic method. The label should be incorporated at the final stage of the 
synthesis, if at all possible. There must also be an appreciation as to how chemically and 
metabolically stable the isotope is likely to be at the selected site.
1.2 Hydrogen Isotopes
Hydrogen, has three isotopes, two of which are stable, protium (1H) and deuterium or 
heavy hydrogen (2H), whilst the third, tritium (3H) is radioactive6.
1.2.1 Protium ^H)
This isotope has by far the highest natural abundance (99.984%).
3
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1.2.2 Deuterium (2H or D)
Deuterium (2H or D), which has a natural abundance of ~ 0.015%7 was discovered in 
1931 by Urey8,9 and was soon used by Lewis10 to prepare D20. Its use in labelling studies 
was first reported for fatty acid metabolism11. It has been extensively used for advancing 
our knowledge of reaction kinetics and mechanisms. Since it is stable, deuterium has been 
used in various clinical investigations e.g. as in the case of deuteriated steroids to study 
bile acid metabolism12. The use of deuterium provides the chemist with a convenient 
method for developing and improving radiosyntheses with tritium, as the chemistry of the 
hydrogen isotopes is virtually identical.
1.2.3 Tritium (3H or T)
Tritium (3H or T) is a radioactive isotope (ty2 = 12.3 y)13 with a natural abundance
< 10“16%. It is produced in a nuclear reactor by the bombardment of lithium (usually as 
the carbonate) with thermal neutrons (Figure 1.1). It decays through the emission of a 
low energy p~-particle (Table 1.1).
36Li +  Jn  ► jH  +  jH e (a)
’H -------------------------------------------- ► ,H e +  _,V (b)
Fig. 1.1: Tritium production and decay process.
P~-Particles travel only a short distance in tissue (particles with 3 MeV energy travel
< 1.5 cm) before being absorbed3. Such p_-emitters are therefore inappropriate for 
medical imaging. Compounds labelled with p~-emitters are however useful for 
autoradiographic studies e.g. measuring uptake of tritiated compounds in tissue slices post 
mortem. Tritium by now the most widely used radionuclide in biology.
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The special properties of tritium that make it such a useful isotope are summarised in 
Table 1.1. It is one of the least expensive radioisotopes and its long half-life makes it very 
suitable as a radioactive label. The many uses of tritiated compounds have been widely 
reviewed6,8,13,14. Because they can be prepared at very high specific radioactivity they can 
be used in drug metabolism and receptor binding studies5,15. In addition, the tritiated 
compounds can be measured by liquid scintillation counting2,3. The positions labelled can 
be determined by tritium NMR spectroscopy16.
Table 1.1: Some important properties of tritium6.
Production 6Li(n, oc)3H
Radiation p“ (100 %)
Half-life 12.3 y
Decay constant 1.8 x 10'9 s'1
Max p“ energy 18.6 keV
Mean |3~ energy 5.7 keV
Maximum specific activity (per site) 29.1 Ci/mmol
Volume of 1 Ci of tritium gas under
standard conditions 0.385 ml
1.3 Procedures for Labelling Compounds with Deuterium or Tritium
Hydrogen isotopes can be incorporated into organic compounds by synthetic and non­
synthetic methods. In the synthetic methods, the hydrogen isotope is incorporated into the 
precursor by, for example, catalytic dehalogenation or catalytic reduction to yield the 
desired labelled product. These procedures can be performed to give almost carrier-free 
products. In non-synthetic methods, the incorporation can be achieved directly by 
catalytic exchange or radiation-induced exchange. Such exchange processes result in 
products of low specific radioactivity17.
5
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1.3.1 Direct Chemical Synthesis
Direct chemical synthesis can be achieved by reduction with metal tritides18, catalytic 
hydrogenation19 (unsaturated compounds), catalytic halogen-tritium replacement or 
methylation e.g. with tritiated iodomethane. These reactions are employed when tritium 
labelled compounds are required at very high specific radioactivity.
1.3.1.1 Reduction of Unsaturated Compounds
The catalytic hydrogenation of unsaturated organic compounds constitutes one of the 
most important reduction methods, and is therefore widely used in organic synthesis and 
for labelling compounds with 2H and 3H. It involves reacting the substrate and the gas 
(deuterium or tritium) on a gas line in the presence of a metal or metal oxide catalyst14. 
An example is the addition of 2H2 or 3H2 across a C=C double bond as in Fig. 1.2. Other 
groups such as COOH, CHO, COR, COOR or CN can also be reduced20.
* T T
R C H = C H R ’ „  , 2-----► RCH*H— CH*HR'
Catalyst
H2 is either 2H2 or 3H2.
Fig. 1.2: Addition of deuterium or tritium across a C=C double bond.
1.3.1.2 Catalytic Halogen-Hydrogen Replacement
This method involves the replacement of a halogen atom such as Cl or Br in an organic 
compound by a hydrogen isotope such as tritium under catalytic conditions, similar to 
those used in hydrogenation reactions. In order to incorporate most of the tritium into the 
desired product, the generated tritium halide has to be neutralised by a small amount of 
base, such as hydroxide or triethylamine. Another problem that may be caused by the 
tritium halide is poisoning of the catalyst21.
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RX + T2 > TX + RT
TX + OH ------ ► THO + X X = Cl, Br
or
TX + Et3N ------ ► Et3N+T + X'
Fig. 1.3 : The halogen-tritium replacement process.
1.3.1.3 Reduction with Metal Hydrides
Tritiated products can also be prepared by reducing unsaturated groups, other than 
carbon-carbon bonds, with tritiated reducing agents. Most widely used are the metal
aluminium tritide. This method gives specific labelling -  the tritium atoms are located only 
on the carbon atom forming the unsaturated group. The reduction of acids, aldehydes,
Fig. 1.4: Reduction of acids and ketones with tritiated borane-THF complex. 
1.3.1.4 Methylation Reactions
Biologically active molecules frequently contain a methyl group often bonded to a 
heteroatom. Therefore, it is often useful to have radiotracers in which these methyl 
groups are enriched with hydrogen isotopes, especially tritium, at high specific 
radioactivity. Thus, methylation represents one of the most important and most widely 
used methods for labelling organic compounds with hydrogen isotopes.
tritides or mixed metal hydrides, such as sodium or lithium borotritides and lithium
ketones, amides and nitriles have been performed using a tritiated borane-THF complex as 
illustrated in Fig. 1.422. Lithium borotritide has also been used as a reducing agent in the 
reduction of an aldehyde23.
R-COCH3
R-COOH
> R-C3HOH-CH3
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Methylation consists usually of adding labelled iodomethane (prepared separately) to 
a solution of the des-methyl precursor24. Preparing tritiated iodomethane of high specific 
radioactivity is usually achieved with tritium gas (Fig. 1.5)25.
Ain r o
BuLi + T ------ ► LiT 3 ► LiAlT. — ^ ---- ► C T Ji HI
Fig. 1.5: Preparation of tritium-labelled iodomethane.
Methylation has been used to prepare tritiated receptor radioligands e.g. |7V-C3H3]- 
trans-(\R,3S)-(-)-1 -phenyl-3-A^A^-dimethylamino- 1,2,3,4-tetrahydronaphthalene, (tritiated 
(1R,3iS)-(-)-H2-PAT)26 (Fig. 1.6). Peptides have also been tritiated by methylation25. For 
example, tritiated iodomethane was used to label a fibrinogen receptor antagonist SK&F 
107260. In another example the [3H]iodomethane was introduced into the organic 
molecule in the middle step of a synthetic procedure27.
H H
C H 3 c 3h ,i
>
Methanol
N /
\
C 3H3
CH,
Fig. 1.6: Synthesis of tritiated ( li?,3*S)-(-)-H2-P  AT.
1.3.2 Catalytic Hydrogen Isotope Exchange Reactions
Hydrogen isotope exchange is widely utilised to introduce deuterium or tritium into 
organic compounds. The procedure involves using a tritium donor (e.g. T2 gas or tritiated 
water), catalyst such as acids, bases, or metals (homogeneous or heterogeneous) and 
solvent. The reaction is illustrated in Fig. 1.7, taking tritium as an example28.
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AT + BH < .......* AH + BT
Fig. 1.7: The hydrogen isotope exchange process
However, most of the exchange reactions require high temperatures and long times 
although the reaction time may be reduced through the use of microwave irradiation29. 
Hydrogen isotope exchange reactions are of two main types:
1.3.2.1 Hydrogen Isotope Exchange Reactions with Tritium Gas
One approach, developed by Wilzbach30, is to expose the organic compound to tritium gas 
at virtually 100% isotopic abundance. This is a radiation-induced method having two 
main disadvantages: (i) difficulties in purifying the labelled compound and (ii) the low 
specific radioactivity of the product. A more useful exchange method using tritium gas 
was developed by Evans and co-workers31. This method is performed by stirring the 
organic compound in the presence of a metal hydrogen transfer catalyst, such as platinum 
or palladium.
1.3.2.2 Hydrogen Isotope Exchange Reactions with Tritiated Solvents
This method is based on the exposure of the compound to a tritiated solvent such as 
water, acetic acid, or trifluoroacetic acid. The reactions are acid-catalysed. The method 
has the advantage of eliminating undesirable hydrogenation reactions that often occur 
when using a gaseous tritium source in the presence of palladium or platinum catalysts32. 
The method is classified according to the type of catalyst that is used, as follows28,33.
1.3.2.2.1 Acid-catalysed exchange method
This is very useful with aromatic compounds and is performed by protonating the organic 
molecule with a strong acid in the presence of tritiated solvent. Acid catalysts alone or 
supported on a polymer (such as Dowex-50-X8, Amberlyst 15 or 1010 and Nafion) were 
used in tritium exchange studies; the reactions proceed through an electrophilic
9
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substitution mechanism34. The acid-catalysed exchange of an aromatic proton can be 
illustrated as follows28:
ArH + *HA Ar*H + HA
H is either 2H or 3H.
Fig. 1.8 : Acid-catalysed hydrogen isotope exchange of an aromatic hydrogen.
1.3.2.2.2 Base-catalysed exchange method
This reaction is usually performed in a strongly basic medium where the organic 
compound forms a carbanion as an intermediate and the latter can withdraw a triton from 
a tritiated solvent. Polymer-supported basic catalysts, such as Amberlite 402, and 
Amberlyst A26, have found use in this type of exchange reaction35. The exchange is 
illustrated in Fig. 1.928.
\  \  -—  c — H + B — C + BH
- ^ C  + HTO  ► - ^ C — T + OH
Fig. 1.9: Base-catalysed hydrogen isotope exchange.
1.3.2.2.3 Homogeneous metal-catalysed exchange method
Usually the catalyst here is a metal or a metal salt, such as Na2PtCl4 , Na3lrCl6 , RuC13, or 
RhCh. The latter has been successfully used to prepare a large number of deuteriated or 
tritiated aromatic drugs36, labelled regiospecifically ortho to many functional groups such 
as carboxyl37-39, amide38,39, aralkylamine38,39 and anilide40, Fig’s 1.10-11.
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Fig. 1.10: Labelled pentamidine36.
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Fig. 1.11: Selective ortho labelling in benzoic acid using RI1CI339.
1.3.2.2.4 Heterogeneous metal-catalysed exchange method
In this method, most of the transition metals in Group VIII can be used as hydrogen 
transfer catalysts, either in supported or unsupported forms. They include Pt, Pd, Ni, Ru, 
Ir and Rh. The isotope label reacts with the metal in the following manner28:
D2 + 2Pt 
D20  + 2Pt
Fig. 1.12: Catalyst-donor interaction.
D
2Pt
D
I
Pt
OD
I
Pt
The heterogeneous metal-catalysed isotope exchange is performed through one of 
two mechanisms -  classical and 7t-complex; each can be divided into dissociative and 
associative exchange mechanism28.
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1.4 Carbon Isotopes
Carbon has several isotopes e.g. 10C, n C, 12C, 13C and 14C of which only 12C and 13C are 
non-radioactive. UC, 13C and 14C are the most frequently used trace isotopes. Many 
instances of their use in clinical research5,41 have been reported.
1.5 Procedures for Labelling Compounds with Carbon Isotopes
1.5.1 Carbon-13
The non-radioactive carbon-13 occurs at 1.10% natural abundance. It is enriched by the 
cryogenic distillation of carbon monoxide42. However, carbon-13 can also be enriched by 
chemical exchange reactions that involve carbon dioxide or cyanide43. Many 13C-labelled 
compounds enriched to 60 atom % or more are commercially available.
’ Carbon-13, being non-radioactive, does not suffer from the hazards associated with 
radioisotopes and is relatively cheap. It is sometimes used as a supplementary isotope to 
carbon-14. An example of the latter case is in breath tests, where the release of 
[14C]carbon dioxide samples in large numbers into the atmosphere is not acceptable12. 
Most of the intermediate compounds labelled with 13C start from [13C]carbon monoxide. 
13C-Labelled compounds such as [13C]tyrosine, have been used to measure protein
44turnover in man .
Carbon-13 also finds application in 13C NMR spectroscopy which is a powerful tool 
for structure determination42. 13C Has a magnetic moment (spin = Vi) that is ideal for 
NMR studies.
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1.5.2 Carbon-14
The radioisotope 14C is a ^"-emitter with a half-life of 5730 y. In the upper atmosphere it 
is formed by neutron bombardment of nitrogen (Fig. 1.13).
>  +  > ---------------------------► uf  + ; P
*jc  ► >  + p~
Fig. 1.13: Carbon-14 production and decay process.
Commercially 14C is produced in a nuclear reactor by bombardment of a nitrogen- 
containing material such as Be3N2 , with neutrons. The most common 14C reagents are 
[14C]carbon dioxide, [14C]barium carbonate, [14C]sodium cyanide and [14C]iodomethane45. 
As a tracer, 14C can in principle, be incorporated into the carbon skeleton of many organic 
compounds with the advantage that these are generally metabolically stable positions45. 
Unfortunately 14C has a nuclear spin of zero and is therefore NMR inactive. Furthermore, 
the long half-life means that the maximum specific radioactivity is not as high as for 
shorter-lived radioisotopes such as 3H.
1.5.3 Production of C - l l  and Its Derived Labelling Agents
Carbon-11 is a positron-emitter (I13+ = 100%; E13+ = 0.96 MeV) with a short half-life (tm 
= 20.4 min) so that it can be used safely in humans. Carbon-11 is produced in a cyclotron 
which obviously must be located close to the site of use. Production involves 
bombardment of nitrogen with protons, to enact the 14N(p,a)u C reaction. When the 
nitrogen is doped with 0.1% oxygen the n C is produced as [n C]carbon dioxide46, whereas 
if 5% hydrogen is present the product is [u C]methane47. Both production procedures are 
discussed in Chapter 3 (Sections 3.3.4.1 and 3.3.4.2). From the former procedure high 
specific radioactivities (> 2 Ci/fimol) are produced.
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The theoretical maximum specific radioactivity for carbon-11 is 3.4 x 105 
GBq/jjmol. However, in practice, the maximum specific radioactivity is seldom achieved 
since it is very difficult to exclude all dilution effects. For example, in the production of 
[u C]carbon dioxide and its subsequent conversion into other compounds such as 
[n C]iodomethane, traces of stable carbon dioxide either from the target, or the 
experimental set-up or reagents are unavoidably introduced. Consequently, [n C]tracers 
are typically prepared with a specific radioactivity in the range 37 -  555 GBq/pmol. This 
diluted specific radioactivity is however more than sufficient for preparing effective 
neurotransmitter receptor radioligands (typically 1 -1 0 0  GBq/p.mol).
Virtually all the known primary and secondary n C-labelling agents are derived from 
cyclotron-produced [n C]carbon dioxide or [n C]methane (Fig. 1.14). The production of 
[n C]carbon dioxide will be discussed in more detail in Chapter 3 (Section 3.3.4.1). 
[n C]Carbon dioxide can be used directly for the photosynthesis of [n C]sugars48. 
However its application is mainly through reactions with Grignard reagents to form 
Arn C02MgX or Rn C02MgX and organo-lithium compounds to form [n C]carboxylate 
salts such as Me2n C 02Li and Me2n C(OLi)2. [n C]Carbon monoxide can also be produced 
by reduction of [n C]carbon dioxide on a metal; the procedure is discussed in more detail 
in Chapter 4 (Section 4.3.5). [n C]Methanol can be produced from [n C]carbon dioxide by 
treating the latter with lithium aluminium hydride, followed by hydrolysis with water or t-  
butoxy-2-ethoxy ethanol49. [n C]Iodomethane is the most widely used 1 ^ -labelling agent 
and more details concerning its preparation and reactions together with alternative 
[n C]methylation agents are discussed in Chapter 3 (Section 3.1.3).
[n C]Methane can be produced via catalytic reduction of [n C]carbon dioxide over a 
supported nickel catalyst in a hydrogen atmosphere47. [n C]Methane is not very useful 
itself and is usually converted into other labelling agents. An important example is the 
preparation of [n C]hydrogen cyanide which is produced from reacting [n C]methane with 
ammonia over a platinum catalyst47,50. Adsorbing the latter on a cobalt oxide/ceramic bed 
and subsequent heating result in the formation of [n C]carbon dioxide51. [n C]Methane 
can also be chlorinated to give [nC]carbon tetrachloride which can then be catalytically
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oxidized over iron filings to [nC]phosgene52. Catalytic chlorination of [nC]methane on 
pumice stone, impregnated with cupric chloride, gives [n C]chloroform53.
The remarkable feature about Fig. 1.14 is the wide range of simple, yet important, 
compounds that can be synthesised from [n C]carbon dioxide and [n C]methane. From 
such key intermediates, more complex compounds such as [n C]amino acids54, sugars48 
and fatty acids55 can be readily synthesised as well as many [n C]-labelled 
radiopharmaceuticals.
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Me, CO
- Rn CH2I  ►R11CH2N 0 2
------------------► RCHn CH2
c.Pr n CH2Br -*>c. Prn CH2I
CO►
CH-►
C.HqSO, CH
CH,NCO
COCL
Fig. 1.14: [nC]Labelling Agents Derived From Cyclotron-Produced [n C]Carbon
Dioxide and [nC]Methane53,56-61.
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1.6 The Importance of PET in Biological and Clinical Research
Positron emission tomography (PET) is a non-invasive technique for the quantitative 
external detection of positron-emitters in vivo, in other words it gives the exact value of 
the radiotracer concentration in vivo.
The distribution of positron-emitting tracers within various organs of the body after 
their intravenous injection can be imaged quantitatively through the use of PET. PET 
imaging can provide, for example, measurements of blood flow49,62-64, oxygen utilisation64- 
66, blood volume65, glucose metabolism67,68 and receptor radioligand interactions69. Also it 
is an important tool for the pharmaceutical industry in drug development. Labelling of the 
drug with a positron-emitter for PET facilitates pharmacokinetic studies. PET may also 
measure the effects of the drug on regional metabolism (such as that of glucose67,68, 
water70 and oxygen64,71-73), receptor occupancy74-77, or substrate transport78,79.
The rational choice of compounds for labelling with positron-emitters requires an 
understanding of some of the limitations of PET for providing biochemical measurements. 
The metabolism of the radiotracer must usually be understood to allow a suitable bio- 
mathematical model to be utilised so that primary PET data can be converted into 
meaningful information80.
1.6.1 The Principles of PET
The PET technique involves the placing of a number of gamma-ray detectors around the 
body of the patient to measure the y-emissions from an injected or inhaled positron- 
emitting radiotracer53. The number, size and orientation of the detectors are set to 
optimise the resolution of the sampling of the radiation emissions from all around the 
body. Computer reconstruction techniques are then used to produce an image of the 
radioactivity distribution throughout that part of the patient under study81. The 
quantitative power of this technique stems from the physical characteristics of positron 
emission and annihilation.
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The decay of carbon-11 provides an example of a positron emission process82. The 
unstable neutron-deficient, n C nucleus, emits a positron ((3"), a particle with the same rest 
mass as an electron but with a positive charge; in fact it is the anti-matter equivalent of an 
electron and a neutrino (v), and in the process decays to stable nB. The positron travels a 
short distance in tissue (maximally a few millimetres dependent on its kinetic energy and 
tissue density)83, colliding with surrounding electrons (e ) and gradually losing energy, 
before combining with an electron to form positronium, a transient particle-like structure 
({3 + e ). Almost instantaneously, the positronium annihilates, forming two y-rays with 
equal energy (511 keV) emitted at 180° to each other -  to conserve near zero momentum. 
The sum of the energies of the two y-rays (1.022 MeV) corresponds to the rest mass of 
the two particles according to E = me2. It is these y-rays that are detected by the PET 
camera and used to localize the positron-emitter, see Fig. 1.15.
✓
^  Proton 
&  Neutron 
O  Positron (0+) 
O  Electron (e") 
# Neutrino(o)
* o
11B
Unstable nucleus 
e-g- ( “ C )
T-ray
511 keV  
A
Positronium
r-ray  
511 keV
Fig. 1.15: The positronium annihilation process.
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The principle underlying PET is external coincidence detection (or electronic 
collimation) (Fig. 1.16) of the opposed pair o f y-rays as they simultaneously emerge from 
the subject82. It is this coincidence detection that gives PET the ability to locate and 
quantify the distribution of picomolar concentrations of the radiotracer under 
investigation. A major advantage for clinical investigations, using short-lived positron- 
emitting nuclides, is that there is a low radiation dose exposure to the patient in each 
experiment and hence multiple experiments within short time intervals can be performed.
Fig. 1.16: The coincidence detection process from a subject in a PET camera.
T$ie use of the PET procedure involves several steps: (i) the labelling of a tracer with 
a positron-emitter in sufficiently high specific radioactivities, (ii) the use of a camera that 
provides quantitative images of transverse sections of an organ with high sensitivity, good 
spatial and temporal resolution and great accuracy, (iii) the development of 
biomathematical models that translate radioactive concentration values into physiological 
binding parameters such as receptor density and equilibrium dissociation constants.
PET cameras usually use scintillation detectors which consist of crystals capable of 
emitting a flash of light when struck by ionizing radiation. A modern PET camera uses
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bismuth germanate (BGO) detectors that have a coincidence resolving time of slightly 
over 20 ns. The crystals are interfaced to photomultiplier tubes, placed on opposite sides 
of the radiation source, with the result that light is converted into an electronic signal. The 
signals from two detectors are fed into separate amplifier and energy discrimination 
circuits. If these circuits both produce a signal within a very narrow time interval (ns), a 
coincidence event will be detected. Since annihilation photons are emitted in opposite 
directions, the detection of a coincidence event localizes the positron annihilation to a 
point lying somewhere on the line that joins the two detectors. This line is referred to as a 
coincidence line. During a PET scan, several million coincidence events are recorded, 
forming a large number of coincidence lines and hence information about the quantity and 
spatial location of positron-emitters within the body82.
The spatial resolution of a PET camera is a measure of how well the scanner can 
distinguish 2 small objects placed closely together. Three main factors restrict the spatial 
resolution that can be achieved with PET: (i) the size of the individual detector, (ii) the 
non-colinearity of annihilation y-rays and (iii) the distance a positron travels before 
annihilating.
1.7 General Labelling Procedures
Many synthetic routes used in organic chemistry have been used in preparing radiotracers. 
In these studies many factors have to be considered:
(i) The precursor -  its structure and properties such as physical stability under various 
conditions.
(ii) The type of labelling84 -  specific, uniform, general or nominal.
(iii) The isotope availability and forms -  in the case of a radioactive isotope attention 
has to be given to the half-life, type of radiation and specific radioactivity.
(iv) The reaction conditions -  the simpler the procedure, with the isotope incorporated 
at the end of the synthesis, the better.
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Labelling with the isotopes of hydrogen can involve the use of an isotopic source as 
a gas, liquid or solid. In the first case it is necessary to set up a gas line and the reactions 
are frequently slow whereas speed is all important for the preparation o f 11C-tracers. Use 
of shielded cells to protect the radiochemist from high radiation exposure is necessary and 
in many places the procedure is fully automated85,86 through the use of robotics systems87. 
Any method that can lead to a large reduction in the time required for synthesis is to be 
welcomed and in this area ultrasonic irradiation88,89 has met with some success but the 
most promising area is that of microwave activation.
1.7.1 Microwave Technique
Microwaves are electromagnetic waves with frequencies between 30 GHz and 300 MHz. 
These are in the infra-red and radio-regions of the electromagnetic spectrum. For 
industrial and scientific heating applications certain frequencies (915±25 MHz, 2450±13 
MHz, 5800±75 MHz, and 22125±125 MHz) have been set aside. At these frequencies, 
there is no interference from other microwave applications, such as in telecommunications 
and radar90-92. However, the most common frequency used for heating purposes is 
2450±13 MHz, corresponding to a wavelength of 12.2 cm.
As emphasised in a number of recent reviews90-98 the use of microwave technology 
in the chemical industry has increased exponentially in the last decade. This has not been 
entirely without danger as there have been reports of explosions due to the high pressure 
build-up inside the reaction vessels99,100. Improvements in reaction vessel design have 
however increased the safety factors101,102.
Microwave technology has been used in some hydrogen isotope labelling 
procedures, such as catalytic transfer hydrogenation e.g. hydrogenation of 
benzaldehyde101,103-105 and for acid-catalysed hydrogen-deuterium exchange of aromatic 
protons106. Good yields have also been reported for reactions conducted in dry 
media107,108.
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Microwave heating has also been successfully used in PET radiochemistry with 
carbon-11, as for example, in alkylations60,100,109’110, reactions with [11C]cyanide111-113, 
nucleophilic aromatic and aliphatic substitutions86’114-116, Bucherer-Strecker syntheses117, 
condensations and hydrolyses111. PET radiopharmaceuticals have been prepared in 
shielded cells, with the assistance of a specially designed microwave cavity118.
Unlike conventional heating, microwave heating is produced as a result of dielectric 
loss. Consequently, the amount of heat generated in a sample is highly dependent on its 
dielectric properties. Materials use up microwave energy by two main mechanisms90, 
dipole rotation and ionic conduction. Dipole rotation is the alignment of irradiated 
molecules that have permanent or induced dipoles with the electric field component of the 
radiation. When the microwaves operate at 2450 MHz, the field oscillates at close to 4.9 
x 109 times per second and the agitation of the molecules generates heat. In this case, the 
efficiency of heat transfer from dipole rotation will depend on the dielectric relaxation 
time, which itself depends on the temperature and viscosity of the material. Energy can 
also be transferred by ionic conduction, which relates to the migration of dissolved ions in 
the oscillating electric field. Here heat generation is due to frictional loss, which depends 
on the size, charge, conductivity and the interaction of the ions with the solvent.
The microwave technique depends on using a solvent that absorbs microwave 
energy efficiently and is therefore heated rapidly under irradiation. The preferred solvents 
are those that have a boiling point that is at least 20-3 0°C higher than the reaction 
temperature119. As a result, compounds with high dielectric constants120 such as water, 
dimethyl sulfoxide (DMSO), dimethyl formamide (DMF), alcohol and acetonitrile tend to 
heat readily under microwave irradiation. On the other hand, less polar substrates such as 
aromatic and aliphatic hydrocarbons or compounds with no net dipole moment, such as 
carbon dioxide, dioxan and carbon tetrachloride and highly ordered crystalline materials, 
are poor absorbers.
The dramatic reductions in reaction times that are observed can be described to four 
main factors121: (i) the microwave power, (ii) the dielectric constant and induction 
currents, (iii) the exposure time and (iv) the quantity and volume of material, although it is
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not clear yet which of these is the most important. Some workers122 have changed the 
ionic strength of the sample by, for example, adding salts.
1.8 Analytical Methods
A wide range of analytical methods are available for the analysis of isotopically 
compounds. Detecting and measuring both the position(s) labelled and the degree of 
isotopic incorporation are the main requirements. For compounds labelled with short­
lived positron-emitters much use is made of radio-chromatographic methods (TLC, GC 
and HPLC)123’124 for determining purity whilst co-labelling with 13C and 19F, together with 
NMR and mass spectrometric (MS) studies, provides much needed complementary 
information.
Liquid scintillation counting is ideal for measuring the weak p_-radiation emitted by 
tritium and at higher levels of radiation 3H NMR spectroscopy can provide information on 
the positions tritiated. For deuteriated compounds 2H NMR spectroscopy is very useful 
although the signals are broadened and the technique is not as sensitive as for 3H NMR 
analysis (see Table 1.2).
1.8.1 Nuclear magnetic resonance (NMR) spectroscopy
Since the development of NMR spectrometry125,126 in the 1970’s the use of and 13C 
NMR spectroscopy has become routine, at least for solution studies. The nuclear 
properties of some isotopes used in the life sciences, including the hydrogen isotopes, are 
listed in Table 1.2.
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Table 1.2: Nuclear properties of isotopes used in the life sciences13,127,128.
Isotope Natural abundance 
(%)
Nuclear
spin
Resonance frequency 
(MHz at 7.1T)
Relative
sensitivity3
JH 99.984 1/2 300.13 1.0
2H 0.0156 1 46.07 9.65xl0'3
3h A o O
N
1/2 320.13 1.21
13c 1.11 1/2 75.46 1.59xl0"2
14N 99.63 1 21.83 l.OlxlO'3
15n 0.37 1/2 30.63 1.04xl0'3
170 0.037 5/2 40.97 2.91xl0'2
19f 100 1/2 284.27 0.834
3 1 p 1.00 1/2 122.35 6.63xl0‘2
3 2 p 00 1 13.64 2.46X10-4
a Sensitivity given for equal numbers of nuclei in the same field.
1.8.1.1 Deuterium NMR spectroscopy
Deuterium has a low natural abundance (~ 0.0156%) and the chemical shifts in 2H NMR 
spectroscopy are virtually the same as for NMR spectroscopy so that the 
interpretation of the spectra can rely on information already available in the literature. 
However, the deuterium nucleus is quadrupolar and spectra with broad lines are obtained 
so that the signals may be poorly resolved. The deuterium nucleus also has a low 
sensitivity compared to protons so that some 104 more accumulations are needed to give a 
signal of similar intensity to hydrogen, assuming an equivalent number of nuclei. 
However, as instruments of higher field are becoming available this is becoming less of a 
problem.
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1.8.1.2 Tritium NMR spectroscopy
In the use of tritiated compounds 3H NMR spectroscopy is invaluable, capable of 
providing information on the degree and pattern of labelling129,130 as well as the 
radiochemical purity131. With improvements in NMR sensitivity brought about by magnets 
of superior performance it is now possible to obtained a satisfactory 3H NMR spectrum 
(S/N: 10/1) with as little as 18 jnCi (0.67 MBq) located in one site after an overnight (16 
h) run. Some other features of the technique are summarised below125,128,129,130:
1. 3H has a spin of XA and therefore the NMR spectra consist of narrow lines, much 
narrower than for 2H.
2. 3H is some 21% more sensitive to NMR detection than -  it is in fact the most 
sensitive of all NMR active nuclei.
3. The 3H chemical shifts are virtually the same as for ^  thereby simplifying the 
interpretation of the spectra.
4. As the natural abundance of 3H is low (< 1CT16 %) there are no background signals in 
the 3H NMR spectra.
5. No 3H internal standard is necessary.
6. The spectra can be simplified by decoupling.
7. The technique does away with the need for chemical degradation, which itself can be 
time-consuming and sometimes misleading.
Since the development of 3H NMR spectroscopy in the late 1960’s it has been 
employed in many applications in addition to assigning labelling patterns. Two examples 
are the study of protein structure and dynamics16, and the labelling of biocompatible 
polymers132.
1.8.2 Liquid Scintillation Counting
Liquid scintillation counting2,3 is the most commonly used technique for detecting and 
measuring the radioactivity associated with tritium labelled compounds. The tritium p--  
particle energy is very low so that end window counting such as in Geiger-Muller or 
proportional counters is not possible.
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The tritiated compound is usually dissolved in a liquid scintillator. The latter 
consists of a primary solute and, sometimes a secondary solute dissolved in an aromatic 
solvent. 2,5-Diphenyloxazole (PPO) is a frequently used primary solute, and toluene a 
widely used solvent. For materials that are not soluble in toluene a blending agent such as 
dioxane or an alcohol is employed. The week radiation excites the primary solute leading 
to a light pulse which is detected by a photomultiplier and then converted into an electric 
signal which can then be processed.
Liquid scintillation counting lends itself to automation so that large numbers of 
samples can be counted in relatively short times. The efficiency of counting is usually 
high, typically 50% for 3H and over 90% for 14C. Only when the samples are coloured do 
these values decrease.
1.9 Work Described in The Thesis
The work is concerned with devising new and better ways of introducing isotopic 
hydrogen, usually deuterium, and carbon, n C, into organic compounds. In the former, the 
investigation will deal with catalytic hydrogen transfer reactions using solid hydrogen and 
deuterium donors such as formates under both thermal and microwave-enhanced 
conditions. The procedures will be compared using several compounds with C=C bonds. 
The work will concentrate on establishing a safe and reproducible labelling procedure.
As far as carbon-11 labelling procedures are concerned, the work will involve the 
radiosynthesis of \0-m ethyl-nC]CGP 62349 as a prospective radioligand for GABAb 
receptors. High specific radioactivity labelling agents, [u C]iodomethane or [n C]methyl 
triflate will be used. The performance of the two methylating agents will be compared.
Furthermore, the work will deal with the use of [n C]carbon monoxide as a labelling agent 
for developing new and novel routes adaptable to the 1 ^ -labelling of compounds, based 
upon: (i) the direct insertion of [n C]carbon monoxide into lithiated amines and (ii) 
palladium(II)-mediated cross coupling reactions of either aryl iodides or diaryliodonium
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salts with arylorganostannanes plus [n C]carbon monoxide insertion. Higher radiochemical 
yields and better reaction conditions in preparing [n C]ketones using palladium(II)- 
mediated cross coupling carbonylations are required. Applying diaryliodonium salts 
instead of aryl iodides in the latter procedure will also will be investigated. The 
[n C]carbon monoxide trapping efficiency is also a factor that needs to be considered.
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2.1 Introduction
The work in this chapter is concerned with devising new and better methods of 
introducing isotopic hydrogen, usually deuterium, into organic compounds.
As mentioned in Chapter 1, hydrogenation is one of the most widely used methods 
for introducing deuterium or tritium into organic compounds. In the same way that 
hydrogen isotope exchange reactions can be used to study the effect of substrate structure, 
the catalyst (acid, base or metal), and the solvent, on the rates of the exchange reactions 
similar possibilities exist for hydrogenation reactions. Thus, to take a simple case:
R C H = C H 2 + *H2 Catalyst > RCH*H— CH2H*
H2 is either 2H2 or 3H2.
(a) the R group can be varied;
(b) the reaction can be carried out under heterogeneous or homogeneous conditions;
(c) the catalyst can be varied, and
(d) so also can the solvent.
The attractions of the hydrogenation reaction for labelling compounds with 2H or 3H are 
many. Thus,
(a) a large number of suitable precursors are either available or can be easily synthesised;
(b) the hydrogenation is a one-step reaction;
(c) the label is inserted into a stable position;
(d) it is a reaction that can lead to the introduction of two deuterium or two tritium atoms; 
(f) if the double bond is replaced by a triple bond four deuterium or four tritium atoms can
be introduced. Thus, tritiated compounds of very high specific radioactivity (> 100 Ci 
mmol-1) can be prepared.
Despite these attributes there are many limitations, thus
(a) H2 / D2 / T2 gases are sparingly soluble in many common organic solvents so that
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(b) the reactions are frequently slow, requiring many hours to reach equilibrium;
(c) in order to obtain complete reduction it is customary to use excess gas and whilst this 
is no problem in the case of H2 or D2 , with T2 there is the question of how to store the 
radioactive gas. This is a considerable problem as the legislation being introduced is 
being directed at reactions which produce less and less radioactive waste, so that the 
problems associated with storage are kept to a minimum.
With these factors in mind we started to look into the possibility of replacing D2 / T2 with 
solid donors. Success here would mean that
(a) the donors could be safely stored for extended periods of time;
(b) the exact quantity required could be easily dispensed without the need to use a gas 
line;
(c) no excess donor would be required;
(d) if the donor is readily soluble in suitable solvents much faster reactions can be 
obtained.
All these factors could greatly increase the attractions of hydrogenation reactions. In 
addition there is another possibility. Some forty years ago Wilzbach1 produced a very 
important paper in which he showed that when organic compounds were kept in the 
presence of T2 gas at room temperature for a number of days extensive tritiation took 
place. This radiation-induced reaction elicited a great deal of interest but the initial 
promise was not borne out by subsequent events. Studies showed that much of the tritium 
was located in labile positions and could be easily washed out. Furthermore some of the 
impurities formed were shown to be highly radioactive so that purification of the required 
product often turned out to be very difficult. The outcome of these studies was that whilst 
interest in radiation - including ultraviolet, X-rays and y-rays - induced reactions 
continued, it was at a low level2.
Some 12 years ago two papers were published in which the possible benefits of 
using microwave irradiation3,4 were highlighted and since then the field has expanded 
rapidly. Some 400 papers5,6 have been published showing how microwave-enhanced 
reactions can lead to higher yields in shorter times with greatly reduced levels of waste
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being produced. This therefore prompted us to investigate whether hydrogenation 
reactions using solid donors could also benefit from this new approach and this is the 
subject of the present chapter.
For our choice of reactant we decided to choose the following compounds:
1 Styrene
2 trans- (3 -Methyl styrene
H v CHLcr-
3 3-Phenyl-1-propene (Allylbenzene) | f
4 Cinnamyl alcohol
5 frvms-Cinnamic acid
CO„H
6 a-Methylcinnamic acid
C 02H
7 7ra«s-4-Phenyl-3-butenoic acid
H . / CH2C 02H 
H
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For our choice of solid donors we decided to pick the formates7’8 as they are
(a) commercially available and inexpensive;
(b) the metal ion can be easily varied;
(c) they exhibit good solubility properties;
(d) the deuteriated and tritiated formates can be easily prepared9;
(e) multi-formates, such as the formic acid/tetramethylethylenediamine (TMEDA) salt, 
can be used and
(f) by using them in the presence/absence of a labelled solvent such as D2 O/H2 O the 
pattern of labelling can be varied.
In the catalytic hydrogenation reactions several catalysts, both heterogeneous and 
homogeneous, were used. Thus, in the former category we have platinum, palladium and 
rhodium usually on a carbon support, and Raney nickel10,11. In the latter category we 
relied on tris(triphenylphosphine)rhodium chloride, (RhCl[(C6H5)3P]3), otherwise known 
as Wilkinson’s catalyst. For many years now this compound has been found to be a very 
efficient hydrogenation catalyst for a wide range of unsaturated compounds under mild 
conditions.
The objectives therefore were to investigate hydrogenation reactions with solid 
hydrogen and deuterium donors of the formate kind under both thermal and microwave- 
enhanced conditions and in the presence of catalysts under either homogenous or 
heterogeneous conditions. In due course the benefits of such an investigation could be 
extended to the tritiation of a number of organic compounds.
2.2 Experimental
General Remarks: All NMR spectra were recorded using a Bruker AC-300E spectrometer 
operating at 300 MHz for XH and 46 MHz for 2H spectroscopy. Chemical shift values are 
in parts per million (ppm) and referenced to tetramethylsilane (TMS) for the XH NMR 
spectra and to the solvent(s) for the 2H NMR spectra. The microwave facility used was a 
750 Watt Matsui M l67 BT domestic oven.
40
Chapter 2 Microwave-Enhanced Hydrogenation Reactions
Reagents: All reagents were purchased from Aldrich Chemical Co. in greater than 99.5% 
purity and used without further purification. All solvents were AR grade.
2.2.1 Gas Line Procedure
The substrate (100-200 j l i I  or 30-40 mg) and 5% Pd/C catalyst (30-50 mg) were weighed 
into a 5 ml round bottom flask equipped with a small magnetic flea. Chloroform (3-5 ml), 
as solvent, was then added and the flask was immediately frozen in liquid nitrogen. The 
flask was then connected to the gas line using the procedure outlined below. Upon 
completion of the reaction the flask was again frozen before removal from the gas line. 
The catalyst was filtered from the reaction mixture and the solvent was then removed by 
passing a stream of nitrogen gas over the surface of the solvent. The product was then 
taken up in the appropriate solvent. The and 2H (*H decoupled) NMR spectra were 
then recorded.
The Gas Line; The synthesis of the deuteriated compounds was carried out on the gas line 
shown in (Fig. 2.1). The apparatus is designed to transfer small quantities of gas to the 
reaction vessel.
4
Helium^
reservoir
5B
Reaction
vessel5A
Vacuum
pump Dewar flask 
containing liquid 
nitrogen Deuterium gas 
cylinder
Mercury
reservoir
Fig. 2.1: Diagram of the deuterium gas line
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Operational procedure; The vacuum pump was turned on with all the taps, except tap 4, 
in a closed position. The Dewar flask contains liquid nitrogen in order that solvent 
vapours can be trapped. A helium balloon was attached to the apparatus at tap 3. The 
reaction vessel containing catalyst, substrate, solvent and a stirrer bar was attached to B. 
The stirrer bar is a short piece of paper clip encapsulated in a glass tube manufactured 
from the tip of a disposable pipette. Air can now be removed from the system by opening 
taps 1 , 2, and A (4 is already open). Tap C, rear to the burette, is then very carefully 
opened so that the mercury level rises close to the top of the burette. In this way most of 
the air in the system is removed.
The next stage is to cool the contents of the reaction vessel in liquid nitrogen. After this, 
tap B is opened. This is followed by closing taps B, A, 2 and 1. Then tap 3 is opened in 
order to pass helium into the system. Then taps 2, A, and C (very carefully) are opened. 
Tap C is then closed and tap B opened whilst removing the liquid nitrogen from around 
the reaction vessel. The source of helium is then closed off via taps B, A, 2 and finally 3.
The system is now re-evacuated by opening taps 1, 2, A, and C (very carefully); the 
mercury level should again be allowed to rise to close to the top of the burette. This 
“sweeping” process is repeated twice more with helium. Finally the helium is allowed to 
pass into the system up to the tap A and the latter opened for a short time to enable the 
gas to pass into the connection tree. Finally all taps are closed. At this stage tap C is 
carefully opened, followed by tap D and then the deuterium cylinder valve 5A, followed 
(very carefully) by valve 5B. The mercury level should now go down to approximately 
the middle of the mercury bulb reservoir. Now valves 5 A and 5B are closed, followed by 
tap D. The deuterium gas can now be transferred to the reaction vessel by opening tap B, 
and at the same time removing the liquid nitrogen from around the reaction vessel which 
gradually attains room temperature. The stirrer can now be switched on. During this time 
all taps except B and C are closed and the vacuum pump switched off. After the desired 
reaction time has elapsed taps B and C are closed and the reaction vessel is frozen in liquid 
nitrogen. The reaction vessel can now be removed from the system and left to gradually 
attain room temperature. The catalyst may now be filtered off and purification of the 
deuteriated product carried out.
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The reactions were carried out by vigorously stirring a solution of the reactant containing 
the catalyst (palladium on charcoal) as a suspended powder under an atmosphere of 
(hydrogen or deuterium) until the uptake of gas was complete. In this work all the 
experiments were performed at room temperature.
2.2.2 Using Formates
There have been several reports7 , 1 4 - 1 8 in which the use of formic acid as a hydrogen 
transfer agent have been mentioned. The use of several metal formate salts has also been 
reported19. In the former case, the formic acid decomposes to give free hydrogen and
<^A Ay j  a  a i  a a
carbon dioxide (Fig. 2.2) whilst in the latter case a reactive metal hydride ’ ’ is 
formed (Fig. 2.3).
catalyst _
H 0 2CH - — -  h 2 +  c o 2
Fig. 2.2: Formic acid decomposition.
\  /  + _ \  // C = C N + MHC02  * / C =  C '  + C 0 2 + MH
\  /  H ,0  \  /  + _
/ C = C \  + MH   — ► — C  + M OH
Fig. 2.3: Proposed hydrogenation of alkenes using metal formates.
In order to prepare the fully reduced product labelled with two deuterium atoms, 
there will be a need for a second deuterium donor such as deuterium oxide together with 
the formate salt. An alternative is to use d2-formic acid, DOOCD. However because of 
its physical properties -  a hygroscopic liquid, with a short shelf life and high cost this is
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not attractive. Therefore, the d2-formic acid -  tetramethylethylenediamine (DCOOD- 
TMEDA) salt was prepared -  (see Section 2.2.3) -  and used.
2.2.2.1 Microwave procedure
Various power levels were available on the microwave that I used but in nearly all cases 
only the lowest (150 W) was used. Similarly, although the time in which the sample was 
irradiated in the microwave could also be varied this was usually kept at 2 min.
The reaction vessel consisted of a 25 ml pear shaped conical flask with a B 14/23 
joint to which a Quickfit stopper (thermometer adapter) with a screw cap into which a 
septum is fitted was attached. The septum also enabled the flask to be evacuated (Fig. 
2.4). The thermometer adapter, was held in place by a plastic quickfit clip. This allowed 
small pressures to build up in the reaction vessel but in the event of high pressures being 
produced the septum became detached.
\
F 1 screw top
septum
--------------  thermometer
1 1
adapter
reaction flask
j  (25 ml, pear shaped)
reaction mixture
V J
Fig. 2.4 : The reaction vessel used for microwave reactions.
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General preparation procedure for the microwave reactions
The substrate (10-25 mg or 100-200 |_il), formate (0-150 mg) and Rh(PPh3)3Cl (5-15 
mg) were weighed into the above reaction vessel (25 ml). Water or deuteriated water (0- 
100 til) and DMSO (0.5 ml) were then added to the reaction vessel, which was then 
equipped with a modified thermometer adapter and septum seal, as described earlier. The 
reaction vessel could then be frozen in a liquid nitrogen bath and evacuated; it should be 
left under vacuum after removing the liquid nitrogen as a slight pressure is generated 
inside the reaction vessel due to the increase in the temperature. Inside the microwave 
oven the reaction vessel was placed in a 250 ml beaker containing vermiculite so that in 
the event of an explosion much of the energy would be absorbed.
2.2.2.2 Conventional heating
The same reaction set-up procedure used with the microwave experiments was repeated. 
The reaction vessel was then placed in an oil bath kept at the appropriate temperatures, for 
a specified period.
2.2.3 Preparation of d2-formic acid-tetramethylethylenediamine (TMEDA) salt
The d2-formic acid-TMEDA salt (10) was prepared by stirring TMEDA, 
(CH3)2N(CH2)2N(CH3)2, (8 ), 5 ml, (0.03 mol) in a 50 ml round bottom flask. The flask 
was then cooled to 0°C in an ice bath. The d2-formic acid (DCOOD), (9), 3.0 g, (0.06 
mol) was then added slowly. The mixture was left to stir for a few minutes, when a white 
solid precipitated. The solid was dried using a freeze-drier to give a white solid product, 
stable for long periods of time (> 4 months). The molar ratio of the reactants is 1: 2, of 
(8 ): (9), as illustrated in the following Figure.
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2D C 02D
(9)
+ 9 h 3 o ° c
CH.
CH3
I "OOCD 
.N+
1CH,
.N
*■
DCOO”
N CH3 CH3 (10)
C H 3 (8)
Fig. 2.5: Preparation of d2-formic acid-TMEDA salt (10).
The relevant NMR data are as follows:
*H NMR TMEDA (8), (CDCb): 8 2.38 (s, 4H, 2 x (-CH2-)), 2.24 (s, 12H, 4 x (-CH3)). 
2H NMR d2-formic acid (9), (CHCb): 5 11.20 (s, -C02D), 8.09 (s, -CD-).
‘H NMR d2-formic acid/TMEDA (10), (CDCb): 8 2.98 (s, 4H, 2 x (-CH2-)), 2.58 (s, 
12H, 4 x (-CH3)).
2H NMR d2-formic acid/TMEDA (10), (CHCb): 8 12.65 (s, -C02D), 8.43 (s, -CD-).
2.2.4 Isolation procedures
The isolation procedure depended on whether the products were acidic, basic or neutral:
2.2.4.1 Isolation of neutral compounds (1, 2, 3 and 4)
The contents of the reaction flask were extracted into chloroform (5 ml), and washed with 
water (3 x1 0  ml). The chloroform was then removed by passing a stream of nitrogen gas 
over the surface, and then the product was collected and analysed by NMR spectroscopy.
2.2.4.2 Isolation of acidic compounds (5, 6 and 7)
The contents of the reaction vessel were diluted with chloroform (5 ml). The contents 
were then transferred to another vessel containing water (5 ml) and 5M sodium hydroxide 
(~ 2 ml). The aqueous layer was collected and acidified by adding some hydrochloric acid. 
Then the contents were re-extracted with chloroform and washed at least twice with water 
(3 x 10 ml) and filtered. The chloroform was then removed by passing a stream of 
nitrogen gas over the surface.
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2.3 Results and Discussion
The thermal and microwave-enhanced methods were compared using the hydrogenation 
of a-methylcinnamic acid as a test case (Fig. 2.6). Under thermal conditions at 50°C, the 
reaction is nearly complete after 2 h. A similar high yield was achieved at 100°C after 20 
min. However under microwave-enhanced conditions the same high yield can be achieved 
in less than 5 min, thereby producing a considerable saving in time.
100
100 120
Time (min)
Fig. 2 .6 : Plot of product yield against time for the hydrogenation of a-methylcinnamic
acid (6 ) under different experimental conditions;
(a ) thermal conditions, (50°C);
(♦) thermal conditions, (100°C);
(■) microwave-enhanced reaction, 2  min pulses.
47
Chapter 2 Microwave-Enhanced Hydrogenation Reactions
2.3.1 Using the gas line
I first of all performed the heterogeneous hydrogenation of compounds (1-7) on the gas 
line, using either H 2  or D2 , to establish the conditions necessary to produce complete 
conversion of reactants into products. All of these experiments were performed at room 
temperature. As can be seen from the results, given in Table 2.1, the reactions usually 
took between 120-300 min to come to completion. !H NMR spectra of the products 
isolated at the end of the reactions (there may well be unchanged reactants as well as the 
desired product present) were used to calculate the yields, using the appropriate integrals 
for the relevant protons. The yields are probably accurate to ± 5%. Because of space 
considerations only a representative number of NMR spectra are provided.
Table 2.1: Reaction conditions for full hydrogenation (100% yield) of compounds (1-7) 
with H2 or D2 gas. In all cases, the catalyst was 5% Pd/C ( 40-50 mg) and 
chloroform (3 ml) was the solvent.
Exp. No. Cmpd. Wt (mg)/Vol. (pi) Time (min) Product Fig. No.
2 . 1 1 1 0 0  pi 1 2 0 11 2.7 b
2 . 2 1 1 0 0  pi 1 2 0 12 2.7 c
2.3 2 1 0 0  pi 150 13 2 . 8  b
2.4 2 1 0 0  pi 150 14 2 . 8  c
2.5 3 1 0 0  pi 240 13 2 . 8  ba
2 . 6 3 1 0 0  pi 240 15 2.9 b
2.7 ■ 4 40 mg 180 16 2 .1 0 b
2 . 8 4 40 mg 180 17 2 . 1 0  c
2.9 5 35 mg 1 2 0 18 2 .1 1 b
2 . 1 0 5 35 mg 1 2 0 21 2 . 1 1  c
2 . 1 1 6 40 mg 300 19 2 . 1 2  b
2 . 1 2 6 40 mg 300 22 2 . 1 2  c
2.13 7 30 mg 1 2 0 20 2.13 b
2.14 7 30 mg 1 2 0 23 2.13 c
a The same product as in exp. No. 2.3.
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Fig. 2.7 NMR spectrum of (a) styrene, (b) of hydrogenation product; and (c) the 
2H NMR (XH decoupled) spectrum of the deuteriated product.
a)
ppm
b)
c)
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Fig. 2.8 :H NMR spectrum of (a) /raws-p-methylstyrene, (b) of hydrogenation 
product; and (c) the 2H NMR (XH decoupled) spectrum of the deuteriated product.
a)
ppm
b)
6 4 2 ppm
c)
8 6 4 2 ppm
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Fig. 2.9 NMR spectrum of (a) 3-phenyl-l-propene and (b) the 2H NMR (*H 
decoupled) spectrum of the deuteriated product, 
a)
68 4 2 ppm
b)
8 6 4 2 ppm
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Fig. 2.10 NMR spectrum of (a) cinnamyl alcohol, (b) of hydrogenation product; and 
(c) the 2H NMR (:H decoupled) spectrum of the deuteriated product.
a)
— ^ UL 1
c)
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Fig. 2.11 *H NMR spectrum of (a) trans-cinnamic acid, (b) of hydrogenation product; 
and (c) the 2H NMR (XH decoupled) spectrum of the deuteriated product.
a)
8 6 4 2 ppm
b)
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Fig. 2.12 NMR spectrum of (a) a-methylcinnamic acid, (b) of hydrogenation 
product; and (c) the 2H NMR (*H decoupled) spectrum of the deuteriated product.
a)
ppm
b)
JU
c)
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Fig. 2.13 ‘H NMR spectrum of (a) *ra/«'-4-phenyl-3-butenoic acid, (b) of 
hydrogenation product; and (c) the 2H NMR (XH decoupled) spectrum of the 
deuteriated product, 
a)
ppm
b)
c)
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The results (Table 2.1 and Figures 2.7-2.13) show that styrene has been converted 
quantitatively to ethyl benzene, frvms'-P-methylstyrene or c/s-3-phenyl-1 -propene to 
propylbenzene, cinnamyl alcohol to dihydro-cinnamyl alcohol, /raws-cinnamic acid to 
dihydro-cinnamic acid, a-methylcinnamic acid to a-methyl-dihydro-cinnamic acid and 
frvms,-4-phenyl-3-butenoic acid to 4-phenylbutyric acid. The same has occurred when 
H2 has been replaced by D2, with very even addition across the double bond.
2.3.2 Using microwave irradiation
The next phase of the investigation was to establish whether the hydrogenations could be 
carried out under microwave-enhanced irradiation and to determine optimum conditions. 
Again styrene was chosen as the starting material although the investigations were now 
extended to other compounds. Results are summarised in Table 2.2 and Figures 2.14, 
2.15 and 2.16. They show that in a very short time interval complete hydrogenation has 
occurred. The experimental set-up at present does not allow the temperature to be 
measured. It could be that the results arise simply from the acceleration of the reaction 
due to a higher temperature. Even if this is the case there are still other advantages, such 
as the simplicity of the operation, the need not to operate a gas line and if T2  rather than 
H2 or D2 were used, the problem of how to store the excess tritium gas..
Table 2.2: Microwave-Enhanced Hydrogenation of Selected Compounds.
Exp. No. Cmpd. Donor (mg-pl) Product Yield (%) Fig. No.
2.15 1 NH402 CH/D20; (150-100) 1 1 90.2 2.14
2.16 4 K 0 2 CD/D20; (65-50) 17 8 6 2.15
2.17 7 K 0 2 CD/D2 0; (100-50) 2 0 1 0 0 2.16
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Fig. 2.14 2H NMR (XH decoupled) spectrum of [2H]ethylbenzene.
6 48 2 ppm
Fig. 2.15 2H NMR (^H decoupled) spectrum of [2H]dihydro-cinnamyl alcohol.
8 6 4 2 ppm
Fig. 2.16 2H NMR (XH decoupled) spectrum of [2H]4-phenylbutyric acid.
ppm
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Furthermore, because of the well known lack of solubility of H2 / D2  / T2  in many 
organic solvents and the ability to use much higher concentrations of donors, much faster 
reactions, neglecting the temperature differences, can be expected. Indeed the study of 
some sterically hindered reactions which either do not proceed at all or if so, very slowly, 
in the presence of H2  / D2  / T2, may well be possible. This is an area that deserves further 
investigation.
We have used a domestic microwave oven for the present studies and it is to be 
expected that improvements could be made to the microwave design so that the energy is 
transferred more efficiently to the reaction vessel. Whilst this is not crucial for 
deuteriation/tritiation reactions it could be of considerable benefit to the synthesis of n C- 
labelled compounds where the short-half life of n C (20.4 min) puts a premium on the kind 
of reactions that can be used for synthetic purposes. Again there could be benefits in the 
deuterium/tritium labelled compounds area- slow/difficult/sterically- hindered reactions 
may proceed under these more efficient conditions. Again this is an area for further 
investigation.
In Table 2.2 the results for the microwave-enhanced hydrogenation of compounds 
1, 4 and 7 are given. Equally satisfactory results were obtained for the remaining four 
compounds but because of space considerations these are not given in the thesis. 
Although no kinetic data is reported here it should be possible with some of the new 
combined NMR techniques e.g. HPLC -  NMR to study the reactions of all 7 compounds 
in a competitive manner and obtain relative rates and thus study the effect of structure in a 
more quantitative way than has been done in the present investigation.
The change from a gas, such as D2, to a solid donor such as DCOOTC+ brings with it 
several possibilities. As mentioned earlier to introduce a second deuterium atom one 
needs to use a second source such as D2 0 . One immediately creates three permutations: 
DC00TC+-D 2 0 , HC00"K+-D 20  or DCOOlC-EhO and with it the possibility of 
changing the pattern of labelling in a way that is not possible with D2  gas. We also have 
the possibility of changing the metal ion in the formate e.g. replacing K+ with +NH4 or 
4ND4. Finally, through the preparation of the di-formic acid salt of
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tetramethylethylenediamine (TMEDA) one has the opportunity of donating two deuterium 
atoms directly. These alternatives create the opportunity of varying the pattern of 
labelling which can be very useful. Thus, in some cases one would be interested in 
introducing two deuteriums whilst in other cases the selective incorporation of one 
deuterium would be the prime objective.
2.3.2.1 Hydrogenation of styrene (1)
At the beginning and before the above mentioned investigations had taken place, several 
experiments were designed to determine the amounts of (i) catalyst (Wilkinson’s), (ii) 
ammonium formate ( N H 4 O 2 C H )  -  as hydrogen donor, or the prepared d2 -formic acid- 
TMEDA (10) -  as a double deuterium donor, that were needed to produced a fully 
hydrogenated product. These studies were carried out with styrene (1) (Fig. 2.17), and 
the procedure described earlier -  Section 2.2.2.1, was used in each case. The results are 
summarised in Tables (2.3 and 2.4).
MW, 2  min 
DMSO, 150 W
► -►
Wilkinson's catalyst 
(15 mg)
> = < ,
(la )
gas, and the same conditions as in D2  gas
>
(12)
Fig. 2.17: Preparation of ethylbenzene (12) and [2H]ethylbenzene (11) by hydrogenation
of styrene (1 ).
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Table 2.3: The effect of varying the amount of ammonium formate and the weight of the 
catalyst in the hydrogenation of styrene (1) to [2H]ethylbenzene (11). 
Deuteriated water was used in (100 pi) volume in each case. The solvent in 
each case was (0.5 ml) DMSO.
Exp. No. NH4O2CH 
mg (mmol)
RhCl[(C6H5)3P]3
(mg)
Yield
(%)
Fig. No.
2.18 0.0 (0.0) 15.0 0 . 0 —
2.19 50.0 (0.80) 15.0 69.4 2.18 a
2 . 2 0 100.0 (1.60) 15.0 8 6 . 8 2.18 b
2 . 2 1 150.0 (2.40) 15.0 90.2 2.14
2 . 2 2 100.0(1.60) 5.0 29.7 2.18 c
2.23 100.0(1.60) 10.0 71.3 2.18 d
2.24 1 0 0 . 0  (1.60) 15.0 8 6 . 8 2.18 b
Table 2.4: The effect of varying the amount of d2 -formic acid-TMEDA (10) on the 
hydrogenation of styrene (1) to [2H]ethylbenzene (11). No NMR figures 
have been given due to space considerations.
(10) 
mg (mmol)
Ratio of reactants 
[styrene: (10)]
Yield
(%)
50.0 (0.30) 1:0.35 77.0
76.5 (0.47) 1: 0.54 84.55
95.5 (0.58) 1 : 0 . 6 6 8 8 . 0
109.0 (0.66) 1:0.76 92.0
124.0 (0.76) 1: 0.87 96.0
After having studied the way in which the concentrations of formate, di-formate and 
catalyst affected the reaction yield the stage was set to see how the pattern of labelling 
could be varied. These results are summarised in Table 2.5.
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Table 2.5: The effect of using various combinations of hydrogen/deuterium donors on the 
pattern of labelling in the case of styrene (1 ) hydrogenation to 
[2H]ethylbenzene (11). 15 mg of Wilkinson’s catalyst was used in each case, 
the solvent being (0.5 ml) DMSO.
Exp.
No.
Label source 
source mg/fil
Yield
(%)
Relative deuterium 
incorporation (%)a
Fig. No.
2.25 N a0 2 CH/D20 90/50 37.9 oc-CH3= 33, P-CH2= 23 2.18 e
2.26 NH4 O2 CH/D2 O 150/100 90.2 a-CH3= 44, P-CH2= 35 2.14
2.27 KO2 CD 85 3.7 a-CH3= 0 , p-CH2= 0 —
2.28 KO2 CHZD2 O 85/100 11.3 a-CH2= 2 , P-CH2= 3 —
2.29 KO2 CD/H2 O 85/100 7.2 a-CH2= 2 , P-CH2=1 —
2.30 KO2 CD/D2 O 85/100 2 1 . 6 a-CH3= 13, P-CH2= 11 —
2.31 (10) 125 96.8 a-CH3= 61, P-CH2= 39 2.18 f
2.32b (10) 80 1 0 0 a-CH3= 50, p-CH2= 34 2.18 g
a Exchange with the starting material has taken place.
bOil bath experiment.
Fig. 2.18 2H NMR (JH decoupled) spectra of [2H]ethylbenzene (11) in chloroform. 
2.18a Using 50 mg N H 4 O 2 C H / D 2 O ,  microwave experiment (Table 2.3, exp. No. 2.19).
8 6 4 2 ppm
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2.18b Using 100 mg NH4 O2 CHZD2 O, microwave experiment (Table 2.3, exp. No. 2.20).
8 6 4 2 ppm
2.18c Using NH4 O2 CH/D2 O, microwave experiment (Table 2.3, exp. No. 2.22).
8 6 4 2 ppm
2.18d Using NH4 O2 CH/D2 O, microwave experiment (Table 2.3, exp. No. 2.23).
>"/Y ^ lV l^ WV^ VvV>v'jl^  vvW \Tvy^/>V'|vv,^ »/1'
8 6 4 2 ppm
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2.18e Using Na02CH/D20 , microwave experiment (Table 2.5, exp. No. 2.25).
68 4 2 ppm
2.18f Using TMEDA/DCO2D salt, microwave experiment (Table 2.5, exp. No. 2.31).
68 4 2 ppm
2.18g Using TMEDA/DCO2D salt, oil bath experiment (Table 2.5, exp. No. 2.32).
8 6 4 2 ppm
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2.3.2.2 Hydrogenation of traws-P-methylstyrene (2)
c h 3
H^ gas, 150 min, 5% Pd/C, Chloroform
>
CK
CH.
MW, 150 W, 2 min, DMSO
or D2  gas,150min, 5  % Pd/C, Chloroform
Fig. 2.19: Preparation of propylbenzene (13) and [2H]propylbenzene (14) by
hydrogenation of /ftms-P-methylstyrene (2 ).
Table 2.6: The effect of using various hydrogen/deuterium formates in the hydrogenation 
of /raws-p-methylstyrene (2) to [2H]propylbenzene (14).
Exp. Label source Yield Deuterium Fig.
No. source mg/pi (%) incorporation (%) No.
2.33 N a0 2 CH/D20 50/50 < 5 + exchange tracer quantity only —
2.34 NH402 CH/D20 65/50 45 + exchange a-CH2= 45, P-CH2= 21, 
CH3(D)= 0
2 . 2 0  a
2.35 k o 2c d 1 0 0 exchange only no deuteriated product —
2.36 k o 2 c h /d 2o 85/100 < 7 + exchange tracer quantity only —
2.37 k c o 2d /h 2o 85/100 exchange only no deuteriated product —
2.38 k o 2 c d /d 2o 65/50 exchange only no deuteriated product —
2.39 (1 0 ) 125 >90 a-CH2= 53, P-CH2= 32, 
CH3(D)= 14
2 . 2 0  b
2.40a (1 0 ) 90 1 0 0 a-CH2= 50, P-CH2= 26, 
CH3(D)= 14
2 . 2 0  c
a Oil bath experiment.
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Fig. 2.20 2H NMR decoupled) spectra of [2H]propylbenzene (14) in chloroform. 
2.20a Using N H 4 O 2 C H / D 2 O ,  microwave experiment (Table 2.6; exp. No. 2.34).
48 6 2 ppm
2.20b Using TMEDA/DCO2D salt, microwave experiment (Table 2.6; exp. No. 2.39).
8 6 4 2 ppm
2.20c Using TMEDA/DCO2D salt, oil bath experiment (Table 2.6; exp. No. 2.40).
8 6 4 2 ppm
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2.3.2.3 Hydrogenation of 3-phenyI-l-propene (3)
H2 gas, 240 min
-►
5 % Pd/C, chloroform
D
D2 gas, 240 min CHjD>
5 % Pd/C, chloroform
MW, 150W, 2 min
>
Wilkinson's catalyst, 
DMSO
Fig. 2.21: Preparation of propylbenzene (13) and [2H]propylbenzene (15) by 
hydrogenation of 3-phenyl-1-propene (3).
Table 2.7: The effect of using various hydrogen/deuterium formates in the hydrogenation 
of 3-phenyl-1-propene (3) to [2H]propylbenzene (15).
Exp.
No.
Label source Yield
(%)
Relative deuterium 
incorporation (%)
Fig.
No.source mg/pl
2.41 N a0 2 CH/D20 65/50 A no deuteriated product —
2.42 NH402 CH/D20 65/50 48.0 + A <x-CH2= 31, p-CH2(D)= 06, 
CH2/D= 30
2 . 2 2  a
2.43 k o 2c d 50 A no deuteriated product —
2.44 k o 2 c d /h 2o 65/50 A no deuteriated product —
2.45 k o 2 c d /d 2o 65/50 A no deuteriated product —
2.46 (10) 1 2 0 81.0 a-CH2= 43, p-CH2(D)= 25, 
CH2/D= 24
2 . 2 2  b
$2.47 (10) 90 1 0 0 a-CH2= 56, p-CH2(D)= 22, 
CH2/D= 22
2 . 2 2  c
afc
(A) = Exchange on the starting material has taken place; Oil bath experiment.
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Fig. 2.22 2H NMR (!H decoupled) spectra of [2H]propyIbenzene (15) in chloroform. 
2.22a Using N H 4 O 2 C H Z D 2 O ,  microwave experiment (Table 2.7; exp. No. 2.42).
6 4 28 ppm
2.22b Using TMEDA/DCO2D salt, microwave experiment (Table 2.7; exp. No. 2.46).
68 4 2 ppm
2.22c Using TMEDA/DCO2D salt, oil bath experiment (Table 2.7; exp. No. 2.47).
68 4 2 ppm
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2.3.2.4 Hydrogenation of cinnamyl alcohol (4)
Hj gas, 180 min, CHC13, 5 % Pd/C
MW, 150 W, 2 min, DMSO
(4)
(16)
CHDOH
Fig. 2.23: Preparation of dihydrocinnamyl alcohol (16) and [2H]dihydrocinnamyl alcohol
(17) by hydrogenation of cinnamyl alcohol (4).
Table 2.8: The effect of using various hydrogen/deuterium formates in the hydrogenation 
of cinnamyl alcohol (4) to [2H]dihydrocinnamyl alcohol (17). The reactions 
were performed using the same quantities of deuterium sources as in Table 2.7.
Exp.
No.
Deuterium
sources
Deuterium incoruoration (%) 
oc-CH2 p - c h 2 CH2(D)
Yield
(%)
Fig.
No.
2.48 N a0 2 CHZD20 76 24 0 0 76 2.24 a
2.49 NH402 CH/D20 54 40
e?oo 70 2.24 b
2.50 k o 2c d 05 50 30b 78 2.24 c
2.51 k o 2 c d /h 2o 36 43 2 1 81 2.24 d
2.52 k o 2 c d /d 2o 57 27 16 8 6 2.15
2.53 (10) 52 40 08 1 0 0 2.24 e
2.54° (10) 6 8 32 0 0 1 0 0 2.24 f
a Exchange with the starting material has taken place (~ 6 %). 
b There is an unidentified deuterium signal at 5 3 ppm, (~ 15% deuterium). 
c Oil bath experiment.
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Fig. 2.24 2H  NMR (1H decoupled) spectra of [2H]dihydrocinnamyl alcohol (17) in 
chloroform.
2.24a Using NaC^CHZE^O, microwave experiment (Table 2 .8 ; exp. No. 2.48).
68 4 2 ppm
2.24b Using N H 4 O 2 C H / D 2 O ,  microwave experiment (Table 2 .8 ; exp. No. 2.49).
8 6 4 2 ppm
2.24c Using K 0 2 CD, microwave experiment (Table 2.8; exp. No. 2.50).
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2.24d Using KO2 CD/H2 O, microwave experiment (Table 2.8; exp. No. 2.51).
p pm
2.24e Using TMEDA/DCO2D salt, microwave experiment (Table 2.8; exp. No. 2.53).
8 6 4 2 ppm
2.24f Using TMEDA/DCO2D salt, oil bath experiment (Table 2.8; exp. No. 2.54).
VVV v^VWVvV1
8 6 4 2 ppm
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2.3.2.5 Hydrogenation of a,P-unsaturated carboxylic acids (5, 6, and 7)
MW,150W, 2 min, DMSO 
Wilkinson's catalyst 
Deuterium sources
(5 or 6 or 7)
or D2  gas, 120-300 min 
5 % Pd/C, Chloroform (18 or 19 or 20)
Hj gas, 120 -300 min 
5 % Pd/C, Chloroform
(21 or 22 or 23)
Fig. 2.25: Preparation of:
(18 or 21) [*H or 2H]dihydrocinnamic acid, Y = C 02H R = H.
(19 or 22) [*H or 2H]a-methylhydrocinnamic acid, Y = C 02H R = CH3.
(20 or 23) [XH or 2H]4-phenylbutyric acid, Y = CH2 C 02H R = H.
Table 2.9: The effect of using various hydrogen/deuterium formates in the hydrogenation 
of trans-cinnamic acid (5) to [2H]dihydrocinnamic acid (18).
Exp.
No.
Label source Yield
(%)
Relative deuterium 
incorporation (%)
Fig. No.
source mg/pl
2.55 N a0 2 CHZD20 50/100 92 a-CH2= 15, P-CH2= 85 2.26 a
2.56 NH402 CHZD20 60/100 98 a-CH2= 46, p-CH2= 54 2.26 b
2.57 k o 2c d 55 80 a-CH2= 89, p-CH2= 11 2.26 c
2.58 k o 2c d /h2o 45/100 98 a-CH2= 90, P-CH2= 10 2.26 ca
2.59 k o 2c d /d 2o 65/100 98 a-CH2= 50, p-CH2= 50 2.26 d
2.60 (10) 1 0 0 1 0 0 a-CH2= 52, p-CH2= 48 2.26 e
2.61b (10) 90 1 0 0 a-CH2= 64, p-CH2= 36 2.26 f
a Similar result as in exp. No. 2.57. 
Oil bath experiment.
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Fig. 2.26 2H NMR (jH decoupled) spectra of [2H]dihydrocinnamic acid (18) in 
chloroform.
2.26a Using Na0 2 CHZD2 0 , microwave experiment (Table 2.9; exp. No. 2.55).
8 6 4 2 ppm
2.26b Using N H 4 O 2 C H / D 2 O ,  microwave experiment (Table 2.9; exp. No. 2.56).
p pm
2.26c Using K 0 2 C D  or K O 2 C D / H 2 O ,  microwave experiment (Table 2.9; exp. No. 2.57).
8 6 4 2 ppm
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2.26d Using KO2 CD/D2 O, microwave experiment (Table 2.9; exp. No. 2.59).
68 4 2 ppm
2.26e Using TMEDA/DCO2D salt, microwave experiment (Table 2.9; exp. No. 2.60).
8 6 4 2 ppm
2.26f Using TMEDA/DCO2D salt, oil bath experiment (Table 2.9; exp. No. 2.61).
8 6 4 2 ppm
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Table 2.10: The effect of using various hydrogen/deuterium formates in the 
hydrogenation of a-methylcinnamic acid (6 ) to [2H]a-methylhydrocinnamic 
acid (19). The reaction yield was approximately 100% in each case.
Exp.
No.
Label source 
source mg/pl
Relative deuterium incorporation 
(%)
Fig.
No.
2.62 N a0 2 CH/D20 75/50 oc-CH = 45, (3-CH2= 35, CH3 (D)= 20 2.27 a
2.63 NH4 O2 CH/D2 O 100/50 a-CH = 35, p-CH2= 44, CH3(D)= 2 0 2.27 b
2.64 K 02CD 85 a-CH = 07, p-CH2= 55, CH3 (D)= 38 2.27 c
2.65 KO2 CD/D2 O 70/50 a-CH = 35, P-CH2= 38, CH3 (D)= 27 2.27 d
2 . 6 6 (1 0 ) 90 a-CH = 32, P-CH2= 33, CH3 (D)= 35 2.27 e
2.67a (1 0 ) 80 a-CH = 37, P-CH2= 28, CH3 (D)= 35 2.27 f
3 Oil bath experiment.
Fig. 2.27 2H NMR (*H decoupled) spectra of [2H]a-methyIhydrocinnamic acid (19) 
in chloroform.
2.27a Using Na0 2 CH/D2 0 , microwave experiment (Table 2.10; exp. No. 2.62).
2.27b Using N H 4 O 2 C H / D 2 O ,  microwave experiment (Table 2.10; exp. No. 2.63).
ppm
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2.27c Using KO2 CD, microwave experiment (Table 2.10; exp. No. 2.64).
2.27d Using KCO2D/D2 O, microwave experiment (Table 2.10; exp. No. 2.65).
8 6 4 2 ppm
2.27e Using TMEDA/DCO2D salt, microwave experiment (Table 2.10; exp. No. 2.66).
2.27f Using TMEDA/DCO2D salt, oil bath experiment (Table 2.10; exp. No. 2.67).
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Table 2.11: The effect of using various hydrogen/deuterium formates in the 
hydrogenation of /ra«s-4-phenyl-3-butenoic acid (7) to [2H]4-phenylbutyric 
acid (20). The reaction yield was approximately 100% in each case.
Exp.
No.
Label source Relative deuterium incorporation 
(%>
Fig. No.
source mg/pl
2 . 6 8 N a0 2CH/D20 125/50 a-CH2= 49, P-CH2= 36, CH2(D)= 15 2.28 a
2.69 NH4 O2 CH/D2 O 80/100 a-CH2= 41, p-CH2= 32, CH2 (D)= 27 2.28 b
2.70 KO2 CD 95 a-CH2= 40, p-CH2= 60, CH2(D)= 0 2.28 c
2.71 KO2 CD/D2 O 100/50 a-CH2= 39, P-CH2= 43, CH2 (D)= 18 2.16
2.72 (10) 1 0 0 a-CH2= 39, P-CH2= 43, CH2 (D)= 18 2.28 d
2.73a (10) 1 0 0 a-CH2= 31, P-CH2= 34, CH2(D)= 35 2.28 e
a Oil bath experiment.
Fig. 2.28 2H NMR (*11 decoupled) spectra of [2H]4-phenyIbutyric acid (20) in
chloroform.
2.28a Using NaC^CH/E^O, microwave experiment (Table 2.11; exp. No. 2.68).
2.28b Using NH4O2 CH/D2O, microwave experiment (Table 2.11; exp. No. 2.69).
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2.28c Using K 0 2CD, microwave experiment (Table 2.11; exp. No. 2.70).
2.28d Using TMEDA/DCO2D salt, microwave experiment (Table 2.11; exp. No. 2.72).
ppm
2.28e Using TMEDA/DC02D salt, oil bath experiment (Table 2.11; exp. No. 2.73).
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Looking back at the hydrogenation results for the various compounds there can be 
seen several common features. The first point to make is that NMR spectroscopy is an 
excellent technique for following hydrogenation reactions, both from the disappearance of 
reactant and appearance of product. Secondly, through the use of microwaves a great 
saving in time can be achieved. Furthermore where comparisons between the microwave- 
enhanced reactions and the thermal reactions are possible the products are shown to be the 
same. The role of the microwaves is therefore to solely increase the rate of reaction and 
not to create new intermediates and new reaction mechanisms. In the study of the latter it 
is customary to keep the temperature constant and in future investigations work should be 
directed in this direction. Under the present conditions we have no means of measuring 
the increase in temperature, consequently most of the discussion will revolve around the 
pattern of labelling. This of course does provide some information of mechanistic 
importance but in the absence of kinetic data, appearance of intermediates etc., it is not 
possible to obtain a complete picture of the reaction mechanism.
The third point to emerge from the investigations is that the hydrogenation reaction 
is accompanied by extensive hydrogen isotope exchange in both the reactant and product. 
Not all the methods used to follow hydrogenation reactions e.g. uptake of H2  or D2 gas 
would be able to provide this information. The importance of the exchange is also 
reflected in the fact that uneven addition across the double-bond takes place with e.g. 
more label appearing in the a-methyl group than p-methylene group.
The gas line experiments (Table 2.1 and Figs 2.7b -  2.13 c) proceeded very 
satisfactorily with the 2H NMR (JH decoupled) spectra showing two characteristic 
singlets, in most cases of equal intensity, so that equilibrium had been reached. The only 
exception was 3-phenyl-l-propene where some isomerisation had clearly taken place.
Under microwave-enhanced conditions styrene underwent smooth hydrogenation 
when using NH4 0 2 C/D2 0  donor (Table 2.2 and Fig. 2.14). So also did cinnamyl alcohol 
and 4-phenyl-3-butenoic acid when using K 0 2 CD/D20  donor (Table 2 . 2  and Figs 2.15, 
2.16). The effect of varying the amount of ammonium formate donor, the concentration 
of Wilkinson’s catalyst and the amount of di-formate-TMEDA on the hydrogenation of
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styrene was also investigated (Table 2.3, 2.4 and Fig. 2.18 (a -  d)) and a very consistent 
pattern emerged -  hydrogenation with more deuterium in the methyl group than the 
methylene group formed and with hydrogen exchange into the reactant. When using 
NaC^CH/E^O, NH4 O2 CHZD2 O and di-formate of TMEDA (Table 2.5 and Fig. 2.18 (e -  
g)), the pattern of labelling remained the same, the only difference being the amount of 
reactant left and hence deuteriated.
When it comes to looking at the distribution of deuterium in the product it would 
have been useful had we taken samples as a function of time and built up a picture of how 
the deuterium was being incorporated. Unfortunately time constraints did not make this 
possible. The same reason applies to the fact that the variation in donors is rather limited 
-  we would like to have repeated some experiments using H C02M -  D20 , DC02M -  H20  
and DCO2M -  D2 0 , and varying M (Na+, K+, Li+, +NH4). Extension of the studies to a 
wider range of donors would also seem to be justified.
Nevertheless the results obtained for compounds 4, 5, 6  and 7 (Tables 2.8, 2.9, 2.10 
and 2 .1 1 ) do provide some useful findings such as; (i) in all cases when using the 
DCO2D/TMEDA salt the pattern of labelling for both the microwave-enhanced and 
thermal experiments are very similar e.g. compare Figs 2.26e and 2.26f (ii) high selectivity 
can be achieved as in Table 2.9 -  expts. 2.55 and 2.57 and Figs 2.26a and 2.26c. This is a 
particularly useful result as the pressure these days is not only to discover new multi- 
deuteriation routes but also more selective routes.
The extent of hydrogen isotope exchange is very noticeable in some cases, witness 
the results for a-methylcinnamic acid (6 ) and 4-phenyl-3-butenoic acid (7). This does 
have a side benefit, especially in the synthesis of tritiated compounds, where compounds 
of very high specific radioactivity are frequently required. Consequently the more tritium 
that can be incorporated the better.
Finally, it is worth noticing that when KO2 CD is used alone or in combination with 
other donors (KO2 CD/H2 O, KO2 CH/D2 O or KO2 CD/D2 O), no trace of the reduced 
products have been observed, from compounds 1, 2 and 3 (Tables 2.5, 2.6 and 2.7).
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Conversely when the same donors are used with compounds 4, 5, 6  and 7, the results were 
more promising (Tables 2.8, 2.9, 2.10 and 2.11), as the corresponding reduced products 
are produced (Figs 2.15, 2.16, 2.24c — d, 2.26c -  d, 2.27c -  d and 2.28c).
As mentioned earlier the present study was not concerned with a study of the reaction 
mechanism. However, the following points are worth mentioning: (i) KO2 CD is less 
soluble in DMSO than other formates and (ii) the compounds used have different groups 
attached to the a-position (hydrogen (H) as in 1, methyl (CH3) as in 2, methylene (=CH2) 
as in 3, hydroxyl group (OH) as in 4 and carboxylic group (COOH) as in 5, 6  and 7). The 
results suggest that the hydroxyl and carboxylic acid groups may have an accelerating 
effect on the reaction rate by making an intermediate compound with Wilkinson’s catalyst 
react much faster than when the a-position is attached to hydrogen, methyl or methylene 
groups.
2.4 Conclusions
The advantages of using solid formates in microwave-enhanced hydrogenation studies are 
clearly apparent from the results obtained in this chapter. In particular:
1. There is no need to set up and use a gas line.
2 . It is much easier to control the concentration of the donor than when using a gas.
3. Solid formates are very stable and can be stored for long periods of time.
4. The reactions are fast, typically complete in less than 10 minutes.
5. Possible degradation of reactant, product and catalyst is minimised.
6 . The reactions offer the opportunity of regiospecific labelling.
7. The work can be extended to tritiated formates where little or no radioactive waste
is likely to be produced.
8 . The technology can be of benefit in other reactions e.g. dehalogenations,
decarboxylations, which are used to prepare deuteriated and tritiated compounds.
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The investigations reported in this chapter can be easily extended to e.g. more sterically 
hindered compounds, to other donors, and to more reproducible conditions so that more 
information of a mechanistic nature can be obtained.
2.5 N M R  D a ta
The NMR results for the starting materials and products are summarised below;
a) Ethylbenzene (12) and [2H]ethylbenzene (11) were prepared from the hydrogenation of 
styrene (1 ):
‘H NMR Styrene (1), CDCb, 8  7.22-7.43 (5H, Ar), 6.67-6.77 (dd, 1H, -CH-), 5.72-5.78 
(d, 1H, cis =CH2-); 5.22-5.26 (d, 1H, Irans =CH2-).
'H  NMR Ethylbenzene (12), CDCb, 8  7.14-7.30 (m, 5H, Ar), 2.61-2.69 (dd, 2 H, -CH2),
1.21-1.26 (t, 3H, -CH3).
2H NMR [2H]Ethylbenzene (11), CHCb, 8  2.70 ( s , -CHD-), 1.30 (s, -CH2D-).
b) Propylbenzene (13) and [2H]propylbenzene (14) were prepared from the hydrogenation 
of tra/iy-p-methylstyrene (2 ) or 3-phenyl-l-propene (3):
‘H NMR tranv-P-Methyl-styrene (2), CDC13, 8  7.13-7.29 (5H, Ar), 6.35-6.40 (d, 1H, 
benzylic -CH=), 6.14-6.26 (tt, 1H, =CH-), 1.84-1.86 (d, 3H, -CH3).
*H NMR 3-Phenyl-l-propene (3), CDClj, 8  7.17-7.31 (m, 5H, Ar), 5.90-6.04 (m, 1 H, - 
CH-), 5.04-5.11 (2H, -CH2-), 3.37-3.39 (d, 2H, benzylic -CH2-).
‘H NMR Propylbenzene (13), CDCb, 8  7.14-7.29 (m, 5H, Ar), 2.56-2.61 (t, 2H, 
benzylic -CH-), 1.58-1.68 (tt, 2H, -CH2-), 0.91-0.96 (t, 3H, -CH3).
2H NMR [2H]Propylbenzene (14 or 15), CHCb, 8  2.62 (s, benzylic -CHD-), 1 . 6 8  (s, - 
CHD-), 0.95 (s, ex., -CH3).
c) Dihydrocinnamyl alcohol (16) and [2H]dihydrocinnamyl alcohol (17) were prepared 
from the hydrogenation of cinnamyl alcohol (4):
JH NMR Cinnamyl alcohol (4), CDCb, 8  7.22-7.40 (m, 5H, Ar), 6.58-6.64 (d, 1H, 
benzylic -CH=), 6.31-6.40 (dt, 1H, =CH-), 4.30-4.32 (d, 2H, -CH2-), 1.75 (s, 1H, -OH).
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'H  NMR Dihydrocinnamyl alcohol (16), CDCb, 8  7.16-7.30 (m, 5H, Ar), 3.61-3.66 (t, 
2 H, -CH2-), 2.66-2.71 (t, 2H, benzylic -CH2-), 1.84-1.94 (m, 2 H, -CH2-), 1.52 (s, 1 H, - 
OH).
2H NMR [2H]Dihydrocinnamyl alcohol (17), CHCfe, 8  2.75 (s, benzylic , -CHD-), 1.94 
(s, -CHD-).
d) Dihydrocinnamic acid (21) and [2H]dihydrocinnamic acid (18) were prepared from the 
hydrogenation of cinnamic acid (5):
*H NMR Cinnamic acid (5), CDCb, 8  7.78-7.83 (d, 1H, benzylic =CH-), 7.55-7.58 (m, 
2H, Ar), 7.40-7.42 (m, 3H, Ar), 6.44-6.49 (d, 1H, =CH-).
'll NMR Dihydrocinnamic acid (2 1 ), CDCb, 8  7.15-7.25 (m, 5H, Ar), 2.97 (t, 2 H, 
benzylic -CH2-) 2.70 (s, 2H, -CH2-).
2H NMR [2 H]Dihydrocinnamic acid (18), CHCb, 8  2.98 (s, -CHD-), 2.70 (s, -CHD-).
e) a-Methylhydrocinnamic acid (22) and [2H]a-methylhydrocinnamic acid (19) were 
prepared from the hydrogenation of a-methylcinnamic acid (6 ):
'H  NMR a-Methylcinnamic acid (6 ), CDCb, 8  7.84 (s, 1 H, -C0 2H), 7.33-7.46 (m, 5H, 
Ar), 7.26 (s, 1H, -CH=), 2.15 (s, 3H, -CH3).
*H NMR a-Methylhydrocinnamic acid (2 2 ), CDCb, 8  7.16-7.30 (m, 5H, Ar), 3.03-
3.08 (dd, 1H, -CH-), 2.62-2.80 (m, 2H, -CH2-), 1.15-1.20 (d, -CH3).
2H NMR [:H]a-Methylhydrocinnamic acid (19), CHCb, 8  3.02 (s, - C D - ) ,  2.61 (s, - 
C H D - ) ,  1.10 (s, ex., - C H 3 ) .
f)  4-Phenylbutyric acid (23) and [2H]4-phenylbutyric acid (2 0 ) were prepared from the 
hydrogenation of 4-phenyl-3-butenoic acid (7):
‘H NMR 4-PhenyI-3-butenoic acid (7), CDCb, 8  7.21-7.39 (m, 5H, Ar), 6.50-6.55 (d, 
1H, benzylic -CH=), 6.24-6.34 (tt, 1H, =CH-), 3.29-3.32 (d, 2H, -CH2-).
*H NMR 4-Phenylbutyric acid (23), CDCb, 8  7.16-7.31 (m, 5H, Ar), 2.64-2.70 (t, 2 H, 
benzylic -CH2-), 2.34-2.40 (t, 2H, -CH2-), 1.92-2.02 (dt, 2H, -CH2-).
2H NMR [2H]4-Phenylbutyric acid (2 0 ), CHCb, 8  2.63 (s, benzylic -CHD-), 1.92 (s, - 
CHD-).
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3.1 Introduction
3.1.1 Background
The successful development of improved labelling procedures for hydrogen isotopes, was 
reported in the preceding chapter. A second area of radiochemistiy is presented here, that 
with carbon-11, one of the important short-lived isotopes (tm = 20.4 min) used in 
positron emission tomography (PET). The aim was to label CGP 62349 {3—[1—(/?)—[3— 
(4-methoxybenzyl)phosphinyl-2-(/S)-hydroxy-propyl-amino]ethyl]benzoic acid} (Fig. 
3.1), a y-aminobutyric acid type B (GABAb) receptor antagonist, with carbon-1 1 , by 
improved procedures as a prospective radioligand for GABAb receptors. The work is 
based on a well-known labelling procedure, namely uC-methylation. A precursor, 3—[1— 
(i?)-[3-(4-hydroxybenzyl)phosphinyl-2-(6)-hydroxy-propyl-amino]ethyl]benzoic acid 
(CGP 67780), was chosen for reaction with either of two n C-methylating agents, 
[n C]iodomethane or [n C]methyl triflate, produced by improved methods in potentially 
higher specific radioactivity than hitherto. The radiochemical yields of [n C]CGP 62349 
from the improved labelling agents are compared with those produced by a former 
method.
OH
Fig. 3.1: Chemical structure of CGP 62349.
3.1.2 GAB A receptors
y-Amino-w-butyric acid (GABA) 1 (Fig. 3.2) is the most abundant and important inhibitory 
brain neurotransmitter. It decreases the rate of firing of postsynaptic neurons by increasing 
membrane conductance to chloride ions in the mammalian brain, spinal cord and retina. 
GABA is known to interact with two types of receptor, designated as GABAa and 
GABAb2,3. GABAA-receptors are linked to chloride channels and are activated by
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isoguvacine, modulated by barbiturates and benzodiazepines, and antagonised by 
bicuculline3 ,4  On the other hand, GABAB-receptors are transmembrane receptors linked 
to second messenger systems and calcium (Ca2+) and potassium (K+) channels via G - 
proteins5. GABAB-receptors are activated by the (7?)-(-)-enantiomer of the antispastic 
agent, baclofen ((3-/?-chlorophenyl-GABA) (Fig. 3.2)2-4, and antagonised by phaclofen 
(Fig. 3.2), but are insensitive to bicuculline3,4. GABAb neurons have an important role in 
the modulation of the release of several neurotransmitters, such as glutamate and 
dopamine, and their dysfunction may play a role in diseases such as Alzheimer’s and 
epilepsy6. The sulphonic analogues of baclofen, such as saclofen and 2 -hydroxysaclofen 
(Fig. 3.2) are good antagonists towards GABAb receptors. On the other hand, the 
phosphonic analogues of GABA itself and of baclofen are highly effective in GABAb 
receptor binding and as agonists in functional tests. Of these, 3-aminopropane-l-(p- 
methyl)-phosphinic acid (SKF 97541, Fig. 3.2) is a stable and effective agonist4. Other 
phosphinic acid analogues of GABA have found applications as selective GABAb 
antagonists7-9.
Cl
GABA
E^N
OH
Baclofen
COOH
S— OH
R O
R  = H; Saclofen 
R  = OH; 2-Hydroxysaclofen
O
h 2 n \ / v^ | >— o h  
c h 3
SKF 97541
P — OH
OH
Phaclofen
Fig. 3.2: Chemical structures of GABA and some examples of its agonists and antagonists.
At present there is no effective radioligand for imaging GABAb receptors in human 
brain with PET, and for investigating dysfunction in these receptors with respect to the
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evaluation of various neuropsychiatric disorders. CGP 62349 (Fig. 3.1) is a potent 
GABAfi-receptor antagonist (Kd = 0.535 nM; Kj = 0.58 nM) with potential to penetrate 
the blood-brain barrier in vivo10. Hence, there has been interest in developing this 
compound as a prospective radioligand for application in PET10,11. This requires a method 
for efficient labelling of the compound at the highest possible specific radioactivity with 
positron-emitting carbon-1 1 , so that the radioligand can be evaluated in vivo.
3.1.3 nC-Methylation
A high proportion of bioactive molecules (experimental drugs and therapeutics) contain 
one or more methyl groups, often bonded to heteroatoms, such as O, N and S. The need 
for labelled compounds specifically labelled in a methyl group as probes for biological 
studies of metabolism, pharmacokinetics or pharmacodynamics is evermore apparent12. 
Therefore, it is highly desirable to be able to label such methyl groups with carbon-11, 
especially at very high specific radioactivity. [n C]Iodomethane and related methylating 
agents are particularly suited to labelled compounds in the last step of a synthetic 
sequence.
Methylation is one the most important and most widely used methods for preparing 
1 ^ -labelled radiopharmaceuticals. Consequently, many 1 1C-labelled compounds of great 
interest, to PET clinical science - for application in metabolic and pharmacological studies 
in animals and man - have been prepared by this methodology. n C-Methylation is usually 
achieved by adding [n C]iodomethane (prepared separately from a primary cyclotron 
irradiation product, Fig. 3.3) to a solution of the desmethyl precursor of the compound to 
be labelled13.
The classical way of producing [u C]iodomethane is by reduction of cyclotron- 
produced [n C]carbon dioxide with lithium aluminium hydride followed by treatment with 
hydroiodic acid (Fig. 3.3 (A))14. Great care must be taken to produce [n C]iodomethane in 
high specific radioactivity with this method, as lithium aluminium hydride readily absorbs 
traces of carbon dioxide from the atmosphere. A new attractive gas phase method (on-line 
method), starting from cyclotron-produced [u C]methane, has been reported for obtaining 
[n C]iodomethane in higher specific radioactivity15. This method is based on a thermal
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reaction between [n C]methane and molecular iodine (Fig. 3.3 (B)). The reaction is carried 
out in a circulatory system in which a gaseous mixture of [n C]methane and iodine is 
repeatedly passed through a furnace at 725°C in order to achieve low conversion 
cumulatively15,16. The generated [n C]iodomethane is adsorbed from the circulated mixture 
on Porapak Q, from where it is later dispensed at raised temperature. Great control has to 
be taken in this procedure, as [n C]diiodomethane and [n C]iodoform can be formed as 
byproducts and so lower the yield of [n C]iodomethane. [n C]Iodomethane can be 
produced rapidly ( - 1 0  min) in 80% radiochemical yield (decay-corrected) with specific 
radioactivities in excess of 370 GBq (10 Ci)/pmol under optimal conditions15,16.
11 LiAlFL 11 HJ 11
(A) C 0 2   ---------► CH3 OH ------- —-------- ► CH3I
11 I2,725 °C n ™  t
(B) CH4  ----------------------------------------   ► CH3 I
Fig. 3.3: Preparation of [n C]iodomethane by, (A) ‘wet’ chemistry and (B) the ‘on-line’
method.
n C-Methylation of a primary or a secondary amine is a well-established procedure 
that can be performed under mild reaction conditions, for example, by treatment of the free 
base of the amine (Fig. 3.4), either dissolved directly or generated in situ from a salt by 
another mild base. The methylation of an amide requires strong base, such as sodium 
hydroxide to create a highly nucleophilic amide anion17,18. In addition to N -  
[n C]methylation, several 0 - [ n C]methylations19 and ^ -[“ CJmethylations2 0 -2 3  have been 
achieved using [u C]iodomethane.
[nC]CH J, 2-5 min, 80-125 °C
or
[nC] CH^OSOXF,, 1 min, 60°C 
R-NHR' ---------------------------------------------------►R-N [UC] CH3R'
R, R' = H, alkyl, aralkyl.
Fig. 3.4: Synthesis of n C-labelled amines through JV-methylation with
[n C]iodomethane or [n C]methyl triflate.
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[n C]Methyl triflate, prepared ‘on-line’ by passing [n C]iodomethane over silver 
triflate-impregnated graphitized carbon at 180°C (Fig. 3.6 (A)) has been introduced as a 
highly reactive alternative to [n C]iodomethane17,24 It gives high radiochemical yields 
from small amounts of precursor at low temperature and in short reaction times17,18,25-28. 
The use of this methylating agent has now been reported for the n C-methylation of 
amines18,25-28, thiols17, amides17, phenols17,29, methyl ethers29 and carboxylic acids30.
A new method is emerging for the preparation of [n C]methyl triflate via the 
bromination of cyclotron produced [n C]methane to produce [n C]bromomethane for 
conversion over silver triflate (Fig. 3.5)31. This method has potential to be more efficient 
and to achieve a very high specific radioactivity.
I4N (p , <X)" c  o n Ity H , ►"CH4  - - 2V  'CHjBr Ag0 S0 2 C F 3 'CH3 OS0 2 CF3
Fig. 3.5: Preparation of [n C]methyl triflate from [n C]bromomethane.
Some other n C-methylating agents have also been reported. An example is 
[n C]methyl nonaflate, which is prepared analogously to [n C]methyl triflate. However, in 
this case silver nonaflate was adsorbed on a-alumina before its reaction with 
[n C]iodomethane (Fig. 3.6 (B))32. [n C]Methanethiol has been prepared by reacting 
[n C]iodomethane with sodium hydrosulfide in dimethyl formamide at room temperature 
(Fig. 3.6 (C))20. This has been applied to the introduction of an [S-methyI-nC\ group in 
an aryl halide via a nucleophilic substitution reaction20.
A g0S0 2 CF3 / Graphpac GC „ NaSH
CELOSOXF,*---------------------------------------  CH3 I ----------------------------► CH3 SH
11.
3 2 3
180 °C
(A) (C)
C4F9 0 S 0 2Ag
C4F90 S 0 2"CH3
(B)
Fig. 3.6: Preparation of [u C]methyl triflate (A), [u C]raethyl nonaflate (B) and
[n C]raethanethiol (C) from [n C]iodomethane.
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[u C]Formaldehyde is usually prepared by passing [n C]methanol through a quartz 
tube containing silver wool heated to 450°C (Fig. 3.7) 3 3 ,3 4 [n C]Formaldehyde also finds 
application as a labelling agent and shows high selectivity for introducing the nC-N~ 
methyl group by reductive methylation.
"CHjOH
Ag, 500 °C
»  h "c h o
Fig. 3.7: Preparation of [uC]formaldehyde from [u C]methanol.
The radiochemical yields of u C-methylation products are usually sufficient to give
adequate activities (185-370 MBq; 5-10 mCi) for PET experiments in human subjects. 
Higher yields, shorter reaction times and lower reaction temperatures are helpful to 
achieve reliable routine production, or to provide multiple doses simultaneously. In 
addition, the use of a small amount of precursor is often important, for example to ease the 
final purification of the PET radioligand or to conserve precious precursor.
The aim of the work presented here is to obtain a high radiochemical yield of [O- 
methyl-11 C]CGP 62349 as a prospective radioligand for GABAb receptors by using high 
specific radioactivity labelling agents, such as [n C]iodomethane or [n C]methyl triflate, for 
the O -11C-methylation of CGP 67780. An abstract by Todde et al.10 has previously 
reported the radiosynthesis of [0-methyl-nC\CGV 62349 by reacting CGP 67780 with 
[n C]iodomethane at 80°C for 5 min in the presence of base (NaOH). However, an 
average radiochemical yield of only 9% (decay-corrected) was obtained. Also the specific 
radioactivity was low ( 1 100 -  1800 Ci/mmol) posing an obstacle to the rigorous biological 
evaluation of the radioligand in animals (W. Froestl, personal communication). By 
exploring the labelling of CGP 62349 with [n C]methyl triflate it might be possible to take 
advantage of the potentially higher specific radioactivity of this labelling agent (compare to 
[n C]iodomethane) when prepared via the bromination of cyclotron-produced methane.
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3.2 Discussion
3.2.1 Preparation of \0-methyl-n C]CGP 62349
[0-methyI-nC]CGP 62349 was prepared by reaction of NCA [n C]iodomethane with the 
desmethyl precursor, CGP 67780 in dimethyl sulfoxide at 80°C for 5 min in the presence 
of a small quantity of 4M sodium hydroxide solution (Fig. 3.8)10. The base in this reaction 
produces the reactive phenoxide ion for nucleophilic attack on [n C]iodomethane. In this 
precursor the secondary amino group is less nucleophilic. Hence, the phenoxide ion reacts 
preferentially. This type of O-methylation reaction is well-established as it is fast and 
usually produces high yields. However, Todde et a l reported a radiochemical yield of 
only 9% (decay-corrected)10. The reason for this low yield is not apparent from their 
report.
O ^ O H
CGP 67780
i) DMSO
ii) NaOH
iii)n C-Methylating agent 
v) 80°C > 5 min
OH
ii[O-methyl- C]CGP 62349
CHj
Fig. 3.8: Synthesis of [0-methyl-nC]CGP 62349 via 0 - u C-methylation of CGP 67780ii/
The first experiment aimed to reproduce the conditions of Todde et al.10. Because 
of the high level of radioactivity (> 2 Ci), the radiosynthesis was performed in a lead- 
shielded enclosure equipped with remotely-controlled apparatus (Fig. 3.10). The sequence
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of operations needed to achieve the radiosynthesis was controlled in timed steps by a 
Programmable Logic Controller (PLC). An automated reaction vial-penetrator allowed 
the precursor to be introduced, together with the reaction solvent and base into a septum- 
sealed vial. [u C]Iodomethane was then distilled into the precursor solution (methylation 
vial, Fig. 3.10). The vial was lowered into the heating bath for 5 min with stirring.
Further experiments were performed with [n C]iodomethane produced ‘on-line’, 
using a different procedure. [uC]Iodomethane was collected in a 50 ml glass syringe, 
usually at a low level of radioactivity (185-370 MBq; 5-10 mCi), and bubbled into the 
precursor solution. Then the sealed reaction vial was placed in the heating bath at 80°C 
for 5 min. The latter procedure was also performed using [nC]methyl triflate rather than 
‘on-line’ [n C]iodomethane as labelling agent.
In all cases, the reaction mixture was injected into the HPLC system and products 
were detected by monitoring radioactivity and UV absorbance. [0-methyl-nC]CGP 
62349 was identified by co-injection of authentic CGP 62349.
Table 3.1 (page 99) compares the radiochemical yields of [O-methyl-lC\CGV 
62349 for different sources of [u C]iodomethane, ‘wet’ or ‘on-line’. [O-methyl- XC]CGP 
62349 was obtained in highest radiochemical yield (~ 72%, decay-corrected) from 
[n C]iodomethane produced by the ‘wet’ method (Table 3.1, entries 1 and 2). This 
radiochemical yield is much higher than the 9% reported by Todde et al.10, by the same 
procedure. However, there is no obvious explanation for this huge discrepancy. It is 
worth mentioning that they trapped the [n C]iodomethane from a helium carrier stream 
into the reaction solution. I used nitrogen in my experiments.
The amounts of carrier produced during my preparations of [O-methyl-11C]CGP 
62349 were consistently low, irrespective of the duration of the irradiation to produce 
carbon-11. Thus, the highest specific radioactivity (40 GBq, (1.1 Ci)/pmol) was achieved 
from the experiment having the longest irradiation ( 2 0  min) and highest production of n C 
(Table 3.1, entry 1).
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In experiments using [u C]iodomethane produced ‘on-line’, as mentioned earlier, 
only low levels of radioactivity were used. However, good radiochemical yields were 
observed (62.50% and 52.6%; Table 3.1, entries 3 and 4 respectively). These were 
achieved despite the presence of significantly lower amounts of carrier compared to those 
in entry 1 (Table 3.1).
I also examined the effect of precursor weight on radiochemical yield. While 
62.50% radiochemical yield was obtained when 1 mg of the precursor was used (Table 
3.1, entry 3), only 50 and 53% radiochemical yields were obtained when 0.5 mg of 
precursor was used (Table 3.1, entries 4 and 5).
[O-methyl-1 C]CGP 62349 was also prepared using [n C]methyl triflate prepared 
‘on-line’ from [n C]iodomethane. The 1 ^ -methylation was performed using [n C]methyl 
triflate in place of [n C]iodomethane under otherwise identical conditions. The labelling 
agent trapped efficiently (> 90%) in the reaction mixture. \0-methyl-nC\CGP 62349 was 
produced in good radiochemical yields (45.4% and 55.4%), and specific radioactivity of (> 
53.0 and >192  mCi/pmol) (Table 3.1, entries 6  and 7). In both cases the amounts of 
carrier in the product were undetectable. The lower radiochemical yields of [O-methyl- 
n C]CGP 62349 from [n C]methyl triflate compared to those from [n C]iodomethane, may 
suggest that [n C]methyl triflate is more readily hydrolysed to [n C]methanol by the strong 
base (NaOH).
OH-
[nC]CH30S0 2CF3 ---------------------------► [^CfjCHgOH + CF3OSO;
Fig. 3.9: Hydrolysis of the [n C]methyl triflate in the presence of strong base.
Again, it should be noted that the amounts of carrier product from the [n C]methyl 
triflate reactions were lower than from the [n C]iodomethane reactions (Table 3.1). This 
suggests that if a higher level of radioactivity of [n C]methyl triflate were to be used, a very 
high radiochemical yield of the product with a high specific radioactivity could be 
expected.
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The relationship between the radiochemical yields and the estimate of maximal 
amount of carrier methylating agents ([n C]iodomethane or [n C]methyl triflate) can be 
seen in Fig. 3.14. The graph strongly indicates that the radiochemical yield increases with 
the amount of carrier methylating agent in both cases.
Finally, the reaction was performed with and without quenching with hydrochloric 
acid. As expected there was no difference in radiochemical yield (Table 3.1, entries 4 and 
5). Hence, the acid only serves to neutralise the reaction mixture.
3.3 Experimental and Results
3.3.1 Materials
CGP 67780 (3-[l-(jR)-[3-(4-hydroxybenzyl)phosphinyl-2-(1S)-hydroxy-propyl-amino]ethyl] 
benzoic acid) and CGP 62349 (3-[l-(i^)-[3-(4-methoxybenzyl)phosphinyl-2-(6)-hydroxy- 
propyl-amino]ethyl]benzoic acid) were supplied by Dr W. Froestl (Novartis, Basel, 
Switzerland). All reagents were purchased from Aldrich Chemical Co. in greater than 
99.5% purity and were used without further purification. All solvents were AR grade or 
better.
3.3.2 Analytical methods
All reactions mixtures were analysed by HPLC on a Bondclone 10, C-18 column (150 x
3.9 mm, i.d.; 10 jam particle size; “Phenomenex”) eluted with 0.05M sodium dihydrogen
j
phosphate-ethanol (8 8 : 12 v/v) at 2.0 ml/min, with eluate monitored for absorbance at 254 
n m o n a  linear scale (Liner UV-106 instrument) and radioactivity (Bioscan, Nal, 20 mm 
diameter; Lablogic; Sheffield, UK or G-M tube; Minialarm Ltd.) on a linear output Dul 
scale.
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3.3.3 Detection and measurement of carbon-11
A calibrated IG 12 ionisation chamber was used to measure low and high activities of 
carbon-11 (0.037-1110 MBq) in sealed sources, at recorded times. Measurements were 
corrected for background radiation. Finally, all measurements were corrected for physical 
decay of the carbon-11 to a specific time, usually the end of its production EOB. 
Radioactivity in the experiments was monitored using Mini-Geiger Muller tubes.
3.3.4 Preparation of NCA [nC]carbon dioxide and [nC]methane
3.3.4.1 [nC]Carbon dioxide
Carbon-11 was produced as NCA [n C]carbon dioxide by the 14N(p,a)n C nuclear 
reaction3 5 ,3 6 in nitrogen gas containing 0 .1 % oxygen at 2 1 0  psi (14 bar), using a 30 juA 
beam current of 19 MeV protons from a Scanditronix MC40 cyclotron. Typically, a 30 
min proton irradiation gave > 74 GBq (> 2 Ci) of [u C]carbon dioxide at EOB in high 
specific radioactivity. However, irradiation with a 10 fiA beam for 1 min was used in 
almost all experiments. The generated [n C]carbon dioxide was transferred in a nitrogen 
stream from the target to the hot-cell through stainless steel tubing ( 1 / 8 ” o.d.) and passed 
through a column of dehydrating agent [magnesium perchlorate (MgC1 0 4 .H2 0 ) or 
phosphorous pentoxide (P2 O2)]. The target was emptied within 2.5 min from EOB at 2 
L/min. The [n C]carbon dioxide was trapped in a small coil of stainless steel tube (20 cm x 
1/16” o.d . ) 37 immersed in liquid argon ( -  186°C) and recovered by warming the trap to 
room temperature while it was purged with a slow stream of nitrogen. The efficiency of 
radioactivity entrapment was > 98% and recovery was quantitative. A programmable 
logic controller (Toshiba Ltd.) was used for the trapping and dispensing of [n C]carbon 
dioxide in a lead-shielded hot-cell. The lowering and raising of the stainless steel trap, for 
transferring [n C]carbon dioxide in and out of liquid argon, was achieved using a 
pneumatically-driven piston38 (Fig. 3.10).
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3.3.4.2 [nC]Methane
[n C]Methane was produced by the 14N(p,a)n C nuclear reaction on a target of nitrogen 
gas containing 5% hydrogen at 240 psi (16 bar) 39 using a 10 pA beam current. 
[u C]Methane was trapped from the target gas in a Porapak™ Q trap cooled with liquid 
argon ( -  186°C). [n C]Methane was recovered by wanning the trap to room temperature 
while purging it with nitrogen at 1 0 0  ml/min.
3.3.5 Preparation of [nC]iodomethane from [nC]carbon dioxide (‘wet’ method)
The trapped [n C]carbon dioxide was transferred in a stream of nitrogen at 8  ml/min for 2 
min into a solution of lithium aluminium hydride (LiAlFL; 0.2M) in tetrahydrofuran (THF, 
2 0 0  jil) contained in a small vessel (1.5 ml) fitted with a Teflon-faced septum. The solvent 
was evaporated off under nitrogen at 120°C for 3 min and the vessel then cooled by 
compressed air for 2.5 min. The radioactive residue was treated with hydroiodic acid (HI) 
(57% w/v) under reflux for 2 min40^ 2. The generated [n C]iodomethane was then 
transferred into the methylation vessel by purging the heated vessel at 160°C with a 
continuous stream of nitrogen. [n C]Iodomethane was prepared in 10 min from EOB in > 
90% radiochemical yield (decay-corrected). The radiosynthesis was performed in a lead- 
shielded hot cell with remote control of all operations using a programmable logic 
controller (PLC) (Toshiba Ltd.)43. The automated apparatus is illustrated in Fig. 3.1044.
3.3.6 Preparation of [nC]iodomethane from [nC]methane (‘dry’ method)
The preparation was carried out in the apparatus shown schematically in Figure 3.1115’16. 
[n C]Methane was collected in the cooled (liquid nitrogen) Porapak™ N trap. After 
flushing the trap with helium, the pump was started and the Porapak™ N trap raised from 
the liquid nitrogen and heated to room temperature. The [n C]methane-helium mixture 
was pumped at 500 ml/min from the trap into a quartz-tube. The gases were mixed with 
vapours from iodine crystals and heated to 60°C in the first furnace. The mixture was 
passed through the second furnace and the temperature increased to 725°C15. The gases 
were passed through a quartz tube kept at room temperature (the condensation zone),
97
Chapter 3 Synthesis of [Q-methyl-uC]CGP 62349, via Q-[11C]Methylation
where most of the excess of iodine crystallised and then the gas mixture was passed 
through a tube (14 cm long) filled with Ascarite where hydrogen iodide and the rest of the 
iodine was trapped. The [nC]iodomethane was trapped on the Porapak™ N trap at room 
temperature. By increasing the temperature to 190°C the [n C]iodomethane was released 
into a stream of helium15 and bubbled through the reaction mixture (Fig. 3.11). The 
radiochemical yield of [n C]iodomethane from [n C]methane was 40%31. Low levels (185— 
370 MBq; 5-10 mCi) of [u C]iodomethane were collected in gaseous form in a 50 ml glass 
syringe and then bubbled by hand into a reaction vessel.
3.3.7 Preparation of [nC]methyl triflate from [nC]iodomethane
The preparation was carried out in either of the apparatus shown schematically in Figure
3.10 or 3.11. [u C]Methyl triflate was prepared by transfer of [n C]iodomethane through a 
soda glass column heated at 180°C and containing silver triflate (Ag0 S0 2 CF3)- 
impregnated graphitized carbon (Fig. 3.6 (A)). This column was inserted between valves 9 
and 10 in Fig. 3.102 4 ’2 7 ’45 for the production of [n C]methyl triflate from [n C]iodomethane 
produced by ‘wet’ chemistry. The column was inserted after valve 6  in Fig. 3.I I 15’31 for 
production from ‘dry’ [n C]iodomethane. The [n C]methyl triflate was collected in 
gaseous form in a 50 ml glass syringe and then bubbled by hand into the reaction vessel. 
The radiochemical yield of the [n C]methyl triflate was 60-70% (decay-corrected) from 
[n C]iodomethane.
3.3.8 Radiosynthesis of [0-m ethyl-11 C]CGP 62349
CGP 67780 (1 mg; 2.42 jumol), pre-dried under vacuum at 40°C for 2 h, was dissolved in 
anhydrous dimethyl sulfoxide (400 |xl) plus 4M aqueous sodium hydroxide (10 (xl) in a 
sealed reaction vial (2 ml volume). The mixture was left to stir for 5 min at room 
temperature before the labelling agent (n CH3I or n CH3 0 S0 2 CF3) was trapped in the vial 
from a stream of nitrogen. When [n C]iodomethane, produced by ‘wet’ chemistry was 
used, the trapping was performed using an automated system in a lead-shielded hot-cell 
(since a high level of radioactivity was used). The labelling agent (n CH3I or 
n CH3 0 S0 2 CF3) produced on-line, was usually trapped into the reaction vial by collecting
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about 50 ml of the labelling agent into a 50 ml glass syringe and then bubble it into the 
reaction mixture at about 1 atmospheric pressure.
The reaction mixture was heated using an oil bath at 80°C for 5 min. On completion 
of the reaction period the mixture was allowed to reach room temperature, quenched with 
1M hydrochloric acid (90 pi) and then stirred for 2 min at room temperature. The reaction 
mixture was then diluted with 0.05M sodium dihydrogen phosphate buffer pH 7.0 (1 ml). 
Samples from this mixture were analysed directly by reverse phase (see Section 3.3.2) 
HPLC. Co-injection of authentic CGP 62349 was used to identify the radioactive product 
peak.
Table 3.1: Radiochemical yield of [0-methyl-nC\CG? 62349 from different methylating 
agents. All values, initial radioactivities, radiochemical yields and specific 
radioactivities were decay-corrected to EOB.
Entry Labelling
agent3
Initial
radioactivity
(mCi)
Radiochemical
yield
(%)
Product specific 
radioactivity 
(mCi/pmol)
Product carrier 
(pmol/1.5 ml)
1 A(L)b 704 78.3 1080 0.51
2 A(L)° 91.5 65.8 >335 <0.18
3 Ag) 68.7 62.5 >239 <0.18
4 V 27.5 52.6 >80 <0.18
5 V 27.3 50.0 >76 <0.18
6 B(g) 9.6 55.4 >53 < 0 . 1 0
7 B(g) 42.4 45.4 > 192 < 0 . 1 0
a A = nCH3I and B = "CHsOSOzCFs. 
b From 20 min irradiation at 30 pA.
c From a 1 min irradiation at 30 pA. All other runs were performed using 10 pA for 1 min 
irradiation.
d 0.5 mg of the precursor was used; other reactions used 1 mg of precursor.
(D indicates labelling agent produced by ‘wet’ chemistry.
(g) indicates labelling agent produced by ‘on-line’ chemistry.
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i f CGP 62349
1 1 (reference)
CGP 67780
ii
{ O - m e th y l -  62349
CGP 62349 
(reference)
CGP 67780
[ 0 - m e t h y l - \ ; \ C G V  62349
______I
Time (min) 
(A)
Time (min)
(B)
Fig. 3.12: Analytical radiochromatogram of the reaction mixture from the treatment of
CGP 67780 with [n C]iodomethane;
(A) [n C]CH3I prepared by ‘wet’ chemistry, (B) [nC]CH3I prepared ‘on-line’.
3.3.9 Estimation of carrier product
The specific radioactivities in the above Table were derived from estimates of the carrier 
product (CGP 62349) present in the reaction mixture at the end of the methylation 
reactions. However, in most cases the carrier was low or almost undetectable. This made 
it difficult to estimate the carrier amounts accurately from the calibration graphs obtained 
by analytical HPLC of standard solutions o f CGP 62349. These graphs were produced in 
two ways; (i) using the peak paper weight (mg), and (ii) using the peak height (cm) (Fig. 
3.13, A and B). These proved that in all experiments the desired radioactive product was 
obtained with no or very little carrier present (Fig. 3 .12).
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(A)
25
15
10
5
0
15 250 5 10 20
CGP 62349 concentration 
((ig/ 2 0  jj.1 ofinjectate)
(B)
12
10
8
6
4
2
0
0 5 10 15 20 25
CGP 62349 concentration 
(pig/ 2 0  |j,l ofinjectate)
Fig. 3.13: Calibration of the analytical HPLC method for the detection of CGP 62349, 
using standard solutions; (A) using the peak paper weight (mg), (B) using the peak height
(cm). The error bases are ± 5 (n = 3).
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Fig. 3.14: Dependence of radiochemical yields of [O-methyl-lC\CGV 62349 on the
amount of carrier labelling agent.
[preparation from [n C]iodomethane (■), and [n C]methyl triflate] (D)].
3.4 Conclusions
1 ) The y-aminobutyric acid (GABAb) receptor antagonist, [O-methyl- 1C]CGP 62349, 
was prepared in good radiochemical yield (45-78%) by methylating the 
corresponding desmethyl precursor, CGP 67780, with [n C]iodomethane produced 
by ‘wet’ or ‘dry’ chemistry. The present radiochemical yields are > 5 times higher 
than that previously reported (9%) by Todde et al.10. As mentioned earlier in the 
discussion, no clear explanation for this discrepancy is apparent.
2) Radiochemical yields of [O-methyl-11 C\CGP 62349 were found to show some 
dependency on the amount of carrier methylating agent in the reaction mixture. The 
presence of high amounts of carrier methylating agent gave the highest yields (Fig. 
3.14).
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3) Even so, useful yields were obtained in the presence of low amounts of carrier (< 0.1 
jumol), suggesting good prospects for producing the radioligand at very high specific 
radioactivity (> 238 mCi/fimol) from [n C]iodomethane prepared by ‘dry’ chemistry, 
once this is optimised.
4) [u C]Methyl triflate was shown to be a useful alternative 1 ^ -methylating agent for 
the radiosynthesis of [O-methyl-11 C]CGP 62349, even under basic conditions. The 
radiochemical yields obtained were (45 and 55%).
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4.1 Introduction
Carbon monoxide has a low reactivity in organic synthesis. Rather harsh conditions, 
including high pressures, high temperatures, long times and highly reactive reagents often 
have to be employed to achieve conversions of carbon monoxide1. Carbon-11 can be used 
in the form of [n C]carbon monoxide, as it is a readily available precursor available from 
the ‘on-line’ thermal reduction of cyclotron-produced [nC]carbon dioxide over heated 
zinc powder2, molybdenum3 or charcoal4 (Fig. 4.1). [n C]Carbon monoxide is used as a 
radiotracer for blood volume measurement in humans3. [n C]Carbon monoxide has also 
proved useful for the preparation of certain carbonylated organic compounds5, such as 
[n C](*S)-CGP 12177 via conversion into [n C]phosgene6-9.
(A) Zn + "CO, — — ► ZnO + nCO
ocn°r
(B) Mo + 2 UC 0 9 ---------------- ► MoCL + 2 nCO
(C) C + CO,
ii  900°C
*  2  CO
Fig. 4.1: Methods for reducing [n C]carbon dioxide to [n C]carbon monoxide.
[n C]Carbon monoxide has not yet found widespread use as a labelling agent for the 
production of radiopharmaceuticals for positron emission tomography (PET). One of the 
reasons has been the difficult solubilisation of [n C]carbon monoxide in organic solvents, 
which has limited the efficiency with which it can be trapped in solution for reaction. 
However, there are now methods to overcome this problem including recirculation of 
untrapped [n C]carbon monoxide through the reagent solution10 or confinement of the 
[n C]carbon monoxide with reactants in a high pressure (300 atm) micro-autoclave11.
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4.1.1 Development of [nC]Amides
[nC]Amides can be produced with cyclotron-generated [nC]carbon dioxide via 
carboxylations of Grignard reagents. The product from the HC-carboxylation of a 
Grignard reagent has been used in two main ways: (i) by treating the intermediate 
magnesium halide (bromide or chloride) salt of the [nC]carboxylic acid directly with the 
secondary amine in the presence of base (Fig. 4.2, procedure A)12, or (ii) by reacting the 
same salt with phthaloyl dichloride (PDC) or thionyl chloride in tetrahydrofuran (THF) to 
prepare the corresponding highly reactive [carbonyl-11 C]acid chloride. The latter 
compound is then treated with a secondary amine in the presence of base (Fig. 4.2, 
procedure B)13-18.
14N (p,oc)nC on N 9 - O . l % 0 2
CO,
RMgX
-> [R nCOOMgX] R R N 'H
PDC or 
SOCl2/THF
R uCOCl
70°C 
5  min
1 2  11 ^ .,
► R R N - C - R
70°C, base, THF O
Procedure A
r ‘r 2 n - h
Et3N
1 2 1 UR R N - C - R
O
Procedure B
Fig. 4.2: Established procedures for the preparation of [nC]amides from [nC]carbon
dioxide through Grignard reagents and secondary amines.
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Procedure A also produces the [n C]carboxylic acid corresponding to the unreacted 
[u C]carboxylate (Rn COOMgBr) in a variable ratio with the [n C]amide. [n C]Amides are 
obtained in 65-80% yields, decay-corrected in a 20 min overall synthesis time.
On the other hand, procedure B is older1 3 -1 8  and has been used much more 
extensively; a wide range of [n C]acid chlorides can be prepared. Volatile [n C]acid 
chlorides (e.g. Rn COCl, R = Me, Et, Pr, c.Pr, Bu) can be prepared by treating the 
Rn COOMgBr adduct with phthaloyl dichloride and 2,6-<7/W-butyl pyridine. The volatile 
[n C]acid chloride can be flushed out of the heated reaction mixture, in a stream of 
nitrogen, into a second pot for labelling a particular precursor. Several compounds have 
been labelled in this manner e.g. [u C]melatonin15 and [n C]diprenorphine19. Less volatile 
[n C]acid chlorides (e.g. [2-n C]furoyl chloride) 14 can be prepared in this manner but are 
difficult to isolate from the reaction mixture16,17. One option is to prepare and use the 
[n C]acid chloride in a single pot. An important example of the application of this 
procedure is in the preparation of an effective radioligand for the study of 5-HTiA 
receptors in human brain with PET, namely [carbonyl-lC\WAY 10063 517 [TV—(2—(1—(4— 
(2-methoxyphenyl)-l-piperazinyl)ethyl))-7V-(2-pyridyl)cyclohexanecarboxamide]. The 
preparation starts with the synthesis of [carZ>o«y/-n C]cyclohexanecarbonyl chloride (Fig. 
4.3, HI). [n C]Carbon dioxide is dispensed into a solution of cyclohexylmagnesium 
chloride (Fig. 4 .3 ,1) in a mixture of diethyl ether and THF at 0°C; thionyl chloride in THF 
is added to the [n C]adduct (Fig. 4.3, H), and then the sealed reaction mixture heated to 
70°C for 2 min to generate the [car&o«y/-n C]cyclohexanecarbonyl chloride (Fig. 4.3, HI). 
Addition of the amine WAY-100634 [l-(2-methoxyphenyl)-4-(2-(pyridylamino)- 
ethyl)piperazine] to the same pot generates [carZ?o«^/-n C]WAY 100635.
Alternatively, [carZ>o«y/-n C]cyclohexanecarbonyl chloride (Fig. 4.3, m )  can be 
generated by passing [n C]carbon dioxide through a polypropylene tube that has been pre­
washed with a solution of cyclohexylmagnesium chloride in a mixture of diethyl ether and 
THF17. Thionyl chloride in THF is passed through the polypropylene tube. The generated 
[carbonyl-11 C\cyclohexanecarbonyl chloride (Fig. 4.3, m )  is then transferred into a 
septum-sealed vial containing pre-dried WAY-100634 and triethylamine in THF. Heating 
of the reaction mixture at 70°C for 5 min with magnetic stirring gives [carbonyl-11 C]WAY 
100635 (Fig. 4.3) in 60% radiochemical yield decay-corrected.
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MgCl
CO,
COOMgCl
SOCL
’COCl
a ) (H)
N
("I)
MeO r  'N  
•N/■
T„ /
MeO f N O
/ N .
WAY 100634 [carbonyl- C]WAY 100635
Fig. 4.3: Radiosynthesis of [carSony/-11C]cyclohexanecarbonyl chloride (HI) and its
use for the preparation of [ca/'Ao/tjV- 1 [C] WAY 100635.
["CJAmides have also been prepared by palladium(0)-mediated coupling of aryl 
iodides to amines with [n C]carbon monoxide insertion (Fig. 4.4)11. These reactions open 
up wide possibilities for n C-labelling. The method is a useful alternative to the use of 
[u C]carboxylate salts.
O
Pd(PPh,)., “CO, DMSO ..II /  \
P H  ^ ^ P h - C - N  N - U J - C 1
Fig. 4.4: Synthesis of a [n C]amide via Pd-catalysed insertion of [n C]carbon monoxide
Another palladium-catalyzed carbonylation has been reported as a route to primary 
amides (Fig. 4.5) 20. The procedure is based on the use of hexamethyldisilazane (HMDS) 
as a nucleophilic partner in carbonylative coupling to aryl or vinyl iodides or triflates, and 
produces primary amides. The procedure could be highly valuable if adapted to n C- 
radiochemistry.
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X
+ HN(SiMe3 ) 2
PdCl2 / PPhj
DMF, 80°C> CO 
MeOH / H+
CONH,
X -  I, OTf? \ /  = aryl, vinyl
Fig. 4.5: Preparation of primary amides via Pd-catalysed insertion of carbon monoxide.
However, all the above methods have some difficulties. For example, some are 
multi-step processes and others involve the preparation of volatile compounds. A 
promising method, reported in the early 1980’s by Kilboum et a l21, is based on inserting 
[n C]carbon monoxide directly into a nitrogen-lithium bond, followed by quenching the 
generated intermediate with different electrophiles (Fig. 4.6). However, it was reported 
that only low yields of [n C]amides (12-15%) were obtained from these carbonylations of 
lithium dialkylamides.
N -L iNH +
N — CHO
R = Me, Et
Fig. 4.6: Preparation of [n C]amides via direct [n C]carbon monoxide insertion into a
lithiated-nitrogen bond, according to Kilbourn et a l21.
This work was followed by another investigation by Lindsay, aimed at synthesising 
carbamoylstannanes and aromatic carbamoylates from carbon monoxide22. The latter 
report claims that Kilbourn et aV  s method could be performed using various electrophiles 
(Fig. 4.7). However, the work was not frilly repeated using [n C]carbon monoxide, only
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the measurement of the efficiency of the trapping of [n C]carbon monoxide in the reaction 
mixture was reported23.
R.NH
BuLi. THF / DME, -78°C
C O , E+
-► R^NCOE
E+ = Ph-CO-Me 
Ph-CO-Ph 
Mel, CH2=CHCH2Br 
PhCH2Br 
RCN 
RCOC1
E = PhC(OH)Me 
PhC(OH)Ph 
Me, CH2=CHCH2  
PhCH2  
R
RCO
Fig. 4.7: The scheme proposed by Lindsay23 for preparing amides by inserting carbon
monoxide into a nitrogen-lithiated bond followed by treatment with a range of electrophiles.
The possibility of applying this approach to [n C]carbon monoxide has to be treated 
with caution. The possibility of a double carbonylation (insertion of two molecules of 
carbon monoxide into the organic molecule) has been reported by Rautenstrauch and 
Joyeux24, in the carbonylation of lithium piperidide (Fig. 4.8). In the presence of 
cyclohexanone, a 4: 1 molar ratio of mono to di-carbonylation was observed. Di- 
carbonylation only was observed when methyl iodide was the electrophile. These findings 
are consistent with Lindsay’s23 experience, as he claimed that the reaction of 
lithiocarboxamide with the quenching iodomethane is difficult to control, because the 
ketones formed will have an acidic hydrogen (alpha to a carbonyl group) that can react 
further with «-butyllithium or lithiocarboxamide to give a mixture of products (Fig. 4.8).
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CO
y
CO
CH3I
A 0  
N-y
HO
+
A O
7  ) - CH3
o
\ OHN
/
1
Fig. 4.8: The dicarbonylations resulting from the treatment of lithium amides with
carbon monoxide and subsequent quenching with difference electrophiles.
The expected advantages of [n C]carbon monoxide insertion reactions for the 
preparation of [n C]amides are: (i) short reaction time (5-7 min, after the reduction of 
[n C]carbon dioxide), (ii) use of a single pot, (iii) no involvement of involatile intermediate 
compounds and, (iv) possibility of being able to prepare different amides by varying the 
amines and electrophiles.
The above approaches to the radiosynthesis of [n C]amides have seen little 
development since they were first reported. The aim of the work in this chapter was to 
explore and develop these approaches, with a view to real utility in the preparation of new 
PET radiopharmaceuticals. Initial experiments were designed so as to repeat the direct 
insertion of [n C]carbon monoxide into the nitrogen-lithium bonds of lithiated secondary 
amines21. If the procedure worked it might then be employed as an alternative production 
method for the important radioligand [carZ>o«y/-u C]WAY 100635. In addition, variation 
in the structure of dialkylamine and carbon electrophiles should allow the synthesis of 
many other [n C]amides.
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4.1.2 Development of [n C]Ketones
[n C]Ketones, as PET radiotracers, have been mostly prepared using catalysed procedures. 
For instance, palladium-mediated [n C]carbonylation is a versatile method for the 
transformation of organohalides to labelled aldehydes, ketones, carboxylic acids and 
amides3’25-27. The use of carbon monoxide has been extended to a promising palladium- 
catalysed carbonylative cross-coupling reaction of organostannanes with boron
OS o n
compounds and carbon monoxide for the facile synthesis of ketones ’ - . This method 
could become an important procedure for the routine preparation of 1 1C-labelled PET 
tracers3. Recent reports have highlighted the use of [n C]carbon monoxide as a labelling 
agent in the preparation o f 1 1C-labelled ketones10’11.
Lidstrom et a / . 10’11 reported the synthesis of [carbonyl-nC]ketones via the treatment 
of vinyl and aryl halides and trifluoromethanesulfonates (triflates) with [n C]carbon 
monoxide in the presence of palladium catalyst followed by quenching with an organotin 
compound (Fig. 4.9). By using water father than an organotin compound as the quenching 
material in the same procedure, [carbonyl-11 C]carboxylic acid was obtained (Fig. 4.9)26’27. 
The reactions were carried out at 80-130°C for 4-5 min under 1 atmosphere pressure of 
nitrogen-[n C]carbon monoxide, in a system which re-circulated unreacted [n C]carbon 
monoxide. The radiochemical yields were between 35-70%27. The effects of different 
solvents on the [n C]carbon monoxide trapping efficiencies and on the radiochemical yields 
of the [n C]ketones were examined10’11. Polar solvents, such as 7V-methylpiperidin-2-one 
(NMP) and dimethyl sulfoxide (DMSO), gave more promising results than ethers, such as 
tetrahydrofuran (THF) and 1,3-dioxane. However in DMSO more by-product was 
formed than in NMP10’11.
RSnMe, ..
--------------------------  ► R' COR
DMSO or DMF or THF or NMP
nCO (1 atm), 80-13 0°C, 4-5 min 
--------------------------------------------► R' COOH
h 2o
Fig. 4.9: Palladium-catalysed coupling of vinyl and aryl halides and triflates with
[n C]carbon monoxide and an organotin compound or water.
R'X +Pd(PPh3 ) 4  or Pd(II) —  
X = I, OTf
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A general mechanistic scheme was proposed for the synthesis of [carbonyl- 
n C]ketones from [n C]carbon monoxide in the presence of palladium(O) catalyst. It 
includes four basic steps in the carbonylative cross-coupling reaction: (i) oxidative 
addition, (ii) [n C]carbon monoxide insertion, (iii) transmetallation and (iv) reductive 
elimination (Fig. 4.10)10.
L L O
RX ' CO I n ll
PdL, :------------ — --------► X —Pd—R .---- ► X - P d  — C — R
(i) Oxidative addition I (u) Insertion |
L L
O
Jl (iv) Reductive elimination
R'—C — R «----------------------------------
(iii) Transmetallation 
L O
R'SnR"3
L O
11.
L - P d  —!c  - R  * --------r - r -  R '-P d  -  C - 1| isomerisation |
R' L
ds trans
Fig. 4.10: A mechanistic scheme for the synthesis of [carbonyl-llC\ke\onQ$ from 
[n C]carbon monoxide using palladium(O) catalyst.
The development of [n C]carbon monoxide as a labelling agent has thus far been 
heavily based on the extensive preliminary work performed with stable carbon monoxide. 
Recently31, a palladium-catalyzed carbonylative cross-coupling procedure was reported 
for the rapid preparation of ketones using iodonium salts with organostannanes and carbon 
monoxide under mild conditions (Fig. 4.11). The molar ratio of reactants was 1: 1.03-1.1 
(iodonium salts: organostannanes), in the presence of palladium(II) chloride (0.2%) as 
catalyst and a solvent mixture of 1,2-dimethoxyethane (DME) -  water (4: 1 v/v)31.
1?I1+DW -  PdCL(0.2 m ol%)
RSnBu, + R I PhX ----------1-----------------------► RCOR'
3 D M E/H 20  (4 : 1), r.t.
CO (1 atm), 2 0  min
Fig. 4.11: Synthesis of ketones from palladium-catalysed cross-coupling reactions of
iodonium salts with organostannanes.
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This and other reports32 ,33 provide an opportunity to test the scope of the reaction for the 
preparation of [u C]ketones from [n C]carbon monoxide, especially since convenient 
syntheses of a wide range of diaryliodonium salts has recently been reported within our 
research group34 ,35 (Fig. 4.12).
SnMe
X
os
,+ Tos
w // w //
x
Fig. 4.12: Synthesis of diaryliodonium salts by treatment of substituted arenes with
Koser’s reagent35.
In conclusion, the above considerations suggested a means to widen the utility of 
[n C]carbon monoxide as a labelling agent, or at least to better understand its behaviour in 
palladium(II)-mediated reactions. First, this might be achieved by repeating some of the 
reported reactions with aryl iodides, before proceeding to develop a new labelling process 
with iodonium salts by optimising reaction conditions (amount of iodonium salt precursor, 
catalyst and organostannane, [u C]carbon monoxide trapping efficiency, reaction time, 
solvent, temperature and type of catalyst).
In this work iodobenzene and its derivatives were first used in catalytic coupling 
carbonylations with organostannanes compounds and [n C]carbon monoxide. Subsequently 
these reactions were performed with readily available diphenyliodonium salts.
4.1.3 Aims
The general aim and objectives of this work were to develop novel routes adaptable to 
1 ^ -labelling of amides and ketones, based upon
i) the direct insertion of [n C]carbon monoxide into lithiated amines and,
ii) palladium(II)-mediated cross coupling reactions of aryl iodides or diaryliodonium salts 
with arylstannanes plus [n C]carbon monoxide insertion.
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4.2 Discussion
4.2.1 P rep ara tio n  of ^C JA m ides
The aim of the first part of the study was to investigate the 1 ^ -carbonylation of lithium 
dialkylamides and the reactions of these carbamoyl-lithium products so as to develop 
routes to [n C]amides, such as [carbonyl-11 C]WAY 100635.
In order to perform this study, three secondary amines were chosen for synthesising 
the [n C]amides via direct insertion of [n C]carbon monoxide into the organic molecules. 
These were the free bases of piperidine, 1,2,3,4-tetrahydroisoquinoline (THIQ) and 
WAY-100634 (Fig. 4.13). It was intended that once the procedure had been worked out, 
W AY-100634 would be n C-carbonylated in order to produce analogues of [carbonyl- 
n C]WAY 100635. However, during the course of this work it proved impossible to 
adhere to this plan, for reasons which will be apparent from the following discussion.
A
NH
J
Piperidine
CO.
1,2,3,4-TetrahydroisoquinoIine
MeQ
WAY-100634
Fig. 4.13: Chemical structures of the three secondary amines used in this study.
The claimed synthesis of [n C]amides via the 1 ^ -carbonylation of lithium 
dialkylamides with [n C]carbon monoxide can be illustrated as follows:
BunLi il 11,
R2NH dlyS0lvent> R.N i /  - 2 2    R.N - COLi - |
r - 7 8 C n
R'X = Mel, EtI, c.Hex-Br, PhBr
 — ------► R^N uCOR’
-  78°C to RT
1L
h 2o
iysr c h o
Fig. 4.14: Reported 1 ^ -carbonylation at a nitrogen-lithium bond.
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4.2.1.1 [n C] Carbonylation of piperidine
Piperidine was expected to undergo lithiation and then carbonylation of the nitrogen- 
lithium bond with [n C]carbon monoxide at -  78°C. Quenching with electrophiles was 
expected to give [7V-carZ>o«y/-11C]piperidine derivatives (Fig. 4.15).
"\ dry solvent /  \ - + .  n c o
NH ----------------------------► \  N Li/  n \  /  78°C
J  BuLi N '
I
LiX
^  11 .N — C—Li —\
J  II 
O
RX 7  /  \  11
N —C — R
-  78°C to RT
7
O
\  ii N — C — H
n  H. 0  \ — /
o
RX =MeI, EtI, c.Hex-Br, PhBr 
Fig. 4.15: Proposed scheme for preparation of [A^-carZ>o«y/-n C]piperidine derivatives.
The major problem in attempting this procedure with organohalides (RX) is to exclude 
water from the reaction medium as its presence may promote the formation of unwanted 
side products, especially the 7V-formamide derivatives. To overcome this problem all the 
reaction glassware was super-dried before use. This entailed drying the solvent (THF) 
immediately prior to use and also a re-distilling the piperidine. Furthermore, the reaction 
vial was vented through magnesium sulphate contained within a plastic syringe to avoid 
any ingress of atmospheric moisture.
In these carbonylation studies, two procedures were examined. The first was a 
procedure (A) based on that reported by Lindsay22,23. The second procedure (B) was the 
exact procedure followed by Kilbourn21, as further defined by personal communication 
with him. However, there was very little difference between the procedures, except that 
the solvent in procedure (A) was dry THF and in procedure (B) a mixture of dry THF and
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dry DME in a 1: 1 molar ratio. In addition, the reactants in procedure (B) were used on a 
larger scale.
For the examination and testing of procedure A, blank reactions were performed. 
The first reaction involved dissolving w-butyllithium in dry THF, stirring at -  78°C for 5 
min, and then bubbling the measured activity of [n C]carbon monoxide though the mixture. 
Only 2.5% of the [n C]carbon monoxide was trapped and only a small radioactive product 
(retention time 3 min) was observed by radio-HPLC analysis (Table 5.1, entry 1). The 
detected radioactive product was not identified. However, from the reaction contents, one 
possibility for product formation is the following reaction:
„  n . Dry THF ^  n nnriT ■BuLi + CO --------   ► Bu COLi
-  78°C
Fig. 4.16: Proposed product of the blank reaction.
Unfortunately, no reference compound for this suggested product was available. Of 
course another possibility is the dicarbonylated product (BunllCOn COLi). However, for 
NCA [n C]carbon monoxide, the chances of achieving double carbonylation (i.e. insertion 
of two carbon monoxide molecules) into one molecule of product are statistically very 
low. Hence, double carbonylation should not be such a great problem in NCA n C- 
carbonylation.
A second blank reaction was performed as in the first one, but this time with 
piperidine present and without quenching with an electrophile. The trapping of 
[n C]carbon monoxide was higher than in the first blank reaction (13.4%) (Table 4.1, entry
2). The radioactive product observed by radio-HPLC analysis eluted at 4 min. The 
obvious product possibilities are shown in Fig. 4.17. Mass spectrometry of the product 
solutions was consistent with the presence of compounds I -  in (Fig. 4.17).
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A n „ Dry THF
N H + BuLi + n C O   ---------►
J  -  78°C
A
N — C -H
J O
A
J
N —-C — Li and/or BiPfcOLi
O
m
Fig. 4.17: Suggested products from the blank reaction without electrophile.
The lithiated TV-butylcarbonyl species (Fig. 4.17, EOT) is expected to elute at the 
solvent front (3 min) in the HPLC, and small amounts of a radioactive product(s) were 
observed to elute there. The main radioactive product in the latter blank experiments 
eluted at 4 min (i.e. slightly earlier than 7V-formyl-piperidine (4.5 min) under the same 
HPLC conditions).
After the blank reactions, the n C-carbonylation of piperidine was performed using 
procedure (A) and different quenching electrophiles (Mel, EtI and c.Hex-Br). The 
[n C]carbon monoxide trapping efficiency was between 11.1 and 16.4% (n = 8 ) at -  78°C 
(Table 4.1, entries 3-6). In all cases only one radioactive product eluted at 4 min was 
observed in analytical radio-HPLC. This is possibly the lithium carbamoyl species (Fig. 
4.17, II). Fig. 4.28 is a typical radiochromatogram from the analysis of the above 
reactions.
For the investigation of procedure (B), a reaction was first performed with non­
radioactive carbon monoxide. Iodomethane was used as electrophile in this experiment. 
No expected product (/V-acetyl-piperidine) was observed by HPLC; only the starting 
materials were detected. However, radioactive experiments were pursued, beginning with 
blank reactions. The first one was similar to the first blank reaction performed for the 
investigation of procedure (A) (Fig. 4.16). The [UC]carbon monoxide trapping in this 
experiment was much higher (25.0%; Table 4.2, entry 1) than for procedure (A). The 
reason for this result can be explained by the huge difference in the amount of n-  
butyllithium in both procedures, as it is > 28 times higher in procedure (B). Even with this 
high trapping efficiency, no single radioactive product was observed in the radio-HPLC
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analysis. This suggests that the radioactivity is free [n C]carbon monoxide that is absorbed 
in solution but not detectable under the HPLC conditions. An unexplained observation is 
that a white precipitate was obtained after bubbling the [n C]carbon monoxide into the 
reaction vial. The second blank reaction was carried out in the same manner as the first, 
except that the reaction mixture was quenched with iodomethane after bubbling with 
[n C]carbon monoxide. No radioactive product was observed, even though the 
[u C]carbon monoxide trapping efficiency was high (Table 4.2, entry 2). The last two 
blank reactions indicate that in the absence of piperidine there is no formation of 
radioactive products.
Procedure (B) was performed using water or iodomethane as electrophile. The 
efficiencies of [n C]carbon monoxide trapping were between 9 and 16.3% (n = 4) (Table 
4.2, entries 3 and 4). A single radioactive product was observed in each experiment, 
eluting at 7.2 min in the experiment with water as electrophile and at 7.6 min for the 
experiment with iodomethane as electrophile. However, neither of the radioactive 
products matched the retention times of the reference compounds, A-formyl-piperidine 
(4.5 min) and TV-acetyl-piperidine (12.1 min).
In a further investigation, [n C]iodomethane was used together with stable carbon 
monoxide as a second approach to identify TV-acetyl-piperidine. However, the expected 
radioactive amide was not observed (Table 4.2, entry 5).
4.2.1.2 [nC] Carbonylation of 1,2,3,4-tetrahydroisoquinoline
Using procedure (A), described earlier in Section 4.2.1.1, the experiments were tried with 
another secondary amine (1,2,3,4-tetrahydroisoquinoline; THIQ). However, even with 
different quenching electrophiles (H2 0, Mel and c.Hex-Br) the same radioactive product 
was obtained (HPLC retention time, 5.2 min). Table 4.3 summarises the amounts of 
reactants used and the [n C]carbon monoxide trapping efficiency, which was less than in 
the piperidine experiments.
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4.2.1.3 [*1C] Carbonylation of WAY-100634
The above experiments were repeated with the secondary amine, WAY-100634. In fact, 
with this amine only a single radioactive product (peak) was observed in each case, and on 
HPLC analysis this eluted with the solvent front (retention time, 2 min). Additionally, the 
amount of w-butyllithium was varied. The trapping of the [u C]carbon monoxide increased 
with the quantity of «-butyllithium (Table 4.4, entries 1-3). Two different electrophiles 
were used with no effect on the radio-HPLC analysis. Similarly, increasing the amount of 
electrophile had no effect. Again, the only detected radioactive product was probably 
[carbonyl-11 C]butyllithium [Bun(n CO)Li].
4.2.2 Preparation of [n C]Ketones
The second part of this chapter is concerned with the preparation of [n C]ketones via 
palladium-catalysed carbonylative coupling of organostannanes with aryl iodides or 
diaryliodonium salts. The synthesis of [car^ony/-n C]benzophenone was undertaken as 
the starting point to establish the reaction conditions and to examine the role of the 
reactants. Several precursors, such as aryl halides or diaryliodonium salts, in the presence 
of palladium(II)-mediated catalyst were used. [n C]Carbon monoxide produced from the 
‘on-line’ reduction of cyclotron-produced [n C]carbon dioxide over charcoal at 900°C was 
used in a 40 ml volume, as explained earlier in the attempted synthesis of [n C]amides. 
Several organostannanes were introduced in these coupling reactions. Suitable reaction 
conditions were used to produce several [car^o«y/-n C]benzophenone derivatives.
4.2.2.1 Palladium(II)-mediated catalysed [nC] carbonylative coupling of
iodobenzene and its derivatives with phenyltributylstannane
Iodobenzene was used as a model compound for palladium(II)-mediated catalysed 
coupling of aryl halides with organostannanes and [n C]carbon monoxide. In the beginning 
several non-radioactive reactions were performed, starting with a series of blank reactions 
designed to assess whether any reaction occurred in the absence of the palladium catalyst.
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These reactions used non-radioactive carbon monoxide. The results (Section 4.3.7.1, 
blank reactions) showed that no reaction takes place between iodobenzene and the 
phenyltributylstannane in the absence of the palladium catalyst. Benzaldehyde was 
however observed as a minor product.
The synthesis of [carZ>o«y/-n C]benzophenone was used to examine the role of each 
of the reaction components. This was achieved by running several radioactive blank 
reactions. The results show that the identity of the major radioactive product varies 
according to the absence or presence of palladium(II)-mediated catalyst (Fig. 4.18 and 
Table 4.5).
SnBu3
+ +  n c o
PdCl2 (0 - 1 %) 
DME/H^O (4:1 v/v)
(0 -2 .5  |umol)
[<carbonyl- C]benzaldehyde 
O
[icarbonyl- Cjbenzophenone
OrCOJH
[carbonyl- Cjbenzoic acid
Fig. 4.18: The different radioactive products from the [n C]carbonylation of iodobenzene 
and phenyltributylstannane with [n C]carbon monoxide.
[ctfr&072y/-n C]Benzaldehyde was produced in almost quantitative radiochemical 
yield when the iodobenzene was dissolved in the solvent mixture (DME-H2 0; 4: 1 v/v) 
and treated with [n C]carbon monoxide (Table 4.5, entry 1). The same radioactive product 
was obtained in similar radiochemical yield (> 98%) by repeating the reaction in the 
presence of phenyltributylstannane (Table 4.5, entry 5). The formation of [carbonyl- 
n C]benzaldehyde as an unexpected radioactive product in these reactions cannot be easily
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explained. Even if the iodobenzene were to dissociate into radicals, the expected product 
would be phenol (PhOH), assuming hydroxy radicals (OH*) might be readily available from 
the solvent. The second experiment proved that the phenyltributylstannane cannot react 
with the iodobenzene to form [carbonyl-11 C]benzophenone in the absence of palladium 
catalyst, a finding which is consistent with the experiment performed with non-radioactive 
carbon monoxide.
On the other hand [carbonyl-nC\benzo\Q, acid was obtained in 93.1% radiochemical 
yield when the iodobenzene was reacted with [n C] carbon monoxide in the presence of 
palladium(II)-mediated catalyst. In addition [car&cwy/ - 1 ^ benzaldehyde was formed as a 
minor by-product (Table 4.5, entry 2). This finding might be explained by references to 
the earlier described general mechanism (Fig. 4.10) i.e. that the palladium catalyst is 
involved in oxidative addition (Fig. 4.19, i) to the iodobenzene followed by [n C]carbon 
monoxide insertion (Fig. 4.19, ii) to form an intermediate (Fig. 4.19, B). In the presence 
of a hydroxy group (OFT) derived from the solvent (water), the third step (Fig. 4.19, iii), 
hydroxylation, may take place followed by reductive elimination (Fig. 4.19, iv) to release 
the catalyst and form [carbonyl-n C^ OQxrzo\c acid. Also, a free proton might couple to the 
complex (Fig. 4.19, B) (instead of OFT) to form [ca^o«y/-n C]benzaldehyde.
Cl Cl o
PdCL r^N ^Pd— I
(i)
CO
(A)
Cl (ii)
[carbonyl- C]Benzoic acid
r^ \ ^ P d  —  C —  I
Cl
(B)
(iii) OH
0II 1
— OH 
1 ^ (iv) | 1
C1
Cl O
(C)
Fig. 4.19: Proposed route to the synthesis of [carbonyl-nC\bQnzo\c, acid from
iodobenzene.
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[car&0 «y/-n C]Benzophenone was obtained in 82% radiochemical yield when the 
iodobenzene and phenyltributylstannane were in a 1 : 1 molar ratio, for coupling through 
the palladium(II)-mediated catalyst (1%) with [n C]carbon monoxide (Table 4.5, entry 6 ). 
The radiochemical yield of the [car^o«y/-n C]benzophenone was improved to > 98% by 
increasing the reaction time to 20 min at room temperature (Table 4.5, entry 7). The 
increase in yield with reaction time indicates that the coupling cycle with [n C]carbon 
monoxide continued. However, increasing the reaction time to 20 min is impractical since 
half of the radioactivity will have decayed away. In terms of the last two experiments 
involving addition of phenyltributylstannane (Table 4.5, entries 6  and 7), the mechanistic 
details are likely to be similar to those in Fig. 4.19, except that the third step is 
transmetallation. In Fig. 4.29 A-D the analytical chromatograms for entries 1, 2, 5, 6  and 
7 of Table 4.5 are presented.
Phenyltributylstannane was itself treated with [n C]carbon monoxide to see whether 
under the reaction conditions it could give any radioactive product. \carbonyl- 
n C]Benzaldehyde was produced with another unknown radioactive compound eluting as a 
shoulder peak in the HPLC analysis (Table 4.5, entry 3; Fig. 4.30 A). When the same 
experiment was repeated in the presence of palladium(II)-mediated catalyst, \carbonyl- 
n C]benzophenone was produced in good radiochemical yield (40%), in addition to 
[carZ>o«y/-n C]benzaldehyde and a trace of [carbonyl-11 C^oznzoic acid (Table 4.5, entry 
4; Fig. 4.30 B). The former experiment indicates that [n C]carbon monoxide can react 
directly with organostannane in the absence of the catalyst through an unknown 
mechanism. In the second experiment the palladium(II)-mediated catalyst was present and 
the formation of both [car&6wj7-nC]benzaldehyde and [carbonyl-11 C\benzoic acid might 
be explained on the basis of the mechanistic route in Fig. 4.19. The formation of 
\carbonyl-nC\benzophenone from the second experiment might result from coupling of 
two phenyltributylstannane molecules together as illustrated in the following figure.
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SnBu0
y PdCL
Cl Cl o
ir
(i)
(A) 
(iv)
I
Cl
CO r^ \ <^ Pd —  C —  SnBu
[(carbonyl-  C]Benzopheone
(>i)
a  o
P d—
Cl
(B)
(iii)
Cl
SnBu.
y
(C)
Fig. 4.20: Synthesis of [carZ>o«y/-11C]benzophenone from the coupling of 
phenyltributylstannane with [n C]carbon monoxide via a palladium(II)-mediated catalyst.
In order to extend the above procedure, several iodobenzene derivatives were 
chosen to be coupled with phenyltributylstannane and [n C]carbon monoxide. l-Fluoro-4- 
iodobenzene, 4-iodobenzotrifluoride, 2-iodotoluene and 3-iodotoluene were used to 
produce [car^o«y/-n C]4-fluoro-benzophenone, [car^o«y/-n C]4-trifluoro-benzophenone, 
[carZ?o«y/-11C]2-methyl-benzophenone and \carbonyl-11 C]3 -methyl-benzophenone, 
respectively, in very good radiochemical yields 58-78% (Table 4.6). [carbonyl- 
n C]Benzaldehyde was produced as a by-product in all cases in 17-37% radiochemical 
yields, in addition to [cario«y/-n C]benzophenone (< 5%) (Table 4.6). The by-product, 
[corrZ>o«y/-n C]benzophenone might come from the reaction of the phenyltributylstannane 
with [n C]carbon monoxide through a palladium(II)-mediated coupling reaction as found 
earlier with the blank reaction (Fig. 4.20). The by-product, [car^o«y/-n C]benzaldehyde, 
might be produced by the mechanistic route shown in Figure 4.19, the reaction of 
palladium-ctfrZ>0 «y/-n C-aryl iodide complex with a free solvated proton as described 
earlier.
Figure 4.21 illustrates the palladium(II)-mediated catalysed carbonylative coupling of 
iodobenzene derivatives with phenyltributylstannane and [n C]carbon monoxide.
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SnBu.
R
+  nc o
PdCl2 (l% ) 
DME/H20  (4:1 v/v)
R
[carbonyl- C]benzophenone 
derivative
-CHO
[carbonyl- ^jbenzaldehyde
Fig. 4.21: Synthesis of substituted [carbonyl-11 Cjbenzophenones by the palladium(II)- 
mediated catalysed [n C]carbonylative coupling of iodobenzene derivatives with 
phenyltributylstannane and [n C]carbon monoxide, (R = 4-fluoro, 4-trifluoro, 2 -methyl
and 3-methyl).
The above investigations have given results on the synthesis of [u C]ketones, which
1 ft  1 1 O /I  0*7are comparable with previous reports ’ ’ ’ . However, the modifications made to the 
procedure (e.g. change of solvent) have resulted in higher radiochemical yields under 
milder conditions, namely room temperature for 1 min. Additionally, new substituted 
[carZ>072y/-n C]benzophenones were produced (Table 4.6).
4.2.2.2 Palladium(n)-mediated catalysed [nC]carbonylative coupling of various 
diaryliodonium salts with arylorganostannanes.
It has been reported that iodonium salts can be coupled to organostannanes under mild 
conditions in the presence of a palladium(II)-mediated catalyst31-33. Additionally, there is 
now easier access to several diaryliodonium salts3 4 ,35 and indeed some are commercially 
available. This suggested an opportunity to repeat the work done with the iodobenzene 
using iodonium salts instead, in order to attempt the synthesis of a range of [n C]ketones 
(Fig. 4.22).
130
Chapter 4 Synthesis of [nC] Amides and [nC]Ketones from [HC]Carbon Monoxide
9  DME/H.O, 1 % PdCL
Ar I PhX + Ar SnBu, ---------------1----------------1-----„ A r '-"cO-A/
UCO-N2(l atm), 1 min,RT
1 2 3
la Ar1 =Ph 2a Ar2 = Ph 3a Ar1 = Ph, Ar2 = -Ph
lb 2-MeC6H4 2 b 2 -MeC 6H4 3b 2 -MeC 6H4, -Ph
lc 3 -MeC 6H4 2 c 3 -MeC 6H4 3c 3—MeCgFL*, % -Ph
Id 2 -MeOC6H4 2 d 2 -MeOC6H4 3d 2 -MeOC6H4 , -Ph
le 4-CF3 C6H4 2 e 4-CF3 C6H4 3e 4-CF3 C6H4, -Ph
If 4-F,3-MeC 6H3 2 f 3,5-diF-C6H3 3f 3,5-diF-C6H3, -Ph
2 g 4-FC6H4 3g 4-FC6H4, -Ph
3h 4-F,3-MeC6H3, -Ph
Fig. 4.22: Proposed palladium(II)-mediated [n C]carbonylative coupling of 
diaryliodonium salts with organostannanes. The bold designators define the compounds 
used or produced in this study. In la , X = I or Br or NO3 or Tos and in lb - lf ,  X = Tos.
First of all, diphenyliodonium iodide (PhI+PhT) was reacted with 
phenyltributylstannane in the presence of mediated palladium(II)-chloride catalyst in the 
solvent mixture DME and water (4: 1 v/v) 31 under atmospheric pressure of nitrogen- 
[n C]carbon monoxide at room temperature for 20 min to test for the production of 
[car&072y/-n C]benzophenone. The used procedure was based on that published by Kang 
et al?1 who used non-radioactive carbon monoxide. The production of [<carbonyl-  
n C]benzophenone (Table 4.9, entry 4) encouraged more effort in this area.
The project was developed in a logical sequence. First, I ran a blank reaction using 
non-radioactive carbon monoxide at atmospheric pressure with diphenyliodonium bromide 
and phenyltributylstannane at room temperature for up to 30 min. The HPLC analysis 
gave no benzophenone at any stage of the reaction. This result proved that no reaction 
occurred in the absence of the palladium catalyst. However, a trace of benzaldehyde was 
observed. These observations parallel those from reactions with iodobenzene in place of 
the iodonium salt (Section 4.3.7.1 or p 126).
Diphenyliodonium salt was treated with [n C]carbon monoxide in the solvent 
mixture, [carbonyl-11 CJBenzaldehyde was the only radioactive product produced from 
this reaction (Table 4.7, entry 1). The same radioactive product was obtained under the
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same conditions in the presence of a 2-fold molar excess of phenyltributylstannane (Table 
4.7, entry 3). On the other hand {carbonyl- lC]benzoic acid was the major radioactive 
product when the diphenyliodonium salt was treated with [n C]carbon monoxide in the 
presence of palladium(II)-mediated catalyst alone (Table 4.7, entry 2). Since the results 
from the use of the diphenyliodonium salt (Table 4.7) are similar to those obtained using 
iodobenzene (Table 4.5, entries 1, 2 and 5), there is no quantitative difference in the 
reaction between iodobenzene and diphenyliodonium salt under the present conditions. 
Consequently, the results can be interpreted in a similar manner.
Diphenyliodonium salts may have various anions. I investigated whether there was 
any effect of changing the anion on the radiochemical yield of [<carbonyl-  
n C]benzophenone. The experiments were carried out using the original procedure, 
coupling diphenyliodonium salt with the phenyltributylstannane and [n C]carbon monoxide 
at room temperature for 1 min. The results (Table 4.8) show that the radiochemical yields 
of [carbonyl-11 Cjbenzophenone increase from 75 to 96% with respect to the anion in the 
following order I < Tos < NO3 < Br (Fig. 4.31). The high reactivity of the iodide might 
explain the formation of the by-products in higher radiochemical yields than from the other 
anions (Table 4.8). These experiments indicate that the bromide anion might be preferred 
for maximal radiochemical yield of substituted [carbonyl-11C]benzophenone with minimal 
by-product formation. Therefore, all the coupling experiments with different 
arylstannanes were run with the diphenyliodonium bromide. However, there is no clear 
evidence for the role that the anion may play during the reaction, as will be seen later.
With respect to the reaction time, a good average radiochemical yield of [«carbonyl-  
1 Cjbenzophenone, 65% (n = 5), was obtained from 1 min reaction at room temperature 
(Table 4.9, entry 1). There was little improvement in radiochemical yield on increasing the 
reacting time (to 5, 10 or 20 min) (Table 4.9, entries 2-4). Clearly, the achievement of 
high radiochemical yields from such short reaction times, renders these reactions highly 
practical for n C-chemistry.
The radiochemical yield of [carbonyl- Cjbenzophenone increases with increasing 
amounts of phenyltributylstannane (Table 4.10 and Fig. 4.32). These reactions were 
carried out at room temperature for 2 0  min in order to obtain measurable differences in the
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radiochemical yields. The results suggest that the reaction needs a two-fold molar ratio of 
phenyltributylstannane to salt to produce a good radiochemical yield. Also the reaction 
cycle prefers to go through the transmetallation step rather than coupling to the hydroxy 
group or a free proton in the reaction medium.
No effect of solvent has been studied here. However, it has been reported that THF 
traps [n C]carbon monoxide less efficiently than polar solvents, such as DMSO and 
NMP10,11. However 1,4-dioxane is excellent for trapping [n C]carbon monoxide under 
high pressure (300 atm) and in a micro-autoclave11.
The second step was to produce several [c^ o w y /-n C]benzophenone derivatives. 
The reaction was investigated in two ways, first by using different substituted 
diaryliodonium tosylates (lb -lf;  Fig. 4.22) with phenyltributylstannane (2a; Fig. 4.22) as 
partner (Table 4.11) and second by using different aryltributylstannanes (2a-2g; Fig. 4.22) 
with diphenyliodonium bromide (la; Fig. 4.22) as partner (Table 4.12). All reactions were 
performed under very mild conditions, namely room temperature for 1 min with DME- 
H20  (4: 1 v/v) as solvent31.
Through the use of differently substituted diaryliodonium salts to partner 
phenyltributylstannane (2a; Fig. 4.22), the expected [n C]ketones (3b-3h; Fig. 4.22) were 
obtained in good radiochemical yields (Table 4.11). However, [<carbonyl-  
n C]benzophenone is the major radioactive product from these reactions, [carbonyl- 
n C]Benzoic acid and [car/>o«y/-n C]benzaldehyde are minor by-products. These minor 
by-products were also produced in reactions in which either the iodonium salt or the 
phenyltributylstannane was omitted. The results suggest that a diphenyliodonium salt 
couples to the phenyltributylstannane and [n C]carbon monoxide in a similar manner to 
iodobenzene. The coupling might proceed through one of two routes (Fig 4.23, routes A 
and B), that explain the formation of both [ca r^o ^ /-n C]benzophenone and its substituted 
analogue. The minor by-products mentioned earlier can also be produced, especially from 
route B (Fig. 4.23) when a hydroxy group or solvated proton coupled with the complex of 
the released benzoyl species and palladium catalyst plus [n C]carbon monoxide.
133
Chapter 4 Synthesis of [nC] Amides and [nC]Ketones from [nC]Carbon Monoxide
Route A
Route C Route B
PdCl,
PdC^
Cl Cl
or or
Pd— P Pd—I
COCO
O ClO 9 1
C-Pd
PdCLCoupling as in the 
iodobenzene mechnism lt o
PhSnBiij
Fig. 4.23: Proposed routes for the iodonium salt coupling reactions.
Another route (Fig. 4.23, route C) for the formation of [ca^o«y/-n C]benzophenone 
and other by-products ([carbonyl-11 C]benzoic acid and [carbonyl-nC\benzaldehyde) was 
suggested based on the possible dissociation of the diphenyliodonium salt to give an 
iodobenzene or substituted iodobenzene, which then participate in the coupling 
mechanism. However, there is no particular evidence that the diphenyliodonium salt 
dissociates to any great extent under the present mild reaction conditions. Additionally, 
several reports3 6 -4 0  have described the difficult dissociation of diaryliodonium salts; often 
they need a long time and reflux and sometimes catalysts are used to achieve dissociation.
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Finally the coupling of two molecules of phenyltributylstannane with [n C]carbon 
monoxide was found to produce [carZ>o«y/-n C]benzophenone and the other minor by­
products mentioned above (Table 4.5 entry 4 and Fig. 4.20).
By using various substituted arylstannanes with diphenyliodonium bromide, 
exceptionally high radiochemical yields of several [n C]ketones (3a, 3c-3g; Fig. 4.22) were 
obtained rapidly under very mild conditions (Table 4.12). Only the [carbonyl-11 C]2- 
methylbenzophenone (3b; Fig. 4.22) was obtained in a substantially lower but still useful 
yield. [car^o«y/-u C]Benzaldehyde and [carbonyl-llC^OQnzo\c acid were observed as 
significant by-products in these reactions. The radiochemical yields of the substituted 
[n C]ketones from these reactions are much higher than from the arylphenyliodonium salts. 
These results suggest that the coupling of the arylstannanes with the diphenyliodonium salt 
might proceed faster through route A (Fig. 4.24) than the coupling of two molecules of 
arylstannanes to form substituted [carZ>owj/-n C]benzophenone in route B (Fig. 4.24). 
This was expected, based on the results obtained from the blank reactions of the 
phenyltributylstannane (Table 4.5, entry 4). Also through route B (Fig. 4.24), the 
formation of [carbonyl-11 C\bQrvLO\c acid or [ca^o«y/-n C]benzaldehyde was also 
expected. However, the only major radioactive product obtained in each case was 
substituted [carZ>o«y/-n C]benzophenone.
Route A
Route B
Fig. 4.24: Proposed routes for the coupling reactions of substituted organostannanes
with diphenyliodonium bromide.
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The importance of the sequence of addition of the reagents to the reaction vial was 
examined using the palladium(II)-mediated catalysed reaction of diphenyliodonium iodide 
(PfrTPhT) salt with 4-trifluorophenyltributylstannane (2e; Fig. 4.22) and [n C]carbon 
monoxide. In order to have a spread of yields for comparison, the reactions were 
performed at 80°C for 5 min. [carbonyl-11 C ^ qxyloic acid was obtained in > 92% 
radiochemical yield when the phenyltributylstannane was added as quenching solution after 
the introduction of [n C]carbon monoxide (Table 4.13, entry 1). The result shows that 
even in the presence of a high amount of palladium catalyst (2.2%) the desired [n C]ketone 
was obtained in only about 7% radiochemical yield. \carbonyl-nC\4-Trifluoro- 
benzophenone was the major radioactive product (65%) when the phenyltributylstannane 
was added together with the diphenyliodonium iodide into the reaction vial before bubbling 
the [n C]carbon monoxide, (Table 4.13, entry 2). These findings are consistent with the 
findings of Zeisler et a l3, from a similar reaction (palladium-catalysed 1 ^ -carbonylative 
coupling of iodobenzene with phenyltributylstannane and [n C]carbon monoxide) that a 
large quantity of the palladium catalyst lowered the yield of the benzophenone and 
promoted the formation of by-products. Conversely, less palladium catalyst (0.4%) 
results in a lower trapping of the [n C]carbon monoxide but was good enough to produce 
sufficient radiochemical yield of the desired [n C]ketone, in addition to [carbonyl- 
n C]benzophenone_ and [carbonyl-nC\bmzo\c acid as by-products. The latter two 
experiments indicate that dissolution of the iodonium salt and the organostannane followed 
by addition of the palladium catalyst before introducing [n C]carbon monoxide is the best 
way to achieve a high radiochemical yield of the wanted [n C]ketone.
Clearly, the above work demonstrates that the palladium(II)-mediated catalysed 
[n C]carbonylative coupling of diaryliodonium salts with organostannanes is a highly 
effective route to [n C]ketones.
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4.3 Experimental and Results
4.3.1 Materials
For the attempted syntheses of [n C]amides, the precursors and reagents (e.g. n- 
butilylithum 1.6M in hexane) were purchased from Aldrich Chemical Co., except (free 
base) WAY-100634 and the reference compound WAY 100635 which were supplied by 
the MRC Cyclotron Unit41. The other reference amides were synthesised. 
Diphenyliodonium salts, with different counter anions (I-, Br“ and N O 3  ), and the ketone 
references were purchased from Lancaster Synthesis. Diphenyliodonium tosylate and all 
other diaryliodonium tosylates salts were prepared in house as reported34’35. The 
aryltributylstannanes were purchased from Maybridge Chemical Co., except 
phenyltributylstannane which was purchased from Aldrich Chemical Co. Palladium(II) 
chloride was purchased from Aldrich Chemical Co., and it was used as palladium(II)- 
mediated catalyst by dissolving (3 mg) of PdCb in 15 ml of a mixture of DME-H20  (4: 1 
v/v) to enable the use of small quantities into the reactions,. All other reagents that were 
purchased from Aldrich Chemical Co., had greater than 99.5% purity and were used 
without further purification. Tetrahydrofuran (THF) was obtained from Aldrich Chemical 
Co., refluxed over sodium-benzophenone for 30 min, distilled under nitrogen and then 
kept dried over molecular sieves (4 A). All solvents were AR grade or better and were re­
distilled, if required (e.g. DME).
4.3.2 Analytical Methods
In the preparation of [n C]amides, the reaction mixtures were analysed by semi-preparative 
radio-HPLC on a Waters tt-Bondapak™ C-18 column (7.8 x 300 mm) eluted with 0.05M 
potassium dihydrogen phosphate-acetonitrile (90: 10 v/v) at 4.0 ml/min or using a 
Bondclone C-18 column (150 x 3.90 mm, i.d.; 10 |um particle size; “Phenomenex”) eluted 
with 0.02M potassium dihydrogen phosphate-acetonitrile (60: 40 v/v) at 1.4 ml/min, with 
eluate monitored for absorbance at 254 nm. For the preparation of [n C]ketones, radio- 
HPLC on a Waters (i-Bondapak™ C-18 column, (7.8 x 300 mm) eluted with acetonitrile-
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water-triethylamine (60: 40: 0.25 by vol.) at 3 ml/min was used for analysis. Radioactive 
peaks were detected with a sodium iodide detector (Bioscan, Nal, 20 mm diameter; 
Lablogic; Sheffield, UK or G-M tube; Minialarm Ltd.) and identified by co-injection of 
reference compounds detected by their absorbance at 254 n m o n a  linear scale (Linear 
UV-0106). For all the presented HPLC traces, the solid blue peaks refer to the found 
peaks in the analyses of the reaction mixture and the broken blue lines refer to the 
reference compounds.
4.3.3 Synthesis of Reference Compounds
All ^ -N M R  spectra were recorded using a Bruker AC-300E spectrometer operating at 
300 MHz. Chemical shift values are in parts per million (ppm) and referenced to 
tetramethylsilane (TMS). Mass spectrometry (MS) was performed using a Nermag 
R10/10C analytical quadrupole mass spectrometer with a Nermag probe interface. The 
spectrometer was calibrated for mass number with residual air and FC-43 
(perfluorotributylamine) and run in chemical ionisation mode (Cl +ve) using ammonia as 
reactant gas. Chromatographic data were subsequently analysed using the ONYX 
software program (P2A Systems), running under Microsoft Windows. The HPLC analysis 
of the products was performed on a Waters (i-Bondapak column (300 mm x 7.8 mm; 
o.d.), eluted with 0.05M potassium dihydrogen phosphate-acetonitrile (60: 40 v/v).
Reference amides were prepared by acylation of the amines with acid chloride (acetyl 
chloride, cyclohexanecarbonyl chloride and benzoyl chloride) as described previously42,43,16 
(Fig. 4.25). Y-Formamides were synthesised according to reported methods44,45.
138
Chapter 4 Synthesis of [HC] Amides and [nC]Ketones from [nC]Carbon Monoxide
H C02H, MeCOOH
R.NH
0°C ->70°C
-> RANCHO 
7V-formrmide
R'COCl, Ether
► RANCOR'
r.t.
r 2n h R’ Product
Piperidine Me TV-acetyl-piperidine
f t c.Hex A-cyclohexoyl-piperidine
f t Ph iV-benzoyl-piperidine
THIQ Me N -  acetyl-THIQ
f t c.Hex A-cyclohexoyl-THIQ
f t Ph A-benzoyl-THlQ
WAY-100634 Me W-acetyl-W AY-100634
f t c.Hex WAY 100635
f t Ph Y-benzoyl-WAY-100634
Fig. 4.25: General scheme for the synthesis of amides from a secondary amines.
4.3.3.1 Synthesis of TV-formamides
The reported general procedure44,45 was applied to the synthesis of the following 
compounds.
4.3.3.1.1 Synthesis of 7V-formyl-piperidine
Piperidine (0.8 g, 9.4 mmol) was placed in a 2-necked round-bottom flask under nitrogen 
followed by formic acid (96%) (1.3 g, 27.6 mmol). The mixture was stirred at 0°C for 10 
min before anhydrous acetic acid (1.1 g, 20 mmol) was added. The reaction temperature 
was raised to 70°C and the reaction stirred for a further 2 h. The excess acid and solvent 
were evaporated off under reduced pressure. The evaporation was repeated three times to 
ensure removal of all formic acid. The product was obtained as a colourless oil in 15% 
yield (0.16 g). ‘H-NMR. (CDC13), 6 ppm: 7.85 (s, 1H), 3.34-3.30 (t, 2H), 3.18-3.15 (t,
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2H), 1.57-1.34 (m, 6 H); (the NMR data are consistent with those of the reference 
compound obtained from Aldrich). HPLC analysis, using the system described in Section
4.3.3 and elution at 4 ml/min, gave one peak with a retention time of 4.5 min, which is the 
same retention time as for the reference compound from Aldrich (retention time of 
piperidine, 6.2 min). MS (Cl + ve, NH3) analysis of the product gave m/z = 114 {[M + 
H]+, 100%}, 131 {[M + NH3 +H ]+, 96.2%}, 148 {[M + 2NH3 + H]+, 13%}.
4.3.3.1.2 Synthesis of A-formyl-THIQ
The procedure described in Section 4.3.3.1.1 was used, except that piperidine was 
replaced with THIQ (0.5, 3.8 mmol). The product was obtained as an orange oil in 25% 
yield (0.15 g). ^ -N M R  (CDC13), 5 ppm: 9.65 (s, 1H), 8.19-8.16 (d, 1H), 7.60-7.55 (t, 
1H), 7.46-7.41 (t, 1H), 7.34-7.31 (m, 1H), 4.03-3.99 (t, 2H), 3.07-303 (t, 2H), 1.62 (m, 
2H). HPLC analysis, using the system described in Section 4.3.3 and elution at 3 ml/min, 
revealed one peak with a retention time of 5.0 min (retention time of THIQ, 4.2 min). MS 
(Cl + ve, NH3) analysis of the product gave m/z = 163 {[M + H]+ 100%}.
4.3.3.2 Synthesis of /V-acetylamides
In a 2-necked round-bottom flask, the required secondary amine, piperidine (0.5 g; 5.9 
mmol), THIQ (0.5 g; 3.8 mmol) or WAY-100634 (0.01 g; 0.03 mmol), was dissolved in 
anhydrous diethyl ether (50 ml) under nitrogen. 2 Molar equivalents of triethylamine were 
added to the secondary amine solution and the mixture was stirred at room temperature 
for 5 min. One equivalent of acetyl chloride was added slowly to the secondary amine 
solution. The reaction was stirred at room temperature overnight. The reaction mixture 
was then diluted with more diethyl ether (25 ml) and washed with 1M HC1 (10 ml), 
sodium hydrogen carbonate solution (5%; 10 ml) and brine (10 ml). The organic layer was 
separated, dried over magnesium sulphate, filtered and evaporated under reduced pressure.
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4.3.3.2.1 Synthesis of 7V-acetyI-piperidine
TV-Acetyl-piperidine was obtained as a yellow oil in 52% yield (0.39 g). ^H-NMR 
(CDC13), 5 ppm: 3.33 (m, 4H), 2.01 (s, 3H), 1.44-1.39 (m, 6 H). HPLC analysis, using the 
system described in Section 4.3.3 and elution at 4 ml/min, gave one peak with a retention 
time of 1 2 . 1  min (retention time of piperidine, 6 . 2  min). MS (Cl + ve, NH3) analysis of the 
product gave m/z = 128 {[M + H]+ 100%}, 145 {[M + NH3 + H]+ 54.4%}.
4.3.3.2.2 Synthesis of A-acetyl-THIQ
A-Acetyl-THIQ was obtained as a yellowish oil in 63% yield (0.42 g). ^ -N M R  
( C D C I 3 ) ,  5 ppm: 7.17-7.10 (m, 4H), 4.68-4.58 (d, 2H), 3.80-3.76 (t, 1H), 3.66-3.62 (t, 
1H), 2.80-2.79 (m, 2H), 2.15 (s, 3H), (the NMR data are consistent with the data 
reported by Luthra, 1989)42. HPLC analysis, using the system described in Section 4.3.3 
and elution at 3 ml/min, revealed one peak with a retention time of 6.4 min (retention time 
of THIQ, 4.2 min).
4.3.3.3 Synthesis of A-cycIohexylcarboxamides
A-Cyclohexylcarbonyl-WAY-100634 (WAY-100635) was readily available. The other 
A-cyclohexylcarbonyl derivatives of the amines were synthesised according to the earlier 
procedure (Section 4.3.3.2) except that acetyl chloride was replaced with 
cyclohexanecarbonyl chloride in a 1 : 1 molar ratio to the amine.
4.3.3.3.1 Synthesis of N-cyclohexylcarbonyl-piperidine
A-Cyclohexylcarbonyl-piperidine was obtained as a yellow oil in 50% yield (0.58 g). *H- 
NMR(CDC13), 5 ppm: 3.36-3.40 (dt, 4H), 2.51-2.42 (m, 1 H), 1.80-1.50 (m, 1 2 H), 1.32- 
124 (m, 4H). HPLC analysis, using the system described in Section 4.3.3 and elution at 4 
ml/min, gave one peak with a retention time of 13.5 min (retention time of piperidine, 6.2
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min). MS (Cl + ve, NH3) analysis of the product gave m/z = 196 {[M + H]+ 1 0 0 %}, 213 
{[M + NH3 + H ]+ 29.1%}.
4.3.3.3.2 Synthesis of Y-cyclohexylcarbonyl-THIQ
Y-Cyclohexylcarbonyl-THIQ was obtained as a yellow oil in 58% yield (0.54 g). 1H - 
NMR ( C D C I 3 ) ,  5 ppm: 7.51-7.15 (m, 4H), 4.73-4.67 (d, 2H), 3.85-3.70 (dt, 2H), 3.0- 
2.79 (m, 2H), 2.61-2.56 (m, 1H), 1.80-127 (m, 10H), (the NMR data are consistent with 
reported data)42,43. HPLC analysis of the product by the system described in Section 4.3.3 
and elution at 3 ml/min, gave one peak with a retention time of 9.3 min (retention time of 
THIQ, 4.2 min).
4.3.3.4 Synthesis of /V-benzoylamides
jV-Benzoyl-WAY-100634 {4-(2’-Methoxyphenyl)-1 -[2 ’-(N-2 ’-pyridinyl)-benzamido)- 
ethyljpiperazine} was made available by the MRC Cyclotron Unit41. The other N -  
benzoylamides were synthesised according to the procedure described earlier (Section 
4.3.3.2), except that acetyl chloride was replaced with benzoyl chloride and used in a 1: 1 
molar ratio to the amine.
4.3.3.4.1 Synthesis of 7V-benzoyI-piperidine
Y-Benzoyl-piperidine was obtained as a yellow oil in 56% yield (0.62 g). ^ -N M R  
(CDCI3), 5 ppm: 7.46-7.31 (m, 5H), 3.71 (t, 2H), 3.34 (t, 2H), 1.85-,J53 (m, 6 H). HPLC 
analysis, using the system described in Section 4.3.3 and elution at 4 ml/min, gave one 
peak with a retention time of 13.8 min (retention time of piperidine, 6.2 min). MS (Cl + 
ve, NH3) analysis of the product gave m/z = 190 {[M + H]+ 100%}, 207 {[M + NH3 + H]+ 
64%}.
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4.3.3.4.2 Synthesis of /V-benzoyl-THIQ
N-Benzoyl-THIQ was obtained as a yellow oil in 68% yield (0.61 g). ^ -N M R  (CDCI3), 
5 ppm: 7.62-7.18 (m, 9H), 5.07-4.58 (d, 2H), 4.15-3.65 (d, 2H), 3.05-2.81 (d, 2H), (the 
NMR data are consistent with reported data)42,43. HPLC analysis, using the system 
described in Section 4.3.3 and elution at 3 ml/min, gave one peak with a retention time of 
8.5 min (retention time of THIQ, 4.2 min).
4.3.4 Production of NCA [nC] Carbon Dioxide
[n C]Carbon dioxide was produced from the 14N(p,a)n C nuclear reaction on a N2-0.1% 
0 2 target, as described earlier in Chapter 3 (Section 3.3.4.1, p 96).
4.3.5 Production of NCA [nC]Carbon Monoxide
The cyclotron-produced [n C]carbon dioxide was transferred in nitrogen from the target to 
the hot-cell through stainless steel tubing (1/8” o.d.) at a flow rate of 500 ml/min. The 
[n C]carbon dioxide-nitrogen mixture was then passed through valve A (Fig. 4.26) into a 
heated quartz tube containing charcoal at 900°C. The generated [n C]carbon monoxide 
was collected in a 50 ml syringe as a mixture with nitrogen gas, via valve B, after passage 
through a sodalime trap to eliminate any traces of unconverted [n C]carbon dioxide. The 
[n C]carbon monoxide was then bubbled through the reaction mixture.
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Fig. 4.26: Flow diagram for [n C]carbon monoxide production.
The collected radioactive gas was analysed by gas chromatography (GC) on a Shimadzu, 
GC 14A system. The system was fitted with a Poraplot 007 column (25 m, 25°C) 
connected to a capillary column injector (25°C) supplied with helium as carrier gas (1.5 
bar; flow rate 5 ml/min). The output was connected to a micro-TCD detector connected 
in series to a custom built radioactivity detector. The chromatograms of the radioactive 
samples were compared to that of reference, carbon monoxide (Fig. 4.27; A-C).
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Fig. 4.27: The gas chromatograms for (A) authentic carbon monoxide, (B) partially 
converted [n C]carbon dioxide and (C) pure [n C]carbon monoxide.
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4.3.6 Attempted syntheses of [nC]amides from secondary amines
All the reaction glassware was super-dried in an oven for > 2 h at 110°C. Freshly dried 
solvents were used in each reaction. For ventilation, the outlet of the reaction vial was 
passed through magnesium sulphate contained in a 2 ml plastic syringe. Dry-ice/acetone 
bath was used to cool the reaction mixture to -  78°C. A low amount of [n C]carbon 
monoxide (111-222 MBq; 3-6 mCi) in nitrogen (40 ml) was collected in a 50 ml glass 
syringe (that had previously been flushed several times with nitrogen) and bubbled into the 
reaction vial through a 40 mm (long) needle. «-Butyllithium 1.6M in hexane (10 jal) was 
diluted in 1 ml of dry solvent (in procedure A, dry THF, and in procedure B, dry THF- 
DME mixture) to enable the use of small quantities of the salt.
4.3.6.1 Attempted synthesis of [N-carbonyl-n C]piperidine derivatives
Two procedures were used in these studies. In the beginning, the procedure was based on 
that in the literature22,23 [procedure (A)]. After failing to obtained the desired products, 
and following contact with Kilboum, I attempted to repeat the exact procedure that he 
used in achieving his results21 [procedure (B)]. The reaction mixtures in all the 
forthcoming experiments were analysed by radio-HPLC using a p-Bondapak™ C-18 
column (7.8 x 300 mm) eluted with 0.05M potassium dihydrogen phosphate-acetonitrile 
(90: 10 v/v) at 4 ml/min with eluate monitored for absorbance at 254 nm.
4.3.6.1.1 Procedure (A)
Blank reactions (Table 5.1. entries 1 and 2)
a) In a 2 ml reaction vial, 1.6 M «-butyllithium 1.6M in hexane (19 pi; 0.03 mmol) was 
diluted to 490 pi with dry THF. A known quantity of radioactive [n C]carbon 
monoxide was bubbled into the reaction vial for about 1 min at -  78°C. The 
radioactivity trapped in the vial was then measured, in order to determine the trapping 
efficiency. The reaction products were analysed by radio-HPLC using the set-up 
mentioned earlier (Section 4.3.6.1). Two radioactive compounds were observed, the 
first eluting at the solvent front (retention time, 3 min) and the second at 4 min (Table 
4.1, entry 1).
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b) The same procedure (a) was repeated but in this case piperidine (20 pi; 0.202 mmol) 
was dissolved in dry THF (300 pi) and placed in the reaction vial before adding the n- 
butyllithium. The same measurements and analysis were performed as in (a) and a 
similar radio-chromatogram was obtained (Table 4.1, entry 2).
11 C-Carbonvlation ofpiperidine
A solution of 0.16 M rc-butyllithium in THF (190 pi; 0.03 mmol) was added to a 2 ml 
reaction vial containing piperidine (20 pi; 0.202 mmol) dissolved in super-dry THF (300 
pi), and left to react for 5 min at -  78°C. The collected [u C]carbon monoxide was 
bubbled into the reaction vial for about 1 min and the reaction mixture was left to react for 
2 min at -  78°C. A specific amount of quenching electrophile was then added to the 
reaction vial (Table 4.1). The reaction mixture was then left to reach room temperature 
over 5-6 min. The reaction products were analysed by radio-HPLC using the set-up 
mentioned earlier (Section 4.3.6.1). The desired radioactive amide was not obtained in 
any of the experiments; the detected radioactive compounds eluted at 4-4.2 min. The 
efficiency of [n C]carbon monoxide trapping in these experiments and reaction conditions 
are recorded in Table 4.1.
Table 4.1: Quantities of reactants and [n C]carbon monoxide trapping efficiencies for the 
reactions carried out with piperidine using procedure (A).
Entry Precursor 
pi (mmol)
Bu”Li 
pl (mmol)
Electrophile 
pl (mmol)
Molar
ratio3
nCO trapped 
(%)
1 None 19 (0.03) None None 2.55
2 20 (0.202) 19 (0.03) None 1: 0.15: 0 13.4
3 20 (0.202) 19 (0.03) Mel, 37.8 (0.60) 1: 0.15: 3 14.75 (}n = 5)b
4 20 (0.202) 19 (0.03) Mel, 63 (1.0) 1: 0.15: 5 11.1
5 20 (0.202) 19 (0.03) EtI, 48 (0.60) 1:0.15:3 16.4
6 20 (0.202) 19 (0.03) c.Hex-Br, 75 
(0.60)
1: 0.15: 3 14.0
a Refers to ratio of piperidine: w-butyllithium: electrophile, b (13.3-16.2).
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Fig. 4,28: A typical HPLC/radio-HPLC analys is of the reaction mixture from procedure (A). 
4.3.6.1.2 Procedure (B)
The main difference between this procedure and procedure (A) was that the solvent system 
used by Kilbourn21 was a mixture of dry THF and dry DME (1:1 v/v). Another difference 
was that the reaction was performed on a larger scale.
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Blank reactions
a) A non-radioactive reaction was carried out using procedure (B) conditions. A solution 
of «-butyllithium 1.6M in hexane (540 pi; 0.86 mmol) was added to a 2 ml reaction vial 
containing piperidine (85 pi; 0.86 mmol) dissolved in super-dry THF-dry DME (300 
|l l 1), and left to react for 5 min at -  78°C. Carbon monoxide was bubbled into the 
reaction vial for about 1 min. The reaction was left to absorb carbon monoxide for 2 
min before iodomethane (268 pi; 4.3 mmol) was added to the reaction vial. The 
reaction mixture was then left to reach room temperature over 5-6 min. The reaction 
mixture was analysed by HPLC using the set-up mentioned earlier (Section 4.3.6.1). 
No A-acetylpiperidine was observed.
b) In a 2 ml reaction vial «-butyllithium 1.6M in hexane (540 pi; 0.86 mmol) was 
dissolved in dry THF-dry DME (1: 1 v/v; 300 pi). A measured activity of [n C]carbon 
monoxide was bubbled into the reaction vial for about 1 min at -  78°C. The 
radioactivity trapped in the reaction vial was then measured. The reaction mixture was 
analysed by radio-HPLC using the set-up mentioned earlier (Section 4.3.6.1). No 
radioactive product was observed, (Table 4.2, entry 1).
c) The above procedure (b) was repeated but iodomethane (268 pi; 4.3 mmol) was added 
to the reaction vial after entrapment of the [n C]carbon monoxide. The same 
measurements and analysis were performed as in (b), but no radioactive product was 
observed (Table 4.2, entry 2).
11 C-Carbonvlation ofpiperidine
A solution of w-butyllithium 1.6M in hexane (540 pi; 0.86 mmol) was added to a 2 ml 
reaction vial containing piperidine (85 pi; 0.86 mmol) dissolved in super-dry THF-dry 
DME (300 pi), and left to react for 5 min at -  78°C. [n C]Carbon monoxide was bubbled 
into the reaction vial for about 1 min. The reaction was left to absorb the [n C]carbon 
monoxide for 2  min before a specific amount of electrophile was added to the reaction vial. 
The reaction mixture was then left to reach room temperature over 5-6 min. The reaction 
mixture was analysed by radio-HPLC using the set-up mentioned earlier (Section 4.3.6.1). 
The radio-HPLC analysis revealed a radioactive product eluting at 7.2 min for water as
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electrophile and a radioactive product eluting at 7.6 min for iodomethane as electrophile (n 
= 3), (Table 4.2, entries 3 and 4).
Another approach was to use non-radioactive carbon monoxide in combination with 
[n C]iodomethane (Table 4.2, entry 5). Radio-HPLC analysis revealed radioactive 
compounds eluting at 3.2, 3.8, 4.5 and 4.8 min. Reference A-acetyl-piperidine eluted at
12.1 min. The conditions for each experiment and the efficiencies for [n C]carbon 
monoxide trapping are recorded in Table 4.2.
Table 4.2: Quantities of reactants and [n C]carbon monoxide trapping efficiencies for the 
reactions carried out with piperidine using procedure (B).
Entry Precursor 
pi (mmol)
BunLi 
pi (mmol)
Electrophile 
pi (mmol)
Molar
ratio3
nCO trapped 
(%)
1 None 540 (0.86) None 0 : 1 : 0 25.0
2 None 540 (0.86) Mel, 268 (4.3) 0: 1: 5 14.2b
3 85 (0.86) 540 (0.86) H20 , 100 (5.6) 1: 1: 6.5 9.0
4 85 (0.86) 540 (0.86) Mel, 268 (4.3) 1: 1: 5 12.8 (n = 3)c
5 85 (0.86) 540 (0.86) uCH3I 1 : 1 : trace None
a Refers to ratio of piperidine: rc-butyllithium: electrophile, b After quenching with iodomethane, a 
white precipitate was observed and the mixture trapped 26% of [HC]carbon monoxide. However, 
after dilution and filtration only 14.2% radioactivity was measured,c 9.3-16.3.
4.3.6.2 Attempted synthesis of [carbonyl- 1CJ-A-THIQ derivatives
Procedure (A) was applied with 1,2,3,4-tetrahydroisoquinoline as the amine precursor 
instead of piperidine. A solution volume of n-butyllithium 1.6M in hexane (Table 4.3) was 
diluted in super-dry THF (400-500 pi). In all cases the [n C]carbon monoxide trapping 
efficiency was between 6.0 and 8 .8 %. The reaction mixtures were analysed by radio- 
HPLC using a p-Bondapak™ C-18 column (7.8 x 300 mm) eluted with 0.05M potassium 
dihydrogen phosphate-acetonitrile (60: 40 v/v) at 3 ml/min with eluate monitored for
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absorbance at 254 nm. The reaction conditions and the [n C]carbon monoxide trapping 
efficiencies in the performed experiments are recorded in Table 4.3.
Table 4.3: Quantities of reactant and [n C]carbon monoxide trapping efficiencies for the 
reactions carried out with 1,2,3,4-tetrahydroisoquinoline.
Entry Precursor 
pi (pmol)
BunLi 
pl (pmol)
Electrophile 
pl (pmol)
Molar
ratioa
nCO trapped 
(%)
1 1.88 (15) 14.1 (22.5) H2 0, 4 (2200) 1: 1.5: 147 6 . 0
2 0.94 (7.5) 7.1 (11.3) Mel, 14 (220) 1: 1.5: 30 6 . 8
3 1.88 (15) 14.1 (22.5) Mel, 28 (450) 1: 1.5: 30 6 . 6
4 0.94 (7.5) 7.1 (11.3) c.Hex-Br, 28 (220) 1: 1.5: 30 6.5
5 1.88 (15) 14.1 (22.5) c.Hex-Br, 56 (450) 1: 1.5: 30 8 . 8
a Refers to ratio of piperidine: w-butyllithium: electrophile.
4.3.6.3 Attempted synthesis of [carbonyl-n C]WAY-100634 derivatives
Essentially, procedure (A) was used with WAY-100634. The ultimate intention was to 
prepare WAY 100635 by n C-acylation of WAY-100634. The required amount of the 
prepared, «-butyllithium 1.6 M in hexane (10 pi) in dry THF (1 ml) was added to the 
reaction vial (2 ml) containing WAY-100634 (1-2 mg; 3.2-6.4 pmol) dissolved in super­
dry THF (300 pi) and the mixture was left to react for 5 min at -  78°C. [n C]Carbon 
monoxide was bubbled into the reaction vial for about 1 min, and the reaction mixture was 
left to react for 2  min at -  78°C. A specific amount of the electrophile solution ( 1 0  pi 
electrophile in 1 ml dry THF) was then added to the reaction vial. The reaction mixture 
was then left to reach room temperature over 5-6 min. The reaction products were 
analysed by radio-HPLC using a Phenomenex Bondclone C-18 column (150 x 3.90 mm, 
10 micron) eluted with 0.02M potassium dihydrogen phosphate-acetonitrile (60: 40 v/v) at 
1.4 ml/min with eluate monitored for absorbance at 254 nm. Only one radioactive product 
was observed eluting at 1 .8 - 2  min irrespective of the added electrophile. All the details of 
the performed experiments are summarised in the following table.
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Table 4.4: The [n C]carbon monoxide trapping efficiencies for the reactions carried out 
with WAY-100634 (1-2 mg; 3.2-6.4 pmol) with different quenching 
electrophiles.
Entry 1.6M Bu”Li
pl(pmol)
Electrophile 
pl (pmol)
Molar ratio" uCO trapped 
(%)
1 5 (0.008) c.Hex-Br, 5 (40) 1: 2.5 x 10'3: 12 1.79
2 1 0  (0 .0 2 ) c.Hex-Br, 8.4 (70) 1: 6.3 x 10'3: 22 19.3
3 16 (0.03) c.Hex-Br, 20 (160) 1: 9.4 x 10'3: 50 28.5
4 6.4 (0.01) c.Hex-Br, 42 (330) 1: 1.5 x 10'3: 50 6.4 (« = 3)b
5 6.4 (0.01) PhBr, 36 (340) 1: 1.5 x 10'3: 50 7.44
6 6.4 (0.01) PhBr, 18.8 (180) 1: 1.5 x 10'3: 28 5.72
a Refers to ratio of WAY-100634: «-butyllithium: electrophile, b 3.0-9.8.
4.3.7 Syntheses of [n C]Ketones
4.3.7.1 Blank non-radioactive reaction
The reaction was performed by stirring iodobenzene (2.46 pmol), dissolved in DME-H 2O 
(4: 1 v/v; 0.4 ml), with phenyltributylstannane (5.6 pmol). The reaction was carried out at 
room temperature. The reaction mixture was sampled at 5, 10, 15, 20, 25 and 30 min for 
HPLC analysis on a Waters p-Bondapak™ C-18 column (7.8 x 300 mm; o.d.) and eluted 
with acetonitrile-water-triethylamine (60: 40: 0.25 by vol.) at 3 ml/min with eluate 
monitored at 254 nm. The HPLC showed that no benzophenone was produced.
4.3.7.2 By coupling iodobenzene with phenyltributylstannane
4.3.7.2.1 Blank radioactive reactions
The importance of each reactant to the formation of products was examined in a series of 
blank reactions, as follows.
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a) In a 2 ml reaction vial, iodobenzene (2.46 pmol) was dissolved in DME-H20  (4: 1 v/v,
0.4 ml). A known quantity of radioactive [n C]carbon monoxide was passed into the 
solution for 1 min. The reaction was left to stir at room temperature for 1 min. The 
radioactivity trapped in the reaction vial was measured. The reaction mixture was then 
analysed by radio-HPLC using the set-up described in Section 4.3.7 (Table 4.5, entry 
1). [car/?o«y,/ - 11C]Benzaldehyde was the only radioactive product observed under 
these conditions.
b) The procedure in (a) was repeated in the presence of mediated palladium(II) chloride 
(1%) as catalyst (Table 4.5, entry 2). [car/>o«y/-n C]Benzoic acid was the major 
radioactive product produced under these conditions.
c) The behaviour of the tin compound (phenyltributylstannane) with and without the 
catalyst was examined. Phenyltributylstannane was dissolved in DME-H20  (4: 1 v/v,
0.4 ml) and then a known amount of [n C]carbon monoxide was passed through the 
solution as previously described. The reaction was allowed to take place for 1 min at 
room temperature. The radioactivity trapped in the reaction vial was measured and the 
mixture was then analysed by radio-HPLC as described in Section 4.3.7. This revealed 
the formation of mainly [car/>o«y/-n C]benzaldehyde and a closely eluting radioactive 
compound (unknown) which appeared as a shoulder in the chromatogram (Table 4.5, 
entry 3).
The reaction with the phenyltributylstannane was repeated in the presence of 
mediated palladium(II) chloride (0.5%) as a catalyst. [car/>o«y/-n C]Benzophenone was 
produced in addition to the [carZ>o«y/-n C]benzaldehyde and [carbonyl-11 C\oQnzo\c, acid 
by-products (Table 4.5, entry 4).
d) The reaction in (a) was repeated but in the presence of phenyltributylstannane (2.46 
pmol). The dominant radioactive product was found to be [car/>o^y/-n C]benzaldehyde 
(Table 4.5, entry 5).
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4.3.7.2.2 Synthesis of [carbonyl-nC]benzophenone
The carbonylation reaction was performed using the reaction conditions in Section 
4.3.7.2.1, part (c), in the presence of mediated palladium(II) chloride (1%) catalyst. The 
main radioactive product from this reaction was [car£o72y/-n C]benzophenone. \carbonyl- 
n C]Benzaldehyde was detected as a by-product, (Table 4.5, entry 6 ). The reaction was 
repeated for a longer reaction time ( 2 0  min), with improvement in the (decay-corrected) 
radiochemical yield (Table 4.5, entry 7). The [n C]carbon monoxide trapping efficiency 
was, from a single pass, between 4.5 and 6.2% at room temperature.
Table 4.5: Product radiochemical yields from the [n C]carbonylation of iodobenzene under 
various conditions.
Entry Reactant ratioa Radiochemical yield (%)b 
PhnCOPh PhnCHO PhnC 02H
Fig. No.
1 1 : 0 : 0 0 1 0 0 0 </29; A
2 1 : 0 : ( 1 %) 0 6.90 93.1 ty.29; B
3 0 : 1 : 0 0 >75 0 ^30; A
4 0: 1: (0.5%) 40 55 <5 V-30; B
5 1 : 1 : 0 0 >98 trace ^.29; A
6 1 : 1 : ( 1 %) 82 18 0 */.29; C
T 1: 1.03: (1%) >98 0 0 V.29; D
a Refers to ratio of iodobenzene: phenyltributylstannane: PdCl2. 
b Radiochemical yield (decay-corrected) from trapped [nC]carbon monoxide. 
c Reaction time was 20 min at room temperature, iodobenzene (9.83 pmol), phenyltributylstannane 
(10.1 pmol) and PdCl2 (1.15%) were used.
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Iodobenzene
[carbonyl— C]Benzophenone
[carbonyl— C]Benzophenone
[carbonyl— CjBenzaldehyde
[carbon yl-  CJBenzoic acid
[carbonyl— C]Benzaldehyde
[ carbonyl — C ]B enzaldehyde
Time (mm)
Fig. 4.29: HPLC profile produced from the iodobenzene reaction with [' 'Cjcarbon 
monoxide; (A) alone or with tin compound; (B) with PdCl2 (1%); (C) with tin and PdCl2,
for 1 min ; (D) same as (C) but for 20 min.
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Benz aldehyde
[carbon yl-  CjBenzaldehyde.
[carbonyl— CjBenzoic acid [carbonyl
(A)
I 1- - - - - - - - - - - - - - 1- - - - - - - - - - - - - - 1 I i  I  I I 1- - - - - - - - - - - - - - 1- - - - - - - - - - - - - - 1- - - - - - - - - - - - - - 1- - - - - - - - - - - - - - 1- - - - - - - - - - - - - - 1- - - - - - - - - - - - - - 1
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Time (min)
Fig. 4.30: HPLC profile produced from the phenyltributylstannane reaction with 
[n C]carbon monoxide; (A) with PdCl2 (0.5%); (B) alone.
Benzophenone
[carbonyl— CjBenzaldehyde
- 1 CjBenzophenone
4.3.7.2.3 Synthesis of substituted [carft0 /fy/-nC]benzophenones from substituted 
aryl iodides
Several substituted [n C]benzophenones were synthesised by palladium(II)-mediated 
catalysed coupling reactions. Each reaction was performed by stirring the substituted 
iodobenzene with one molar equivalent of phenyltributylstannane in DME-H20  (4: 1 v/v;
0.4 ml) in the presence of mediated palladium(II) chloride (1%) at room temperature. 
[nC]Carbon monoxide was passed through the mixture. The reaction was left to react for 
1 min at room temperature. The mixture was then analysed by radio-HPLC as described 
earlier in (Section 4.3.7). The results are recorded in Table 4.6. The radioactive products 
were identified through comparison of their retention times with reference compounds 
[Figs. 4.33, 34, 35 and 36; (no. A)].
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Table 4.6: Radiochemical yields of [n C]ketones from the reaction of iodobenzene 
derivatives with phenyltributylstannane in the presence of mediated 
palladium(II) chloride (for 1 min at room temperature).
Entry Iodobenzene derivative 
(Arl)
Radiochemical yield (%)a 
ArnCOPh PhnCOPh PhnCHO
Fig. No.
1 2-M eC6H4l 61 <5 34 *#33 (A)
2 3-M eC6H4l 69 <5 26 y.34 (A)
3 4-F -C 6H4l 78 <5 17 y.35 (A)
4 4-CF3C6H4l 58 <5 37 V-36 (A)
a Radiochemical yield (decay-corrected) from trapped [HC]carbon monoxide.
4.3.7.3 By coupling diaryliodonium salts with organostannanes
4.3.7.3.1 Blank non-radioactive reaction
The same non-radioactive reactions performed with iodobenzene were repeated with 
diphenyliodonium bromide (as a representative example of the salt series) in order to 
ensure that there is no possibility of reaction between the iodonium salt and the tin 
compound in the absence of the mediated palladium(II) chloride. The reaction was 
performed by stirring a solution of diphenyliodonium bromide ( 1  mg, 2.80 pmol) dissolved 
in DME-water (4: 1 v/v, 0.4 ml) and phenyltributylstannane (5.6 pmol). The reaction 
mixture was sampled after 5, 10, 15, 20, 25 and 30 min for HPLC analysis using the same 
set-up as in (Section 4.3.7). No reaction was detected as no benzophenone was obtained.
4.3.7.3.2 Synthesis of [carbonyl-n C |benzophenone
The synthesis of [carZ>cwy/-n C]benzophenone was the starting point for a series of 
investigations including some radioactive blank reactions (Table 4.7). The reactions were 
performed at room temperature for 1 min after passing nitrogen-[n C]carbon monoxide at 
atmospheric pressure. The experiments were performed in order to examine the reaction
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conditions and factors affecting radiochemical yields, as well as monitoring the efficiency 
of [n C]carbon monoxide trapping. The procedure was the same as with iodobenzene, 
except that the latter was replaced by an iodonium salt. Reaction mixtures were analysed 
by radio-HPLC as before. The detected radioactive products were the same as those 
obtained from the iodobenzene blank reactions and the yields were also very similar (Fig. 
4.30 A and B). The [u C]carbon monoxide trapping efficiency was in the range 5.3-7.4%.
Table 4.7: Radiochemical yields of products generated from a series of radioactive blank 
reactions with diphenyliodonium salt.
Entry Reactant ratioa Radiochemical yield (%)b
PhnCOPh PhnCHO PhnC 02H
1 1 : 0 : 0 0 >98 0
2 1 : 0 : ( 1 %) 0 trace >95
3 1 : 2 : 0 0 >98 0
a Refers to ratio of diphenyliodonium bromide: phenyltributylstannane: PdCl2.
b 11Radiochemical yield (decay-corrected) from trapped [ C]carbon monoxide.
The effects of the anion (X-) in the diphenyliodonium salt (PhI+PhX“) on the radiochemical 
yield of the reaction products and on [n C]carbon monoxide trapping were examined by 
running several experiments using diphenyliodonium salts with different anions. The
reactions were run in a 1 : 2  molar ratio between diphenyliodonium salt:
phenyltributylstannane in the presence of mediated palladium(II) chloride (1%). The
reactions were carried out at room temperature for 1 min after passing nitrogen- 
i [u C]carbon monoxide at atmospheric pressure. The results are summarised in Table 4.8 
and Fig. 4.31.
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Table 4.8: The effect of varying the anion of the diphenyliodonium salt on the 
radiochemical yield of the [carZ>o«y/-nC]benzophenone produced.
Entry X Radiochemical yield (%)a 
PhnCOPh PhnCHO PhnC 02H
Trapping1*
(%)
Fig. No.
1 r 75.0 4.6 20.4 5.9 (n = 5) ¥31 (A)
2 Tos- 90.2 9.0 0.8 5.9 ¥.31 (B)
3 NOs" >92.0 <4.0 <4.0 5.7 ¥.31 (C)
4 Br~ >96.0 <4.0 00 6.2 in = 3) ¥.31 (D)
a Decay-corrected yields from trapped [nC]carbon monoxide. 
b [HC] Carbon monoxide trapping efficiency.
The effect of reaction time on the radiochemical yield of [carZ>o«y/-n C]benzophenone was 
investigated. The reactants, diphenyliodonium iodide salt and phenyltributylstannane, were 
in a 1: 2 molar ratio and mediated palladium(II) chloride (1%) was used. The reactions 
were carried out at room temperature for a specific time after passing nitrogen- 
[n C]carbon monoxide at atmospheric pressure (Table 4.9).
Table 4.9: Radiochemical yields (decay-corrected) of [car^o«y/-n C]benzophenone as a 
function of time at room temperature.
Entry Time Radiochemical yield (%)a
(min) PhnCOPh PhnCHO PhnC 0 2H
II Ln a* 1 65 7.75 22.95
2 5 75 0 25
3 10 80 0 20
4 20 80 0 20
a Radiochemical yield (decay-corrected) from trapped [HC]carbon monoxide. 
b 55-75, 4.6-10.9 and 20.4-25.5 for PhnCOPh, PhuCHO and PhnC02H respectively.
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CN)
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Time (min)
Fig. 4.31: HPLC profile produced from the reaction of the diphenyliodonium salt 
containing different anions; (A) I"; (B) Tos ; (C) N 0 3~ and (D) Br~.
Another factor affecting the palladium-catalyzed cross-coupling of diphenyliodonium 
iodide salt with phenyltributylstannane and [u C]carbon monoxide was examined, namely 
the effect of the proportion of phenyltributylstannane on the radiochemical yield o f the 
[car&owy/^CJbenzophenone. The reactions were performed at room temperature for 20 
min after passing nitrogen-[nC]carbon monoxide at atmospheric pressure in the presence
[carbonyl
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of mediated palladium(II) chloride (1%). The results are summarised in Table 4.10 and 
Fig. 4.32.
Table 4.10: The effect of the amount of phenyltributylstannane on the radiochemical yield 
of the [carbonyl-11 C] benzophenone.
Entry Ratio3 Radiochemical yield (%)b
PhnCOPh PhnC 0 2H
1 1 : 2 80 2 0
2 1: 1.5 64 36
3 1 : 1 55 (72)c 45 (28)c
4(n = 3 )d 1: 0.5 43 57
5 1 : 0 0 1 0 0
a Refer to ratio of iodonium iodide: phenyltributylstannane. 
b Decay-corrected yields from trapping [HC]carbon monoxide.
c The numbers in brackets for the same reactions are for the presence of 2% PdCl2 instead of 1%. 
d 33-53 and 47-67 for PhnCOPh and PhnC02H respectively.
100
80 -
60 -
40 -
20 -
0.5 2.5
Stannane: salt (ratio)
Fig. 4.32: The radiochemical yield of [car^ow^/-u C]benzophenone (■) and [carbonyl- 
n C]benzoic acid (a ) against the ratio of phenyltributylstannane to iodonium salt.
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4.3.7.3.3 Synthesis of substituted [carbonyl-11 C jbenzophenones
Several substituted [carZ>0 «y/-n C]benzophenones were synthesised from substituted
diaryliodonium salts in two ways:
a) Using different diaryliodonium salts with tosylate anions, prepared in house with 
phenyltributylstannane in the presence of mediated palladium(II) chloride (1%). The 
molar ratio of the salt to phenyltributylstannane was 1: 2 in all cases. The reactions 
were carried out at room temperature for 1 min after passing nitrogen-[n C]carbon 
monoxide at atmospheric pressure. The average efficiency of [n C]carbon monoxide 
trapping was ~ 6 % at room temperature.
Table 4.11: Radiochemical yields of [n C]ketones from the reaction of diaryliodonium 
salts (ArI+PhTos“) with phenyltributylstannane in the presence of mediated 
palladium(II) chloride.
Entry Ar Radiochemical yield (%)a 
PhnCOPh ArnCOPh Others'5
Trapping0
(%)
Fig. No.
1 Ph 90.2 0 9.8 6.2 ¥.31 (B)
2 2-Me-C6H4 48.1 41.6 10.3 6.1 y.33 (B)
3 3-M e-C6H4 47.2 42.8 10.0 6.1 p 4  (B)
4 4-CF3-C 6H4 66.0 29.9 4.1 5.2 4.36 (B)
5 2-OMe-C6H4 62.2 36.8 < 1 5.5 p i  (A)
6 3-OMe-C6H4 d d <5 6.2 4.38
T 4-F,3-M e-C6H3 51.4 36.5 12.1 6.5 y . 3 9
a Radiochemical yield (decay-corrected) from trapped [nC]carbon monoxide. 
b [carbonyl-11C] Benzoic acid and ’Cjbenzaldehyde.
c [UC]Carbon monoxide trapping efficiency.
d [carZ>o^/-n C]3-Methoxy-benzophenone and [carZ>o«y/-n C]benzophenone elute closely 
at 8.7 and 8.4 min, respectively; this made it difficult to calculate the radiochemical yields. 
e No reference compound was available.
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b) Using different organostannanes and diphenyliodonium bromide. The same reactant 
molar ratio as in (a) was used. The reactions were carried out at room temperature for 
1 min after passing nitrogen-[n C]carbon monoxide at atmospheric pressure. Higher 
radiochemical yields of the [carZ>o«y/-u C]benzophenone derivatives (Table 4.12) were 
obtained compared to experiments (a). The trapping efficiency for [n C]carbon 
monoxide, from one pass, was between 4.7 and 6 .8 % at room temperature.
Table 4.12: Radiochemical yields of [u C]ketones from the reactions of diphenyliodonium 
bromide with different aryltributylstannanes (Bu3 SnAr) in the presence of 
mediated palladium(II) chloride at room temperature for 1 min.
Entry ArSnBu3 Radiochemical yield of 
ArnCOPh (%)a
Fig. No.
1 Ph > 96b V.31 (D)
2 2 -M e-C 6H4 44c 4.33 (C)
3 3 -M e-C 6H4 >98 4.34 (C)
4 2 -OM e-C 6H4 >98 4.37 (B)
5 4-CF3-C 6H4 >98 4.36 (C)
6 3,5-diF-C6H3 >98 V40
7 4-F-C 6H4 >98 4 3 5  (B)
a Radiochemical yield (decay-corrected) from trapped [nC]carbon monoxide.
b 11[icarbonyl-  C]Benzaldehyde was the by-product in < 4% radiochemical yield (decay-corrected). 
c The by-products were [carbonyl-1 C^oqwzoic acid, [carZ?o«y/-HC]benzaldehyde and unknown 
products (retention time 2.2, 5.7 and 21.7 min), in 36.3, 5.4 and 14.1% radiochemical yields 
(decay-corrected), respectively.
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IoaiO
<3
[carbonyl- C]Benzaldehyde
7 8
Time (min)
Unknown 
(at 21.7 min)
[carbonyl- ^jBenzophenone
Fig. 4.33: HPLC profile for the synthesis o f [c«rZ>o«>?/ - 11C]2-methyl-benzophenone
from (A) 2-iodotoluene, (B) 2-methylphenyl(phenyl)iodonium tosylate and (C) 2-m ethyl-
(tributylstannyl)benzene.
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[carbonyl- CjBenzophenone
[carbonyl- CjBenzoic acid
[carbonyl- C]Benzaldehyde
7 8
Time (mm)
Fig. 4.34: HPLC profile for the synthesis of [car^w ?y-u C]3-methyl-benzophenone 
from (A) 3-iodotoluene, (B) 3-methylphenyl(phenyl)iodonium tosylate and (C) 3-methyl-
(tributyl st annyl)benzene.
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[ carbonyl -  C ] 4-Fluoro-benzophenone
[carbonyl- CjBenzophenone
[carbonyl- CjBenzaldehyde
Time (mm)
Fig. 4.35: HPLC profile for the synthesis of [car£o«>'/-11C]4-fluoro-benzophenone from 
(A) l-fiuoro-4-iodobenzene and (B) 4-fhioro-(tributylstannyl)benzene.
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[carbonyl- CjBenzaldehyde
i  1 r
8 9 10
Time (min)
[carbonyl- CjBenzophenone
[carbonyl -  C ] 4-T n f luoro-benzophenon ?
(C)
(B)
Fig. 4.36: HPLC profile for the synthesis of [carbonyl- 1C]4-trifluoro-benzophenone 
from (A) 4-iodobenzenetrifluoroide, (B) 4-trifluoromethylphenyl(phenyl)iodonium 
tosylate and (C) 4-trifhioro-(tributylstannyl)benzene.
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Fig. 4.37: HPLC profile for the synthesis of [car^ohrp/-u C]2-methoxy-benzophenone 
from (A) 2-methoxyphenyl(phenyl)iodonium tosylate and (B) 2-methoxy-
(tributylstannyl)benzene.
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Fig. 4.38: HPLC profile for the synthesis of [car^o«y/-n C]3-methoxy-benzophenone 
from 3-methoxyphenyl(phenyl)iodonium tosylate.
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------ ,-------j-------1-------1-------1-------1-------,-------1-------1-------1-------1-------1-------1-------1
1 2 3 4  5 6 7  8 9 10 11 12 13 14
Time (min)
Fig. 4.39: HPLC profile for the synthesis of [car^o«^/-n C]4-fluoro-3-m ethyl- 
benzophenone from 4-fluoro-3-methylphenyl(phenyl)iodonium tosylate.
3,5—Difluorobenzophenone |
,  11[ carbonyl -  C ] 3 > 5-Difluoro-benzophenone
H  1--------1-------- 1-------- 1-------- 1-------- 1-------- 1-------- 1
7 8 9 10 11 12 13 14 15
Time (min)
Fig. 4.40: HPLC profile for the synthesis of [carZ)OA/y/-u C]3,5-difluoro-benzophenone 
from 3,5-difluoro-(tributylstannyl)benzene.
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Finally, the importance of the sequence of addition of the reagents to the reaction 
vial was examined using the palladium(II)-mediated catalysed [n C]carbonylative reaction 
of diphenyliodonium iodide and 4-trifluorophenyltributylstannane with [n C]carbon 
monoxide as a model reaction. 4-Trifluorophenyltributylstannane was added in two 
different ways to the reaction. In the first method it was added as a quenching solution 
after bubbling the [n C]carbon monoxide into the reaction vial (Table 4.13, entry 1). In the 
second method the tin compound was added together with the iodonium salt into the 
reaction vial and then [n C]carbon monoxide was bubbled through the reaction mixture. 
The reactions were carried out at 80°C for 5 min (Table 4.13, entry 2).
Table 4.13: Radiochemical yield of [carZ>o^y/-u C]4-trifluoro-benzophenone obtained 
form coupling 4-trifluorophenyltributylstannane with diphenyliodonium 
iodide and [n C]carbon monoxide in two different ways.
Entry P hfP hr F3C-C6H4SnBii3 Ratio51 RBA RDP
mg (fimol) pmol (%) (%)
1 1 (2.45) 2.45 1:1:  (2.2) 92.6 7.4
2b 2.4 (5.9) 2.45 1 : 0.4: (1%) 7.5 65
Refer to ratio of diphenyliodonium iodide: 4-trifluorophenyltributylstannane: mediated
palladium(II) chloride.
b 11[carbonyl- C]Benzophenone was obtained in 27.5% radiochemical yield. 
RBA = [carbonyl-11 C]bQnzoic acid.
RDP = [carb onyl-11C] 4-trifluoro-benzophenone.
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4.4 Conclusions
4.4.1 Attempted [uC]Amide Preparations
1. [n C]Carbon monoxide trapping efficiency was 10-20% at -78°C and was in good 
agreement with that in the report of Kilbourn et a l21.
2. The supposed n C-carbonylation of nitrogen-lithium bonds was found to be rapid at 
-  78°C, under ambient pressure, but the acyl and carbamoyl lithiums formed are 
highly reactive and unstable23.
3. The same radioactive product(s) were observed in all cases for each of the tested 
secondary amines, even when different electrophiles were used.
4. Under the conditions of Kilbourn et al.y no desired [n C]amide was obtained by 
performing the reaction with carbon monoxide and [n C]iodomethane.
5. In this work n C-carbonylation of nitrogen-lithium bonds, as developed by Kilbourn 
et al.21 proved to be irreproducible. It is relevant to note that after 15 years there is 
not a single publication in which the approach of Kilbourn et a l21 has been applied 
successfully.
6. The overall findings are consistent with the difficulties reported by Lindsay23.
4.4.2 [nC]Ketone Preparations
Common features between aryl iodide and diaryliodonium salt 11 C-carbonvlation
reactions
1. [n C]Carbon monoxide trapping efficiency was 4.5-7.5% from a single pass at room
temperature.
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2. The presented palladium(II)-mediated carbonylation methodology has the following 
advantages: (i) the reagents are stable and are required in very small amounts, (ii) 
high specific radioactivities can be expected, since the isotopic dilution of the 
[n C]carbon monoxide with stable carbon monoxide from the atmosphere is small 
and (iii) it is a single pot reaction. In addition no special handling precautions are 
needed.
From aryl iodides
1. A faster and milder synthesis of [n C]ketones was developed by changing the 
previously reported10,11 reaction conditions in particular the solvent.
2. Higher radiochemical yields were also obtained (> 95%) compared to 69% reported 
by Lidstrom et al.10 and 85% by Andersson26,27.
From diaryliodonium salts
1. The results obtained from the coupling of diaryliodonium salts with organostannanes 
compare well with the similar preparation of [u C]ketones via carbonylative coupling
i  a  1 1 7 /C  7 7
reactions of aryl iodides ’ ’ ’ and reaffirm the efficiency that can be achieved for 
[n C]ketones synthesis by palladium(II)-mediated catalysed [n C]carbonylation 
reactions.
2. The present approach is versatile with respect to functionality for both the 
diaryliodonium salt or the partner aryltributylstannane and proceeds very rapidly 
under very mild conditions in a single reaction pot.
3. These reactions can be varied in numerous ways, and give new possibilities for n C- 
labelling.
4. The method is a useful alternative to the use of [n C]carboxylate salts, prepared by 
reacting [n C]carbon dioxide with a Grignard reagent, for the preparation of 
[n C]ketones.
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